SUMMARY
Clonorchis sinensis, Opisthorchis viverrini, and Opisthorchis felineus are important liver flukes that cause a considerable public health burden in eastern Asia, southeastern Asia, and eastern Europe, respectively. The life cycles are complex, involving humans, animal reservoirs, and two kinds of intermediate hosts. An interplay of biological, cultural, ecological, economic, and social factors drives transmission. Chronic infections are associated with liver and biliary complications, most importantly cholangiocarcinoma. With regard to diagnosis, stool microscopy is widely used in epidemiologic surveys and for individual diagnosis. Immunologic techniques are employed for screening purposes, and molecular techniques facilitate species differentiation in reference laboratories. The mainstay of control is preventive chemotherapy with praziquantel, usually combined with behavioral change through information, education and communication, and environmental control. Tribendimidine, a drug registered in the People’s Republic of China for soil-transmitted helminth infections, shows potential against both C. sinensis and O. viverrini and, hence, warrants further clinical development. Novel control approaches include fish vaccine and biological control. Considerable advances have been made using multi-omics which may trigger the development of new interventions. Pressing research needs include mapping the current distribution, disentangling the transmission, accurately estimating the disease burden, and developing new diagnostic and treatment tools, which would aid to optimize control and elimination measures.
KEYWORDS: clonorchiasis, Clonorchis sinensis, opisthorchiasis, Opisthorchis felineus, Opisthorchis viverrini
INTRODUCTION
In the Opisthorchiidae family, the three liver flukes, Clonorchis sinensis, Opisthorchis viverrini, and Opisthorchis felineus, are of considerable public health relevance since they cause high infection rates and severe morbidity and mortality (1, 2). C. sinensis was first found in 1874 in a male Chinese in Calcutta, India, by J. F. P. McConnell (3). O. felineus was documented for the first time in 1884 by S. Rivolta in a cat and, 8 years later, by K. Winogradoff in humans in Tomsk, Russia (4). O. viverrini was first described in a civet cat by M. J. Poirier in 1886, followed by documented human infections in Chiang Mai, Thailand, by R. T. Leiper in 1915 (5). However, an infection with these liver flukes likely dates back much longer, as evidenced by eggs detected in ancient excavated corpses and the environment in eastern Asia and Russia (6–10). Indeed, C. sinensis eggs were detected in ancient corpse buried over 2,000 years ago in the People’s Republic of China (8).
The three liver fluke species have complex life cycles with definite hosts (i.e., humans and some animal reservoir hosts) and two kinds of intermediate hosts (i.e., freshwater snails and freshwater fish), characterized by an alternation of sexual and asexual reproduction in the different hosts (11–13) (Fig. 1). Hermaphroditic adult worms parasitize in bile ducts. The life span can exceed 10 years, exemplified by a documented case of C. sinensis of 26 years (14). Eggs with miracidia are discharged in human feces and are ingested by freshwater snails where they hatch. Then, sporocysts, rediae, and cercariae are produced through asexual reproduction. In C. sinensis, cercariae are released after approximately 3 months (15), while it takes 6–8 weeks in O. viverrini (16). Cercariae attach to freshwater fish, encyst in the subcutaneous tissues or muscles, and develop into mature metacercariae after approximately 6 weeks. Infective metacercariae enter human bodies when raw or undercooked freshwater fish are consumed, with excysted larvae from metacercariae entering bile ducts and developing into adult worms. Approximately 4 weeks later, eggs are produced. In humans, an adult liver fluke usually lays around 3,000–4,000 eggs per day (17, 18).
Fig 1.
(A) Life cycle of liver flukes. [Adapted from reference (13) with permission from Elsevier; the illustrations of adult C. sinensis, O. viverrini, and O. felineus were redrawn from illustrations in reference (11) with permission from Elsevier.] (B) Adult worm of C. sinensis (recovered from mice) (courtesy of Liu Liu and Hao Zhang, Qiqihar Medical University; used with permission). (C) Adult worm of O. viverrini (recovered from hamster) [reproduced from reference (20) with permission from Elsevier]. (D) Egg of C. sinensis (expelled from adult worms recovered from rat) [courtesy of Ting-Jun Zhu, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research); used with permission]. (E) Cercaria of O. viverrini (shed from Bithynia siamensis siamensis) [reproduced from reference (21), which is published under a CC BY 4.0 license]. (F) Metacercaria of C. sinensis (digested from Pseudorasbora parva) (courtesy of Ting-Jun Zhu, used with permission).
Adult liver flukes show similar morphology among the three species, characterized by flattened and lance shape (11, 19) (Table 1). The differences in position of the testes and the arrangement of vitelline glands aid species differentiation (11, 20). C. sinensis has branched testes, while both Opisthorchis species have lobed testes (11, 20). Additionally, C. sinensis has continuously distributed vitelline glands, while Opisthorchis have clustered vitelline glands. The main morphologic differences between the two Opisthorchis species are the presence of deeper lobulation and a greater extremity of the testes and no transversely compressed patterns of vitelline follicles in O. viverrini. Eggs of liver flukes present oval sharp, with a convex operculum resting on the “shoulders” at the smaller end of the egg and a small knob at the opposite end (19). The mature cercaria, consisted of a body and tail, looks like a bent tobacco pipe, concaving on the ventral side and bent outward on the dorsal side (21). The metacercaria is embedded in a double-walled cyst, which usually presents oval shape (11, 20).
TABLE 1.
Sizes of human liver flukes in different stages
| Stage | Clonorchis sinensis | Opisthorchis viverrini | Opisthorchis felineus |
|---|---|---|---|
| Adult (19) | 10–25 mm × 3–5 mm | 5–10 mm × 1–2 mm | 7–12 mm × 2–3 mm |
| Egg (19) | 27–35 µm × 11–20 µm | 19–30 µm × 10–20 µm | |
| Cercaria (11) | Body: 154 µm × 75 µm; tail: 392 µm × 26 µm | ||
| Metacercaria (11) | 140 µm × 113 µm | 201 µm × 167 µm | 252–320 µm × 165–225 µm |
In the recently published roadmap for neglected tropical diseases (2021–2030), put forth by the World Health Organization (WHO), an intensified control was proposed for hyperendemic areas of foodborne trematode infections. Three key areas are highlighted in the roadmap, namely, (i) a better scientific understanding, (ii) improved diagnostics, and (iii) effective interventions (2). To fully capture progress on these aspects, this review comprehensively summarizes the knowledge on clonorchiasis and opisthorchiasis with a focus on epidemiology, transmission, clinical features and morbidity, diagnosis, treatment, and control. Finally, we put forward a series of unresolved questions and discuss research needs in these six areas for improved management, control, and even elimination of these human diseases.
EPIDEMIOLOGY
Human liver fluke infections are endemic in Eurasia, with at least 680 million people at risk of infection according to estimates published in 2005 (22). C. sinensis is endemic in eastern Asia, O. viverrini in southeastern Asia, and O. felineus in eastern Europe (Fig. 2). In 1995, WHO provided the first estimates of the population infected with the three liver flukes: 17.34 million (7.01 million of C. sinensis infection, 8.74 million O. viverrini infection, and 1.58 million O. felineus infection) (23). It is estimated that 27.21 million people are infected with one of these species nowadays (Table 2) (23–26).
Fig 2.
Endemic status of clonorchiasis and opisthorchiasis.
TABLE 2.
Global distribution of clonorchiasis and opisthorchiasis
| Estimated population infected | Hot spots | |
|---|---|---|
| Clonorchis sinensis | ||
| People’s Republic of China | 10.82 million (24) | Southeastern region along the Pearl River covering Guangdong and Guangxi provinces, northeastern region along the Songhuajiang River covering Heilongjiang and Jilin |
| South Korea | 1.42 million (25) | Southern part along the major rivers including Nakdong, Seomjin, Geum, and Yeongsan |
| Vietnam | 1.00 million (23) | Northern areas, especially in Nam Dinh and Ninh Binh provinces |
| Russia | 3,000 (23) | Part of far east area |
| Subtotal | 13.24 million | |
| Opisthorchis viverrini | ||
| Thailand | 6.71 million (26) | Northeastern areas, especially in Buengkarn, Sakon Nakhon, Kalasin, Roi Et, and Nakhon Phanom provinces |
| Lao People’s Democratic Republic | 2.45 million (26) | Southern areas, especially in Savannakhet, Khammouane, Champasak, and Saravane provinces |
| Cambodia | 1.00 million (26) | Southern areas, especially in Kampong Thom and Kampong Cham provinces |
| Vietnam | 2.07 million (26) | 10 adjacent provinces in central and southern Vietnam |
| Myanmar | Not available | Cases detected locally in Lower Myanmar |
| Subtotal | 12.39 million (26)a | |
| Opisthorchis felineus | ||
| Russia | 1.22 million (23) | Western Siberia in the Ob River basin, including Khanty-Mansiysk Autonomous Okrug, Yamalo-Nenets Autonomous Okrug, Tyumen Oblast, Tomsk Oblast, Omsk Oblast, and Novosibirsk Oblast |
| Ukraine | 0.31 million (23) | Sumy and Poltava regions distributing in Dnieper River basin |
| Kazakhstan | 0.05 million (23) | North and northeast areas drained by the Irtysh River and tributaries, especially in Pavlodar province |
| Byelorussia | Not available | Brest, Gomel, and Grodno provinces |
| Italy | Not available | Several outbreaks due to fish from two lakes Bolsena and Bracciano in central Italy |
| Subtotal | 1.58 million (23) | |
| Total | 27.21 million |
This number is not equal to the sum of data in Thailand, Lao People’s Democratic Republic, Cambodia, and Vietnam because Bayesian spatial-temporal joint models were applied in this study (26).
Clonorchis sinensis
C. sinensis is endemic in the People’s Republic of China, South Korea, northern Vietnam, and the far east of Russia, with an estimated 13.24 million people infected (Table 2) (23–25). The People’s Republic of China harbors the largest number of C. sinensis cases, with an estimated 10.82 million cases, due to a prevalence of 0.84% in 2015 based on data from a national survey and routine surveillance (24). The largest endemic areas in the People’s Republic of China are located in the southeastern parts along the Pearl River covering Guangdong and Guangxi provinces (27, 28). Heilongjiang and Jilin in the northeastern part of the country form another important endemic region, while high prevalence has been reported along the Songhuajiang River (29, 30). Historically, C. sinensis was also endemic in the central part of the People’s Republic of China, including the provinces of Anhui, Henan, and Shandong, where cases are only occasionally reported nowadays (31, 32).
An estimated 1.42 million people were infected with C. sinensis in South Korea in 2020, based on a prevalence of 2.77% captured from a spatial statistical analysis (25). High prevalence has been recorded in the southern parts along the major rivers, including Nakdong, Seomjin, Geum, and Yeongsan (33). C. sinensis is endemic in over 20 provinces in northern Vietnam, and high prevalence (>20%) has been reported in the provinces of Nam Dinh and Ninh Binh (34, 35). Approximately 1 million people are affected by C. sinensis there, but a clear picture on the epidemiology remains elusive, as national surveys have yet to be conducted (23). In addition, several thousand cases with C. sinensis are likely to occur in the far eastern part of Russia (36).
Historically, C. sinensis was endemic in Japan, with high prevalence observed in Akita, Chiba, Ibaraki, Okayama, Shiga, and Tokushima, while only few cases are documented nowadays (37). C. sinensis was also once reported from central Thailand (38). However, it is not clear whether C. sinensis indeed occurs in Thailand (39, 40).
Opisthorchis viverrini
O. viverrini is endemic in southeastern Asia. Bayesian spatial-temporal models were recently applied to map the distribution of O. viverrini in southeastern Asia, which revealed that an estimated 12.39 million people were infected in 2018, more than half in Thailand (6.71 million), followed by Lao People’s Democratic Republic (2.45 million), Vietnam (2.07 million), and Cambodia (1.00 million) (Table 2) (26).
Repeated cross-sectional surveys demonstrated a decline of O. viverrini infection in Thailand, with an updated crude prevalence of 2.2% (356 infections among 16,187 people surveyed) in 2019. The highest prevalence was observed in the northeastern part of the country (5.0%), followed by areas in the northern part (1.8%), while a lower prevalence was observed in the central (0.9%) and southern parts of the country (0.1%) (41). Buengkarn, Sakon Nakhon, Kalasin, Roi Et, and Nakhon Phanom provinces are hot spots of opisthorchiasis. In Lao People’s Democratic Republic, O. viverrini infections primarily occur in the southern parts of the country, specifically in the provinces of Champasak, Khammouane, Saravane, and Savannakhet (42, 43). Additionally, in the northwestern parts around the capital Vientiane, O. viverrini is also endemic (43). In Cambodia, although O. viverrini infections have been documented in nearly all provinces with the exception of Kampong Speu, Kep, and Prey Veng, major endemic areas were documented in the central parts from Preah Vihear province in the North to Takeo province in the South (44, 45). Kampong Thom and Kampong Cham provinces are hot spots (44, 45). O. viverrini infections occur in 10 adjacent provinces in the central and southern parts of Vietnam, extending from Thua Thien Hue province in the North to Dac Nong province in the South (34). Recently, O. viverrini infections were reported in Myanmar. In 2015 and 2016, O. viverrini was detected in rural populations in three regions, namely, Bago region, Mon state, and Yangon region of Lower Myanmar (46). Meanwhile, a large survey in late 2015 revealed a low endemicity of O. viverrini infection in Yangon (0.7%, 14 infections among 2,057 surveyed individuals) (47).
Opisthorchis felineus
O. felineus is endemic in Russia, Kazakhstan, and Ukraine, while foci have also been documented in Belarus and several outbreaks were investigated in Italy (Table 2) (23, 48). However, no systematic surveys have been implemented in endemic countries.
An estimated 1.58 million people were infected in the 1990s based on expert opinion, while accurate and updated data are still lacking (23). Russia is the predominant endemic area for O. felineus, where approximately 1.22 million people were infected in 1990. High endemic areas are concentrated in western Siberia in the Ob River basin, including Khanty-Mansiysk Autonomous Okrug, Yamalo-Nenets Autonomous Okrug, Tyumen oblast, Tomsk oblast, Omsk oblast, and Novosibirsk oblast (49, 50). Between 2011 and 2013, an incidence of 25 cases per 100,000 people was documented based on surveillance data (49). In the Ukraine, O. felineus infection is endemic in Sumy and Poltava regions in the Dnieper River basin (51). Approximately 312,000 people were infected in 1990 (23). In Kazakhstan, O. felineus infection is mainly endemic in the northern and northeastern parts that are drained by the Irtysh River and its tributaries (52). Pavlodar province is the setting with the highest prevalence. A focus of O. felineus infection in the northwest in the Ural River basin is also documented. Approximately 49,000 people were estimated to be infected in 1990 in Kazakhstan (23), while 1,000–3,000 cases were reported annually from 1997 to 2011 (52). In Brest, Gomel, and Grodno provinces of Belarus, opisthorchiasis was once reported (53). However, no updated information is available. High prevalence of O. felineus is reported in fish from two lakes, Bolsena and Bracciano in central Italy. Indeed, consumption of fish from these two lakes caused several O. felineus outbreaks in Italy (48, 54). Human liver fluke infections are occasionally reported in other parts of the world because of immigrants from endemic countries, consumption of raw or undercooked freshwater fish in endemic areas when traveling, or importation from endemic areas (55–57).
DETERMINANTS OF TRANSMISSION
Human behavior
Many factors influence the transmission of liver fluke infections, of which human behavior, specifically the habit of consumption of raw aquatic food, is critical (58). Differences in raw-eating behavior govern the heterogeneity of liver fluke infections in the population, both spatially and temporally (59). Usually, children ingest raw or undercooked freshwater fish infrequently, while the proportion and frequency increase with age, particularly in males (60). Thus, high infection and intensity of liver fluke are common in elderly males (33, 41, 61). However, the infection reaches a plateau in middle-aged people and usually decreases after the age of around 60 years. Raw-eating habits result from a complex interplay between social, economic, and cultural determinants. Raw-eating behavior is influenced by cultural awareness, community identification, familial environment, and individual choice (60, 62, 63). In many parts of the People’s Republic of China, South Korea, and Vietnam, raw fish are consumed, accompanied with ginger, garlic, and other side dishes (64–66). In southeastern Asia, raw fish spicy salad and fermented fish are often consumed (62, 67). In Russia, smoked, sun-dried, frozen fish and stock fish are ingested (68). Raw-eating behavior is passed on from one generation to the next within the family and community (60, 67). Sharing and consumption of raw fish at social events promote the transmission at community level (69, 70), while interaction among family members might trigger the establishment of raw-eating behavior in those who had not done so before (60, 71). Children, especially boys, are prone to take on the behavior from their parents (60). Alcohol is usually consumed while ingesting raw fish, which also contributes to specific age and gender patterns (66, 72). While alcohol might shelter fishery smell, many people hold the wrong belief that it kills metacercariae in fish. Thus, raw-eating behavior is mingled with misconception and lack of awareness (63).
People’s economic status has been associated with the prevalence of liver fluke infection. Economic development promotes the development of aquaculture and provision of freshwater fish. In some endemic areas, raw fish are often consumed at restaurants (65). This might explain the high endemicity of clonorchiasis in the Pearl River area of Guangdong, an important economic center in the People’s Republic of China (27). In Guangxi, a neighboring province of Guangdong, a significant increase in the prevalence of clonorchiasis has been documented over the past decades because more people attempt to ingest raw freshwater fish (28). However, in other areas, lower economic status is associated with liver fluke infection (68). High prevalence is often found in people with a low educational attainment, such as fishermen and farmers (35, 42) but is also reported in highly educated people, including medical workers and businessmen (27, 28).
High re-infection rates cause persistence of human liver fluke infections. Re-infection is governed by the habit of ingesting raw or undercooked freshwater fish, which depends on disease endemicity, and the demography and infection intensity of individuals (73–75). In general, the higher the endemicity, the more rapid re-infection occurs (73, 75). In highly endemic areas, the prevalence could even bounce to original levels within 1 or 2 years after ceasing treatment and other control measures (73). Males and elderly people show a higher tendency to re-infection (73–75). Those with heavy infection intensity before treatment are particularly prone to re-infection, and they are also more likely to show heavy infection intensity during re-infection (73, 75). High re-infection sometimes leads to the occurrence of an interesting phenomenon, namely, higher re-infection rates of those with previous treatment history, because particularly individuals with frequent treatment are prone to continue ingesting raw or undercooked freshwater fish (76).
Freshwater snails
The distribution of specific freshwater snails determines the range of liver fluke infections. Thus far, at least 13 different species of freshwater snails have been recognized as first intermediate hosts of C. sinensis, most of which belong to the Bithyniidae family (77, 78). However, only three species (i.e., Parafossarulus striatulus, Alocinma longicornis, and Bithynia fuchsiana) were confirmed by experimental infection and/or molecular evidence, while the other species were defined as intermediate host just through morphologic examination (78). Since a large number of diverse foodborne trematodes can infect freshwater snails, an accurate identification by morphology is challenging (79, 80). For example, it has recently been confirmed that Melanoides tuberculata, previously thought to be an important intermediate host snail in the transmission of C. sinensis in Vietnam, is not a suitable host of C. sinensis based on observational, molecular, and experimental studies (78). Three Bithynia taxa (i.e., Bithynia funiculata, B. siamensis goniomphalos, and B. s. siamensis) act as first intermediate hosts of O. viverrini in Southeast Asia (81). B. leachi, B. troscheli, B. inflata, and B. tentaculata are recognized as first intermediate hosts of O. felineus (82).
Snails belonging to the Bithyniidae family show preferences for habitats characterized by slow-flowing muddy rivers, lakes, ponds, canals, and swamps (83). However, different snail species have their own preferences, although they sometimes are found in the same habitat. P. striatulus snails are found in ponds, ditches, streams, and swampy areas, characterized by abundant water grasses and organic materials (84). B. funiculata snails prefer habitats with clear and shallow water (depth: <30 cm) (85). B. s. goniomphalos snails prefer slightly saline water and nitrite-nitrogen, while large snail populations have been observed in rice fields, ponds, road-side ditches, canals, and lakes during the rainy season (86, 87). In the cold and dry season, snails can bury themselves in the mud and survive for prolonged periods. In the northeastern part of the People’s Republic of China, about one-third of P. striatulus snails survives after hibernation during the winter months (November–February) (84). A study demonstrated that in the northeastern part of Thailand, approximately half of B. s. goniomphalos snails survived the entire cool-dry season (November–February) with increasing mortality rates from the beginning to the end of the cold season (88). The mortality of snails is enhanced if droughts persist, with an over 90% mortality reported after a 17-month drought in northeastern Thailand (89).
The prevalence of infection in the first intermediate hosts is usually very low (<1%) (21). However, high prevalence has occasionally been reported, e.g., O. viverrini in B. s. goniomphalos in some areas in Thailand (6.9%, 21/303) and Lao People’s Democratic Republic (8.4%, 17/203) and C. sinensis in P. striatulus in some areas in the People’s Republic of China (12.3%, 25/204), as determined by cercarial shedding (90, 91). Snail infection is influenced by environmental factors (e.g., temperature, precipitation, and hours of sunshine) and human activities (92). Hence, there is often a pronounced seasonality of prevalence, which varies by species and/or locations. High prevalence of O. viverrini in snails was shown in the cool-dry season (November–February) after the rainy season (June–October) (92–94). However, the infection of C. sinensis in P. striatulus was observed to be high in the summer months (June and July) in the northeastern part of the People’s Republic of China (95). The role of temperature in snail infections is complex. On the one hand, increasing temperature causes high mortality of miracidia and low success in egg hatching (96). On the other hand, it was also demonstrated that a 1°C increase (in the temperature range from 16°C to 37°C) was associated with a 5.4% increase in the odds of infection with O. viverrini in B. s. goniomphalos snails, peaking at 34°C (97). There are reports that female snails have a higher prevalence of infection than males, as shown for P. striatulus snails infected with C. sinensis and B. s. goniomphalos snails infected with O. viverrini (88, 95). Infection also depends on the size of snails, although controversial findings are reported in the literature. In Khon Kaen province, Thailand, B. s. goniomphalos snails with a large size (>8 mm in length) had a higher prevalence with O. viverrini compared to their smaller counterparts (88). However, in Vientiane province in Lao People’s Democratic Republic, during the rainy and cool-dry seasons, there was a higher prevalence in small B. s. goniomphalos snails (<8 mm in length) compared to larger specimens, but there were no significant differences during the hot-dry season (March–May) (93). In Sakon Nakhon province, Thailand, higher prevalence was shown in large size B. s. goniomphalos in the hot-dry season, while the opposite was observed in the rainy and cool-dry seasons with higher prevalence in small size snails (98). Experiments pursued with O. viverrini eggs in B. funiculata and B. s. siamensis demonstrated that young snails (aged 1–3 months) bred in the laboratory appear to be more susceptible than field-collected mature ones, while the prevalence in B. s. goniomphalos is low in both young and mature snails (99).
High numbers of O. viverrini cercariae are released from B. s. goniomphalos in the hot-dry season (93, 94, 98). While cercariae do not emerge during darkness, low-intensity light could induce a release (100, 101). The peak of cercarial shedding usually occurs between 08:00 and 14:00 h, which differs among seasons and varies by areas. For example, in Vientiane province, cercarial shedding from B. s. goniomphalos peaks between 08:00 and 10:00 h during the hot-dry season and between 12:00 and 14.00 h during the rainy and cool-dry seasons (93). In Sakon Nakhon province, Thailand, the peak of cercarial emergence occurs between 08:00 and 10:00 h during the rainy and cool-dry seasons and between 10:00 and 12:00 h in the hot-dry season (98). Shell size of snails is usually positively correlated with the cercarial output per day (92, 94).
Freshwater fish
Thus far, approximately 100 species of freshwater fish have been recognized in the transmission of C. sinensis, more than 50 species in the case of O. viverrini, and some 20 species in O. felineus (102–104). Of note, the fish predominantly belong to the family Cyprinidae (carp). Additionally, several shrimp species have been reported as host for C. sinensis (105, 106).
The infection in freshwater fish presents variation, including the species and size of fish, sources of areas, types of water, and seasons, which is determined by the interaction among environmental factors, liver fluke prevalence in definite hosts, distribution of first intermediate hosts, and biology and behavior of freshwater fish (104). Although many fish species could harbor C. sinensis and Opisthorchis spp., the infection in terms of prevalence and intensity varies significantly. Small size fish are usually highly infected, such as Pseudorasbora parva and Pungtungia herzi. Hence, it has been suggested that these fish could serve as index species to assess the risk of transmission (106–108). In the laboratory, it was found that Barbonymus gonionotus is more susceptible to be infected with O. viverrini as a function of growing age and size (109). In a study done with natural bred fish, higher prevalence with O. viverrini was detected in larger sized fish of Cyclocheilichthys armatus and Puntius brevis, while no association was observed in Hampala dispar (110). Another study found that small Cyprinus carpio fish were more susceptible to be infected with other type of trematodes (Heterophyidae) (111). The variation of infection in different species of freshwater fish is probably attributed to a complex interplay of biological susceptibility to infection due to physiology, immunology, and nutrition, coupled with habitat characteristics (112, 113). Fish treated with immunosuppressant (e.g., prednisolone) showed high susceptibility to infection and likelihood of development of infective metacercariae with O. viverrini (112). The activity of superoxide dismutase enzyme involved in defense of parasite infection is reduced in fish treated with an immunosuppressant (112). In terms of habitat characteristics, the species of fish acting as intermediate hosts of liver flukes generally have a broad activity space (113). Usually, high prevalence with C. sinensis is reported in summer months, while with O. viverrini in late rainy and cool-dry seasons (104, 110, 114). Little is known on the morbidity of liver fluke infections on fish, except one laboratory study, which demonstrated that B. gonionotus infected with O. viverrini cercariae from Nam Ngum River in Lao People’s Democratic Republic suffered from higher mortality compared to uninfected fish (115). However, the same species infected with O. viverrini cercariae from the Songkram River in Thailand showed no significant change in mortality compared to the control.
Animal reservoirs
Piscivorous animals act as reservoir hosts in liver flukes. Cats and dogs are the most important species in terms of prevalence and abundance (116–120). The prevalence is usually higher in cats compared to dogs. Infection level is related to the source, feed foods, and age of animals (117, 118). Higher prevalence is usually observed in older animals (118). The prevalence in cats and dogs is usually higher in highly endemic areas with liver fluke infection in humans, but high prevalence in animals is also reported in areas with low infection and even without infection in humans, which indicates the existence of animal circulation (117). Movement and human-induced transfer of animals could spread an infection into other areas (121). In O. felineus, up to 15 wild carnivorous mammals might also serve as hosts (82). Pigs infected with C. sinensis and O. viverrini have also been observed (116, 119). Ducks had been suggested as reservoir of O. viverrini, but recent molecular phylogenetic evidence refuted this claim (122–124).
CLINICAL FEATURES AND MORBIDITY
Clinical features
Infection with human liver flukes causes an array of symptoms and morbidities, in which the hepatobiliary system is predominantly involved. Symptoms and morbidity are related to the infection intensity and duration of infection (125). Early infection leads to nonspecific symptoms, including asthenia, lassitude, nausea, indigestion, anorexia, diarrhea, headache, and abdominal discomfort, especially in the right upper quadrant (54, 126, 127). Jaundice, icteric conjunctivae, hepatomegaly, and tenderness on liver are important physical signs (54, 126, 127).
Morbidity
Chronic infection causes organ damage, including thickening and irregularities of the gallbladder wall, presence of sludge and enlargement of the gallbladder, dilatation and periductal fibrosis of bile duct (68, 72, 128–130). Subsequent complications include cholangitis, cholecystitis, and cholelithiasis (68, 72, 131, 132). Cholelithiasis is frequent, and both stones in gallbladder and bile duct have been associated with an infection (72, 133). Pigment stones are the major stone type caused by liver flukes (134, 135) (Fig. 3). Fatty liver is also a common symptom in those with liver fluke infections (129, 130). This observation has been confirmed by a cross-sectional study in a C. sinensis endemic area (72). Human liver fluke infections have also been associated with renal pathology (136–139). Estimated glomerular filtration rate declines in C. sinensis and O. viverrini infection. Both C. sinensis and O. viverrini infections demonstrate a negative impact on the development of children, including stunting, underweight, and low body mass index, and severe infection might cause dwarfism (140–142).
Fig 3.
Morbidities associated with liver fluke infections. (A) Clonorchis sinensis eggs (white arrow) in gallbladder stone under scanning electron microscopy [reproduced from reference (135)]. (B) Liver with cholangiocarcinoma (white arrow) and Clonorchis sinensis (black arrow) [reproduced from reference (12) with permission from Elsevier].
The most severe and final sequela of liver fluke infection is cholangiocarcinoma. In 1994, O. viverrini was classified as carcinogen (Group 1) to humans, due to a causative role in cholangiocarcinoma, while C. sinensis was classified as a probable carcinogen (Group 2A) to humans (143, 144). In 2009, C. sinensis was re-adjusted and also classified as definite carcinogen (Group 1) to humans (145, 146). In a case-control study, C. sinensis infection based on radiologic evidence was significantly associated with all three subtypes of cholangiocarcinoma (intrahepatic, hilar, and distal extrahepatic) (147). A significant relationship was also found between intensity of infection and cholangiocarcinoma in O. viverrini (148). Odds ratios varied in different studies: it was as high as 13.6 in C. sinensis based on stool examination (149) and 27.1 in O. viverrini infection based on antibody level (150). Evidence provided through meta-analyses reported an odds ratio between 4.5 [95% confidence interval (CI), 2.6–7.7] and 6.1 (95% CI, 4.4–8.6) in C. sinensis (61, 151) and 4.4 (95% CI, 1.0–18.6) in O. viverrini (151), while the combined value was 4.8 (95% CI, 2.8–8.4) (152). The yearly incidence of cholangiocarcinoma attributed to C. sinensis infection is estimated to be 25 per 100,000 in females and 35 per 100,000 in males (61).
Potential related morbidity
O. felineus is not classified as carcinogen, but there also exists potential association from ecologic studies and case reports (49, 153). A recent case-control study adds further evidence in the potential carcinogenicity of O. felineus. Among 39 cholangiocarcinoma cases, the proportion with O. felineus eggs in feces was 61.5%, while it was 43.1% in 160 controls, resulting in an odds ratio of 2.5 (95% CI, 1.2–5.5) (154). C. sinensis infection has also been related to primary hepatocellular carcinoma. Besides some case reports, a case-control study provided evidence in which a C. sinensis infection was 16.4% (73/444) in those with primary hepatocellular carcinoma, while it was 2.4% (12/500) in the control group, yielding an odds ratio of 8.0 (95% CI, 4.3–14.9) (155). Additionally, case reports also documented a potential association of human liver fluke infections with other morbidities, such as pancreatitis (156), eosinophilic pneumonia (157), and carcinoma of the gallbladder (158) in C. sinensis infection and heart diseases in O. felineus infection (159).
Several studies found an association between human liver fluke infections with allergy (160–164). Indeed, C. sinensis infection is associated with a higher responsiveness to common aeroallergens in skin prick test but does not show an association with allergic diseases (e.g., wheezing, airway hyperresponsiveness, asthma, or allergic rhinitis) (164). However, a higher risk of rhinitis is demonstrated in individuals with O. viverrini infection, compared to those without an infection (162). A study considering both rural and urban areas showed an inconsistent correlation between O. felineus infection and allergy (161). In individuals from rural areas, the prevalence of allergic diseases (e.g., bronchial asthma, atopic dermatitis, and allergic rhinitis) was higher in individuals infected with O. felineus. In urban areas, the presence of antibodies to O. felineus was negatively correlated with atopic sensitization to common allergens in skin prick test.
Co-factors
Viral hepatitis is highly prevalent in areas endemic for human liver flukes (165). A study carried out in the southeastern part of the People’s Republic of China showed weaker liver function and higher HBV DNA titers in individuals with C. sinensis and HBV coinfection (166). Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were higher in coinfected individuals, compared to both C. sinensis mono-infection and HBV mono-infection. HBV DNA titers were also higher in coinfected individuals compared to HBV mono-infection. However, another study in the northeastern part of the People’s Republic of China demonstrated that coinfection with C. sinensis and HBV or HCV did not aggravate the manifestations of viral hepatitis B and viral hepatitis C (30). ALT and AST were similar in HBV and C. sinensis coinfected individuals compared to both C. sinensis mono-infection and HBV mono-infection. However, they were higher in individuals coinfected with HCV and C. sinensis, compared to C. sinensis mono-infection, but not in HCV mono-infection. It has been documented that O. viverrini infection is related to a higher frequency of cagA-positive Helicobacter pylori, which contributes to the development of periductal fibrosis in opisthorchiasis (167, 168). Thus, it has been argued that H. pylori may contribute to the development of cholangiocarcinoma caused by O. viverrini (169). Higher liver pathology is documented in individuals with O. viverrini and Schistosoma mekongi coinfection, specifically a higher risk in liver fibrosis and enlargement of left liver lobe (170). Some nonbiologic factors could also exacerbate the morbidity caused by liver fluke infections (171–173). Alcohol is usually consumed when ingestion of raw fish, while alcohol is also related to cholangiocarcinoma (171, 172). Additionally, fermented raw fish containing N-nitroso compounds, e.g., N-nitrosodimethylamine, may also promote the damage and even cholangiocarcinoma (173).
Liver flukes and liver transplantation
Over 20 cases of donor liver containing liver flukes upon transplantation have been documented, of which most donor livers contained C. sinensis (174, 175). Most of the cases were reported from a single hospital in Tianjin, the People’s Republic of China (176). Out of 3,288 donor livers from May 2003 to December 2009, 14 were detected with C. sinensis (176). At present, definitive criteria for the management of donor livers characterized by a liver fluke infection do not exist, and these livers qualify for transplantation. However, proper screening of donors from endemic areas with liver fluke infection is recommended (177). In case an infection is detected in living donor preoperatively, praziquantel is recommended to be administered to the donor before transplantation (178, 179). In most cases, adult flukes or eggs were detected intraoperatively (174–176, 179). Although low-temperature perfusion and cold preservation for the donor livers are considered to kill the worms, praziquantel is still used for the recipients postoperatively (174–176, 179). Regular follow-up of the recipients is important to monitor the occurrence of complications (180). Additionally, life-long surveillance for the development of malignancy is needed because both C. sinensis and O. viverrini could cause cholangiocarcinoma, while prolonged immunosuppression in transplanted receipts could aggravate certain malignancies (177, 180).
DIAGNOSIS
The diagnosis of liver fluke infections not only involves humans but also intermediate hosts and animal hosts (12, 181). In humans, different diagnostic methods are available, including parasitologic methods, immunologic techniques, molecular methods, and imaging. These methods will be summarized below.
Traditional parasitologic methods
Detection of liver fluke eggs in feces is the most widely used diagnostic approach and usually considered as the “gold standard.” Direct fecal smear, the Kato-Katz thick smear method, and the formalin ethyl-acetate (or ether) concentration technique (FECT) are often applied (182, 183). The Kato-Katz thick smear method and FECT are most popular and widely used in epidemiologic surveys and surveillance because they show high sensitivity and allow for a semi-quantitative appraisal of infection intensity (32, 33, 41, 182, 183). The Kato-Katz thick smear method is relatively simple and cheap, while chemical agents and specific laboratory equipment are needed in FECT (e.g., centrifuge). An advantage with FECT is that feces can be stored for a longer time, and intestinal protozoa can concurrently be detected by FECT. No clear conclusion can be drawn related to which method shows superior sensitivity. Some studies reported similar sensitivity of the two methods (184), while other studies showed higher sensitivity of the Kato-Katz thick smear method (185), or FECT (183). However, the sensitivity of fecal examination techniques is highly influenced by the infection intensity, with lower sensitivity in low-intensity infection (182, 186). To overcome this limitation, multiple thick smears, repeated fecal samples, and a combination of several fecal examination techniques have been suggested (184–186). The quality of fecal examination is highly dependent on the availability of experienced technicians. Recently, an automatic vision-based examination system has also been developed, which, however, showed low sensitivity and, hence, needs further improvement to decrease false-negative results (187).
During surgery and clinical examination, the detection of eggs in bile is a sensitive diagnostic marker (188). Detection of eggs in gallstone is also useful (189). The morphology of eggs of the three species of liver flukes covered in this review is similar, and they are also similar to those of other minute intestinal flukes, which usually co-occur in liver fluke endemic areas (190, 191). Hence, morphologic examination of eggs fails to differentiate between the three species, and it is challenging to differentiate them from other minute intestinal flukes. The analysis of adult worms during clinical surgery could help species identification (192, 193). Additionally, collection of worms after treatment with anthelmintic drugs is useful for definite diagnosis (194).
Immunologic techniques
Immunologic techniques are supplementary diagnostic methods for human liver fluke infections, consisting of screening in epidemiologic surveys and clinical settings. Several immunologic diagnostics have been studied and developed, of which enzyme-linked immunosorbent assay (ELISA) has become the mainstay (Table 3).
TABLE 3.
Sensitivity and specificity of different immunologic diagnostics for human liver fluke infectionsr
| Targeted product | Used product | Species | Gold standard | Sensitivity | Specificitya | |
|---|---|---|---|---|---|---|
| Serum antibody | ||||||
| ELISA (195) | Antibody (IgG) | CAW | C. sinensis | Stool examination | 88.2% (449/509) | 100.0% (163/163) |
| ELISA (196) | Antibody (IgG) | CAW | C. sinensis | Kato-Katz method + water washing precipitation method | 81.5% (194/238)b | 92.4% (157/170)c |
| ELISA (197) | Antibody (IgG) | CAW | C. sinensis | Stool examination and/or serologic ELISA | C. sinensis: 91.6% (76/83); O. viverrini: 97.1% (34/35)d | 95.0% (38/40) |
| ICT (198) | Antibody (IgG) | CAW | O. viverrini | Unclear | 86.6% (97/112) | 96.7% (29/30) |
| ICT (198) | Antibody (IgG4) | CAW | O. viverrini | Unclear | 75.0% (84/112) | 100.0% (30/30) |
| ELISA (195) | Antibody (IgG) | ESA | C. sinensis | Stool examination | 92.5% (471/509) | 100.0% (163/163) |
| ELISA (199) | Antibody (IgG) | ESA | C. sinensis | Diverse methodse | 80.4% (41/51) | 78.6% (103/131)f |
| ELISA (200) | Antibody (IgG) | ESA | C. sinensis | Kato-Katz method for cases | 88.6% (31/35) | 97.2% (35/36) |
| ELISA (201) | Antibody (IgG) | ESA | O. viverrini | Stool examination | O. viverrini: 100.0% (92/92); C. sinensis: 80.0% (24/30)g | 100.0% (45/45) |
| ICT (201) | Antibody (IgG) | ESA | O. viverrini | Stool examination |
O. viverrini: 94.6% (87/92); C. sinensis: 90.0% (27/30)g |
100.0% (45/45) |
| ELISA (202) | Antibody (IgG) | ESA | O. felineus | Stool examination | 100.0% (144/144) | 95.5% (105/110) |
| ELISA (203) | Antibody (IgG4) | Antigen (cathepsin L protease) | C. sinensis | Stool examination for cases | 62.5% (15/24) | 95.8% (23/24) |
| ELISA (200) | Antibody (IgG) | Antigen (Cs1)h | C. sinensis | Kato-Katz method for cases | 94.3% (33/35) | 94.4% (34/36) |
| ELISA (204) | Antibody (IgG) | Antigen (CsGSTo1)i | C. sinensis | Stool examination for cases | C. sinensis: 90.0% (108/120); O. viverrini: 95.4% (83/87)d | 100.0% (40/40) |
| ELISA (204) | Antibody (IgG) | Antigen (CsGSTo2)j | C. sinensis | Stool examination for cases | C. sinensis: 89.2% (107/120); O. viverrini: 98.9% (86/87)d | 100.0% (40/40) |
| ELISA (197) | Antibody (IgG) | Antigen (CsAg17) | C. sinensis | Stool examination and/or serologic ELISA | 77.1% (64/83) | 100.0% (40/40) |
| ELISA (205) | Antibody (IgG) | Multiple antigens (Cs26GST + Cs28GST)k | C. sinensis | Stool examination for cases | 76.7% (23/30) | 100.0% (17/17) |
| ELISA (205) | Antibody (IgG) | Multiple antigens (Cs26GST + Cs28GST + CsVpB1)l | C. sinensis | Stool examination for cases | 86.7% (26/30) | 100.0% (17/17) |
| ELISA (197) | Antibody (IgG) | Fusion antigens (Cs28GST-CsAg17) | C. sinensis | Stool examination and/or serologic ELISA | 76.1% (35/46) | 100.0% (30/30) |
| Saliva antibody | ||||||
| ELISA (206) | Antibody (IgG) | CAW | O. viverrini | FECT | 90.0% (27/30) | 65.2% (15/23) |
| ELISA (206) | Antibody (IgA) | CAW | O. viverrini | FECT | 96.7% (29/30) | 4.3% (1/23) |
| Serum antigen | ||||||
| ELISA (207) | Antigen (cysteine proteinase) | Anti-recombinant cysteine proteinase IgY | C. sinensis | Stool examination for cases | 85.7% (36/42)m | 100.0% (20/20) |
| Feces antigen | ||||||
| ELISA (208) | Antigen (cathepsin F) | Anti-recombinant cathepsin F IgY | O. viverrini | FECT | 93.3% (28/30) | 73.3% (22/30) |
| ELISA (209) | Antigenn | Monoclonal antibodyo | O. viverrini | FECT | 91.5% (387/423)p | 68.5% (425/620) |
| Urine antigen | ||||||
| ELISA (210) | Antigenn | Monoclonal antibodyo | O. viverrini | FECT | 89.6% (112/125) | 55.6% (35/63) |
| ELISA (209) | Antigenn | Monoclonal antibodyo | O. viverrini | FECT | 88.7% (375/423)q | 69.2% (429/620) |
Only negative was included, while the cross reactivity to other parasites was not listed.
63.0% (51/81) in eggs per gram of feces (EPG) of 0–999, 92.6% (75/81) in EPG of 1,000–9,999, and 89.5% (68/76) in EPG over 10,000.
90.0% (108/120) in negative individuals from same endemic area and 98.0% (49/50) in negative individuals from non-endemic area.
As a universal antigen, the cross reactivity to O. viverrini was demonstrated in sensitivity.
Stool examination, biopsy, endoscopic retrograde cholangiopancreatography, ultrasonography, or computed tomography.
93.9% (92/98) in low-risk control with no history of ingestion of raw freshwater fish and 33.3% (11/33) in high-risk control with frequent ingestion of raw freshwater fish.
As a universal antigen, the cross reactivity to C. sinensis was demonstrated in sensitivity.
Cs1 contains tandem repeats in excretory-secretory antigens and crude antigens of adult worm.
CsGSTo1, one isoform of omega-class glutathione S-transferases.
CsGSTo2, one isoform of omega-class glutathione S-transferases.
Cs26GST, 26-kDa glutathione S-transferases in C. sinensis, Cs28GST, 28-kDa glutathione S-transferases in C. sinensis.
CsVpB1 is 838 bp long, encoding a polypeptide of 245 amino acids that is homologous with vitelline precursor protein of invertebrates.
75.0% (9 of 12) in EPG of below 1,000; 86.7% (13 of 15) in EPG of 1,000–4,999; 93.3% (14 of 15) in EPG of 5,000–9,999.
Molecules present in the excretory-secretory antigens.
Monoclonal antibody-based (clone KKU505) reactive to excretory-secretory antigens of O. viverrini adult worms.
89.6% (189/211) in EPG of 1–50; 83.3% (60/72) in EPG of 51–100; 98.6% (138/140) in EPG of over 100.
83.4% (176/211) in EPG of 1–50; 87.5% (63/72) in EPG of 51–100; 97.1% (136/140) in EPG of over 100.
CAW, crude antigens of adult worm; ESA, excretory-secretory antigens; ICT, immunochromatographic test; FECT, formalin ethyl-acetate (or ether) concentration technique.
Detection of antibody in serum is the most common type, and crude antigens of adult worms, excretory-secretory antigens, and recombinant proteins have been tested. The sensitivity is high using crude antigen, while specificity is usually low, especially in settings where there is cross-reactivity between different species of liver flukes (e.g., C. sinensis and O. viverrini) and to Paragonimus spp. (195–198). The application of excretory-secretory antigens shows improved performance in terms of sensitivity, specificity, and cross-reactivity (195, 199–202). In view of the high cost and challenges in production of excretory-secretory antigens, recombinant proteins have been developed, such as cathepsin L protease (203), Cs1 (200), glutathione S-transferases (204), or CsAg17 (197). Recombinant proteins usually belong to excretory-secretory antigens and tegument because of their exposure and potential high antigenicity. To increase the sensitivity, two or more proteins are mixed (cocktail) or fused, e.g., the mix of 26-kDa and 28-kDa glutathione S-transferases of C. sinensis (205) and the fusion of 28-kDa glutathione S-transferases and CsAg17 in C. sinensis (197). Compared to the traditional ELISA, the developed immunochromatographic test kits show advantages in rapid diagnosis without a special reading device (196, 198, 201). The sensitivity of those serological tests is usually associated with infection intensity, with higher sensitivity in higher intensity infections (196). The specificity is lower in those individuals from endemic areas compared to people from non-endemic areas (196). Furthermore, the specificity is also lower in those at high risk, e.g., individuals ingesting raw freshwater fish (199). On one hand, cross-reactivity is usually high between C. sinensis and O. viverrini, which hampers species differentiation (195, 198, 205). On the other hand, a particularly high cross-reactivity indicates the role of universal antigens in the diagnosis of both species, e.g., crude antigens of adult worms (197), excretory-secretory antigens (201), and omega-class glutathione S-transferases (204). Saliva samples have also been used for diagnosis because of their ease of collection and non-invasiveness. However, the diagnostic performance in saliva is poor due to the low specificity (206). The major challenge of antibody detection is its inability to differentiate between active and past infections because of the persistence of antibody in serum or other samples after cure, which is demonstrated by the low specificity of serological tests in those individuals from endemic areas and ingesting raw freshwater fish (196, 199).
To overcome this shortcoming, techniques detecting antigens in serum are also explored, such as the detection of cysteine proteinase in serum (207). Coproantigen detection techniques have also been explored in O. viverrini, e.g., a monoclonal antibody (named clone KKU505) targeting molecules present in the excretory-secretory antigens and the chicken IgY-based coproantigen capture ELISA targeting cathepsin F (208, 211). Particularly, the former technique was applied in the field, demonstrating a high sensitivity and moderate specificity (209). The sensitivity is also higher in heavy intensity infections. KKU505 has also been used in capturing antigens in urine with a high sensitivity and moderate specificity (209, 210). Low daily variation is shown in terms of the sensitivity owing to the stability of antigens in urine (212, 213). It is worth highlighting that the performance in terms of sensitivity and specificity is also high in settings that undergo chemotherapy (214). To improve the applicability of antigen-based tests, efforts are made to decrease the time needed to run this assay and increase the limit of detection (215, 216). A portable fluorometer equipped with a smartphone camera has been developed, which promotes its potential application in the field (217).
Molecular methods
A host of molecular techniques targeting copro-DNA have been developed for diagnosis of liver fluke infections in humans. Internal transcribed spacers (ITS-1 and ITS-2) (218–221) and ribosomal RNA gene (222) of nuclear ribosomal DNA, and cytochrome oxidase subunit 1 (cox1) (221, 223–225), NADH dehydrogenase subunits (223, 226), and cytochrome b (221) of mitochondrial DNA are usually applied as target genes, while some other genes, including the long-terminal repeat of C. sinensis retrotransposon1 (CsRn1) gene (227), and pOV-A6 (228–230) are also used. Conventional PCR is mostly employed, which is mainly used for detection rather than differentiation between different liver fluke species. Some primers could be used quite universally, and similar length of base pairs (bp) is presented by all three species of liver flukes (218). In such cases, sequencing is needed to differentiate the species. In most studies, the molecular method was developed to target one particular species, but the differentiation capacity has yet to be evaluated and reported. Multiplex PCR shows the capacity to differentiate between three species of liver flukes as well as other minute flukes (e.g., Haplorchis taichui and Metorchis bilis) (225, 231, 232). PCR-linked restriction fragment length polymorphism can also differentiate among species (38, 40). A set of primers targeting ITS2 demonstrates 375 bp in O. viverrini, 381 bp in C. sinensis, and 526 bp in H. taichui, when AcuI digests C. sinensis into 286 bp and 95 bp (38), and FauI digests O. viverrini into two bands of 129 bp and 247 bp (40). In real-time PCR, the cycle-threshold values reflect parasite-specific DNA loads (233, 234). Loop-mediated isothermal amplification has also been developed, which is quite simple and produces rapid results (224, 235, 236). The efficacy of molecular techniques is highly influenced by infection intensity, with higher sensitivity in high infection intensity indicated by the eggs per gram of feces measured through conventional fecal examination (220, 223, 224, 228, 233).
Besides application in the diagnosis of humans using feces, molecular techniques have also been developed in detection and differentiation of the larval stages (sporocysts, rediae, and cercariae) in snails (237, 238) and metacercariae in fish (234, 239–241). The application of molecular techniques in detection of larvae in snails could increase the sensitivity, when the larvae are still in the early development stages (e.g., sporocysts and rediae), and thus, they cannot be detected through the traditional cercarial shedding techniques (242).
Imaging
Imaging techniques are helpful to detect the damage and specific morbidity (e.g., cholangiocarcinoma), which, in turn, allow estimating the burden attributed to liver fluke infections (68, 72, 129, 243). With regard to liver fluke infections, imaging techniques include cholangiography, ultrasonography, computed tomography (CT), and magnetic resonance (MR) that are clinically used for auxiliary diagnosis (244, 245). The diagnosis is mainly based on two aspects, the imaging characteristics of adult worms and the related damage due to liver fluke infections. In cholangiography, many round filling defects of several millimeters in diameter within the bile ducts represent the adult worms (246, 247). It is challenging to detect worms in the bile ducts using ultrasonography. However, in heavy infection when worms parasitize the gallbladder, imaging appearances such as floating or dependent, discrete, non-shadowing echogenic foci in the lumen can be detected by ultrasonography (246, 248). Detection of flukes in CT is difficult (246). In MR, filling defects of the flukes could also be demonstrated, with small and irregular form (245).
Liver fluke infections can cause periductal fibrosis. Hence, dilatation of the small intrahepatic bile ducts with no or minimal dilatation of the large bile ducts is an important characteristic for diagnosis by the aforementioned imaging techniques, thus presenting as “too many intrahepatic ducts” sign in MR (245, 249). Appearances such as increased periductal echogenicity, diffuse dilatation of the intrahepatic bile ducts, floating echogenic foci in the gallbladder, and gallbladder distention in ultrasonography have been used for diagnosis of liver fluke infections (250, 251). Overall, the diagnostic accuracy, as indicated by the sensitivity and specificity, is rather low. The performance is influenced by the worm burden indicated by the infection intensity through counting eggs in feces, with low accuracy in light-intensity infection (250, 251). Additionally, the abnormalities in ultrasonography persist for a long time (up to several years) after clearance of flukes following drug treatment (252, 253).
TREATMENT
Praziquantel
As a broad-spectrum, safe, and efficacious anthelmintic against trematode and cestode infections, praziquantel is the only recommended drug for treatment of liver fluke infections (254). Praziquantel targets the cellular Ca2+ channels and pumps, which causes the disruption of Ca2+ homeostasis (254, 255). This then leads to the rapid contraction of the musculature and the formation of bleb and vacuole in tegument in parasites. WHO recommends a dose of 25 mg/kg three times daily for two to three consecutive days or a single dose of 40 mg/kg (256). High efficacy is shown with a dose of 25 mg/kg three times daily for two to three consecutive days. However, for ease of administration, a dose of 75 mg/kg divided into three doses of 25 mg/kg each in 1 day or a 50 mg/kg loading dose plus 25 mg/kg in 1 day is more frequently used (257). A recent systematic review determined a cure rate (proportion of patients who turned from egg positive to egg negative) of 79.8% for this treatment schedule in C. sinensis (split into three doses of 25 mg/kg each) and 93.8% in O. viverrini (50 mg/kg loading dose plus 25 mg/kg) (257). A single dose of 40 mg/kg resulted in cure rates of 32.4% in C. sinensis and 82.9% in O. viverrini. However, the corresponding egg reduction rates (percentage reduction of mean egg count) of schedules described above in both C. sinensis and O. viverrini were generally above 90% (258–263). The difference in cure rates observed in individual studies is predominantly attributed to the difference in pre-treatment infection intensity and diagnostic methods applied (257). In general, higher infection intensity is associated with lower cure rates. Additionally, gene polymorphism may affect treatment efficacy (264). It has also been reported in C. sinensis that levo-praziquantel (left isomer of racemic praziquantel) shows higher efficacy than praziquantel (265).
Albendazole
Albendazole, a broad-spectrum agent against nematodes and cestodes, is also efficacious against liver flukes (266). Albendazole blocks microtubule functions by inhibiting the polymerization of β-tubulin into microtubules, which subsequently leads to the decrease of glucose uptake and shortage of glycogen in parasites (266, 267). Indeed, a regimen of albendazole 10 mg/kg for 7 days is an alternative drug recommended for liver flukes by the US Centers for Disease Control and Prevention (19). The regimens of 8 mg/kg twice a day for 5 days and 10 mg/kg twice a day for 7 days both showed cure rates of 100% [39/39 (268) and 31/31 (269)], while the regimen of 5 mg/kg twice a day for 7 days showed a cure rate of 84.4% (27/32) in C. sinensis (269). However, in O. viverrini infection, albendazole 400 mg twice a day for 7 days only resulted in a cure rate of 33.3% (9/27), although the egg reduction rate was as high as 95.0% (270). Low dosage of albendazole (400 mg single dose) and mebendazole (400 or 500 mg) showed low efficacy in both C. sinensis and O. viverrini (271, 272).
Tribendimidine
Tribendimidine, a drug approved by the Chinese Food and Drug Administration for the treatment of soil-transmitted helminth infection, also shows high efficacy against liver flukes (273). The exact mechanism of tribendimidine against liver flukes is still unclear. It was speculated that the observed increase in lysophospholipids in C. sinensis triggers a destruction of the cell membrane and increases membrane permeability, resulting in an exposure to internal antigens, which subsequently are prone to an attack by host antibodies (274). The above mentioned systematic review determined a cure rate of 60.6% in C. sinensis and 89.8% in O. viverrini for a single dose of 400 mg in adults and 200 mg in children (257). The egg reduction rates were above 97% (260, 262, 272, 275). The lower cure rate observed in C. sinensis might be related to the high infection intensity. Additionally, in vivo and in vitro experiments demonstrated a potential effect of tribendimidine against O. felineus (276).
Treatment adverse events
Overall, adverse events of these drugs are mild and transient. Praziquantel produces somewhat more adverse events than albendazole and tribendimidine (262, 272, 275, 277). Dizziness/faintness, headache, and nausea are frequently reported following treatment with praziquantel, while abdominal pain, diarrhea, and vomiting are occasionally reported (262, 277, 278). Additionally, in spite of very few cases, anaphylactic reaction to praziquantel has also been documented (279, 280). The most frequently reported adverse events of albendazole are dizziness/faintness and headache, while abdominal pain and diarrhea are reported only occasionally (268, 269). Adverse events following tribendimidine treatment include vertigo, headache, nausea, fatigue, anxiety, and, occasionally, vomiting (260, 262, 272, 275).
CONTROL
Traditional strategy
The current strategy against liver fluke infections includes several major components, namely, chemotherapy for human beings, screening and management of cholangiocarcinoma attributed to liver flukes, behavioral change, control of animal reservoirs (e.g., cats and dogs), and environmental control.
Chemotherapy is the mainstay of control against human liver fluke infections, which is recommended by WHO and adopted in major endemic countries (Table 4) (256). The considerable global burden of clonorchiasis and opisthorchiasis calls for treatment to control morbidity. Moreover, this strategy decreases environmental contamination, which eventually helps to break transmission. Individual treatment, mass drug administration, or selective drug administration is applied according to prevalence levels in the community, but a standard for thresholds of prevalence level is not yet available. Individual treatment is indicated when the infection is ascertained by fecal examination (74, 281). Treatment is offered to the whole community in the frame of mass drug administration, while selective drug administration is provided only to specific populations at risk. The habitual ingestion of raw or undercooked freshwater fish is an important indicator for screening the population at risk (282–284). Highly endemic areas and adult males should be prioritized for chemotherapy (285). Usually, a regimen of 75 mg/kg praziquantel divided into three doses in 1 day or 40 mg/kg as single dose is used in mass or selective drug administration (74, 281, 286). In high-endemicity settings, mass drug administration once per year or selective drug administration twice per year is recommended, while in moderate endemicity, selective chemotherapy once per year is proposed (286, 287). Usually, 3 years of continuing chemotherapy significantly decreases the prevalence and infection intensity (286, 287). The major challenge of chemotherapy is sustainability because of rapid re-infection (73, 75). Re-infection is particularly high in adult males and those with past heavy-intensity infection (73, 75).
TABLE 4.
Measures against human liver fluke infectionsa
| Target | Strategy | Measures | Feasibility | Sustainability | Challenges |
|---|---|---|---|---|---|
| Human beings | Chemotherapy | Implementation of mass drug administration, selective drug administration for population at risk, or treatment for individuals with diagnosed infection | High | Low | High re-infection due to persistent ingestion of raw or undercooked freshwater fish |
| Behavioral change | Abandoning the practice of ingesting raw or undercooked freshwater fish through education | Moderate (high in children and low in adults) | High | Adults especially men highly afflicted and reluctant to change behavior | |
| Management for cholangiocarcinoma | Screening of cholangiocarcinoma cases to control the morbidity | Moderate | Moderate | High dependence on the imaging techniques and lack of available cancer biomarkers | |
| Vaccine | Immunization with proteins, DNA, or other types of vaccines to produce antibodies against infection | NA | NA | Under development (preclinical stage) | |
| Animals | Chemotherapy | Implementation of drug administration for animals (dogs, cats, pigs, etc.) | Moderate | Low | High re-infection due to persistent ingestion of raw or undercooked freshwater fish |
| Vaccine | Immunization with proteins, DNA, or other types of vaccines to produce antibodies against infection | NA | NA | Under development (preclinical stage) | |
| Environment | Feces management | Blocking the input of human and animal feces into water | Moderate (high in fish pond, low in large waterbodies (lakes, rivers and reservoirs)) | Moderate | High cost and difficult to implement in large waterbodies |
| Snail | Physical control | Environmental modification of fish ponds to clear snail through the drainage of water and remove of bottom mud before the cultivation | Moderate | Low | Large waterbodies: difficult to clear; fish ponds: rapid re-introduction after clearance due to the residual snails or snails from external environment |
| Chemical control | Using molluscicides | Low | Low | Large waterbodies: difficult to implement because of the aquatic habit of snails and potential toxicity to fish; fish ponds: potential toxicity to fish and rapid re-introduction due to the residual snails or snails from external environment | |
| Biological control | Control of snail density through biological competition or predation, e.g., other species of snails, fish, or animals; development of genetically modified snails with resistance | NA | NA | Preliminary study for biological competition and predation; theoretical exploration for genetically modified snails | |
| Fish | Vaccine | Immunization with proteins, DNA, or other types of vaccines to produce antibodies against infection | NA | NA | Under laboratory experiments |
| Chemotherapy | Drug administration for fish | NA | NA | Not yet reported |
NA, not applicable.
Because of the strong association between liver fluke infection and cholangiocarcinoma that is responsible for high mortality, screening of cholangiocarcinoma in areas where liver flukes are endemic is important. At present, among the liver fluke endemic countries, large cholangiocarcinoma screening is only applied in Thailand, where a “cholangiocarcinoma screening and care program” covers the major endemic areas with opisthorchiasis (288–290). Individuals aged 40 years and above with infection or treatment history of O. viverrini or ingestion of raw or undercooked freshwater fish are included, undergoing ultrasound examination to detect liver and biliary abnormality. Suspected cases with cholangiocarcinoma are transferred to hospitals for further diagnosis.
Mathematical modeling indicates that chemotherapy alone cannot sustain the effectiveness (291). Thus, information, education, and communication (IEC) are needed to promote behavioral change to avoid ingestion of raw or undercooked freshwater fish. Individual education or education through community leaders demonstrates higher effectiveness compared to less targeted communication in entire communities (292, 293). However, many adults, especially males who are highly afflicted by liver flukes due to frequent ingestion of raw freshwater fish, might be hesitant to change their life style. They usually have some pieces of knowledge on liver flukes and refuse to the persuasion to giving up traditional raw-eating practice. Childhood is the key stage in sharpening the practice of raw freshwater fish consumption (60). Children are highly susceptible to education and behavioral change, which urge the adoption of IEC at school (294–296). However, because children are not the major afflicted population, the effectiveness in terms of prevalence in community is only shown after many years.
Animal reservoirs especially cats, dogs, and pigs play important roles in the transmission of liver flukes. A regimen of 40 mg/kg praziquantel shows high efficacy against liver fluke infections in animals (297, 298). However, as in humans, the prevalence rebounds quickly after chemotherapy (297). Management of human and animal feces decreases environmental contamination, including removal of simple toilets directly connected to fish ponds, disconnection of animals’ colony houses to water, and blocking of the access to waterbodies by animals through fences, which, in turn, successfully decrease the infection of liver fluke in fish (299–301).
Environmental control of fish ponds to clear snails through the drainage of water and removal of the bottom mud before the cultivation could also be useful, but snails could be rapidly re-introduced due to the residual snails or snails from external environment as well as the input of cercariae from surrounding freshwater bodies (302). Bayluscide (niclosamide) shows a high lethal effect in the laboratory, with a lethal concentration of 95% at <1 parts per million (ppm) (303). However, field trials demonstrated that the mortality is only 31.25% under 20 ppm. Furthermore, using molluscicides poses challenges because of the potential toxicity to fish. Aquaculture development promotes the use of large waterbodies, including rivers, lakes, and reservoirs in cultivation of fish, where the management of human and animal feces and control of snails is challenging and costly. Thus, integrated measures including two or more components of chemotherapy, IEC, and environmental management are gradually advocated and applied, which could increase the effectiveness and sustainability of control efforts (304, 305).
Potential future control strategies
Biological control techniques deserve to be explored. B. s. goniomphalos growth rates were hampered by the presence of another freshwater snail, Filopaludina martensi martensi (306). Of note, Radix auriclaria preys on young P. striatulus in laboratory (307). However, the potential introduction of other parasitic diseases should be monitored when introducing new species of snails. The effectiveness was also demonstrated by using black carp (Mylopharyngodon piceus) to control the density of freshwater snails (308). Additionally, ducks have been applied to control P. striatulus (309). Although ducks consumed a high number of P. striatulus at the beginning, they refused to eat again during a subsequent study (309).
In the early 2000s, crude antigens of adult worms, excretory-secretory antigens, and irradiated metacercariae of C. sinensis were tested in animals, which demonstrated some protective efficacy against re-infection (310, 311) (Table 5). Thus far, 10 proteins have been tested as potential vaccine candidates against infections with C. sinensis (312–322) and O. viverrini (323–326) (Table 5). Diverse types are applied, including protein vaccines, DNA vaccines, and Bacillus subtilis spore-based vaccines. However, these potential vaccines are still at early stage and currently tested in animal experiments. Thus far, only low or moderate efficacy was shown in animals in terms of worm reduction rate, varying between 15% and 70%. Fish vaccination is another potential control intervention. Enolase, cysteine protease, and paramyosin were tested in grass carps (Ctenopharyngodon idellus) against C. sinensis through oral administration as B. subtilis spore-based vaccine (327–329). None of 15 fish were infected when immunized by B. subtilis spore-based cysteine protease, while four were infected, nine were negative, and another two died in the control group (328). The number of metacercariae per gram of fish flesh was 7.2 in those immunized with B. subtilis spore-based paramyosin, lower than 13.2 in the control group (329). Although praziquantel has been applied in fish cultivation, no report has been documented for liver fluke infections (330).
TABLE 5.
Tested vaccines against human liver fluke infections in animalsh
| Vaccine type | Year of publication | Protein | Animal species | Immunization route | Worm reduction rate (%) | Egg reduction rate (%) |
|---|---|---|---|---|---|---|
| C. sinensis | ||||||
| Protein vaccine (310) | 2000 | Crude antigens of adult worm | Albino rats | Subcutaneously and intravenously | 23.4 | NK |
| Protein vaccine (310) | 2000 | Excretory-secretory antigens | Albino rats | Subcutaneously and intravenously | 35.6 | NK |
| Irradiated metacercariae (311) | 2005 | Irradiated metacercariae | Sprague-Dawley rats | Oral administration | NKa | NK |
| DNA vaccine (pcDNA3.1) (312) | 2006 | Cysteine proteinase | Sprague-Dawley rats | Subcutaneously | 31.5 | 15.7 |
| DNA vaccine (pcDNA3.1) (313) | 2006 | Fatty acid-binding protein | Sprague-Dawley rats | Subcutaneously | 40.9 | 27.5 |
| Bacillus subtilis spore-based vaccine (314) | 2008 | Tegumental protein 22.3 kDa | Sprague-Dawley rats | Oral administration | 44.7 | 30.4 |
| Virus-like particles vaccine (315) | 2017 | Tegumental protein 22.3 kDa | Sprague-Dawley rats | Intranasally | 70.2 | NK |
| Protein vaccine (316) | 2010 | Rho GTPase | Sprague-Dawley rats | Subcutaneously and intraperitoneally | 60.5 | 68.8 |
| Protein vaccine (317) | 2012 | The 14-3-3 epsilon | Sprague-Dawley rats | Subcutaneously | 45.4 | 37.9 |
| Protein vaccine (318) | 2012 | Paramyosin | Sprague-Dawley rats | Subcutaneously | 54.3 | 50.9 |
| DNA vaccine (pcDNA3.1) (318) | 2012 | Paramyosin | Sprague-Dawley rats | Intramuscularly | 36.1 | 38.8 |
| Bacillus subtilis spore-based vaccine (319) | 2018 | Paramyosin | BALB/c mice | Oral administration | NKb | 48.3 |
| Bacillus subtilis spore-based vaccine (319) | 2018 | Paramyosin | BALB/c mice | Intraperitoneally | NKb | 51.2 |
| Protein vaccine (320) | 2014 | Enolase | Sprague-Dawley rats | Subcutaneously | 56.3 | NK |
| Protein vaccine (320) | 2014 | Enolase | Sprague-Dawley rats | Intraperitoneally | 15.4 | NK |
| DNA vaccine (pcDNA3.1) (320) | 2014 | Enolase | Sprague-Dawley rats | Intramuscularly | 37.4 | NK |
| Bacillus subtilis spore-based vaccine (320) | 2014 | Enolase | Sprague-Dawley rats | Oral administration | 61.1 | 80.7 |
| Protein vaccine (321) | 2014 | Cathepsin B cysteine protease (CB2) | Sprague-Dawley rats | Subcutaneously | 41.0 | 33.6 |
| Protein vaccine (321) | 2014 | Cathepsin B cysteine protease (CB3) | Sprague-Dawley rats | Subcutaneously | 67.2 | 57.7 |
| Protein vaccine (322) | 2020 | CsAg17 protein | FVB mice | Intraperitoneally | 64.0 | NK |
| DNA vaccine (pcDNA3.1) (322) | 2020 | CsAg17 protein | FVB mice | Intramuscularly | 69.0 | NK |
| O. viverrini | ||||||
| Protein vaccine (323)c | 2019 | O. viverrini tetraspanin-2d | Syrian golden hamsters | Intraperitoneally | 34.0 | 41.0 |
| Protein vaccine (324)e | 2019 | O. viverrini tetraspanin-2d | Syrian golden hamsters | Intraperitoneally | 31.1 | 38.0 |
| Bacillus subtilis spore-based vaccine (325) | 2021 | O. viverrini tetraspanin-2d | Syrian golden hamsters | Oral administration | 56.0 | 56.0 |
| Protein vaccine (326) | 2020 | Chimeric proteinf | Syrian golden hamsters | Intraperitoneally | 27.2 | NKg |
The worm count decreased compared to that in control, but no data provided in detail.
Failed to detect worm.
Produced in Escherichia coli.
The large extracellular loop of O. viverrini tetraspanin-2.
Produced in Pichia pastoris.
The large extracellular loop of O. viverrini tetraspanin-2 and leucine aminopeptidase.
No statistical significance but no data provided in detail.
Data for C. sinensis between the years of 2006 and 2014 were also summarized in reference (12); NK, not known.
Potential value of multi-omics in control
Considerable advances have been made in omics disciplines, including genomics, transcriptomics, and proteomics for liver flukes in the past decade (331, 332). The genomes of all three species of liver flukes have been annotated, which increases the knowledge on biology, pathogenicity, and parasite-host interaction (333–336). For example, genomic comparison of C. sinensis individuals from five different populations in the People’s Republic of China and one from the far east of Russia showed significant genetic variation between the individuals from “southern” and “northern” geographic regions (337). Biologically distinct variants are likely present in C. sinensis, which may lead to the difference in epidemiology, pathogenicity, and even chemotherapy responsiveness (337). Not only the transcriptomes of adult worms have been explored for the three species of liver flukes, but also the transcriptomes of juvenile (of O. viverrini) and metacercaria (of O. felineus) have been analyzed and compared to those of the adults, which increase the knowledge on the developmental transition between different stages and in different hosts (338–340). Furthermore, transcriptomes from multiple C. sinensis tissues (sucker, muscle, ovary, and testis) have also been compared (341). Attention is being paid to excretory-secretory products and tegument in proteomic studies because they are the interface of parasite-host interactions and thus show high potentiality as diagnostic, drug, and vaccine targets (342, 343).
Current diagnosis of cholangiocarcinoma is highly dependent on the imaging techniques, and thus, cancer biomarkers are expected for screening, early detection, diagnosis, prognosis, and follow-up in liver fluke-related cholangiocarcinoma (344). Exome sequencing demonstrated that TP53, KRAS, and SMAD4 show the most frequent mutations in O. viverrini-related cholangiocarcinoma (345). Further comparison on O. viverrini-related and non-O. viverrini-related cholangiocarcinoma revealed differential mutational patterns, with frequent mutation of TP53 in the former (346). Based on multi-omics approach, liver fluke-related cholangiocarcinoma cases are enriched in ERBB2 amplifications and TP53 mutations compared to those non-liver fluke-related cholangiocarcinoma cases (347). Gene expression profiles are also different between O. viverrini-related and non-O. viverrini-related cholangiocarcinoma, exhibiting increased expression of genes involved in xenobiotic metabolism in the former (348). Elevated expression of 14-3-3 eta is found in O. viverrini-infected hamsters through proteomics analysis, and the percentage of high expression of 14-3-3 eta in cholangiocarcinoma reached 84.2% (187 out of 222 cases), while it was not detected in hepatocellular carcinoma and healthy liver tissues (349). Proteomic analysis in animal models also showed the overexpression of plasma orosomucoid 2, and the sensitivity and specificity in using elevated orosomucoid 2 to discriminate cholangiocarcinoma cases from healthy controls were 92.9% (65 out of 70 cases) and 73.7% (350). Exostosin 1 in plasma is also found to be upregulated through proteomic analysis in animal models, and the upregulation was detected in 89.7% of cholangiocarcinoma cases (61 out of 68) (351). However, further studies are needed to explore the use of these potential cancer biomarkers in clinical settings (344).
The extreme low infection rate of snail hosts by liver flukes shows an amplification role in transmission and also indicates potential defensive mechanisms in snails (331). Based on the transcriptome of B. s. goniomphalos (352), differences in gene transcription between O. viverrini-infected and uninfected B. s. goniomphalos are captured (353). Compared to the uninfected snails, transcripts encoding distinct proteases are highly downregulated in infected snails, while those encoding heat-shock proteins and actins are significantly upregulated (353). Proteomic analysis also demonstrates the expression changes in O. viverrini-infected B. s. goniomphalos, with a downregulation in the expression of oxidoreductases and catalytic enzymes and upregulation of stress-related and motor proteins (354). Furthermore, compared to the headfoot tissues, the differences of protein expression after O. viverrini infection are more obvious in the body of the snails (354). Additionally, proteomic analysis on the hemolymph of B. s. goniomphalos demonstrates the upregulation of proteins related to immune response in both hemocyte and plasma in infected snails (355). These pieces of evidence probably point to the existence of differences in susceptibility of snails to liver flukes (331). Further understanding and decoding on the differences may promote the development and application of genetically modified snails for control of liver fluke infections (331).
CONCLUDING REMARKS AND FUTURE PERSPECTIVES
High endemicity of clonorchiasis and opisthorchiasis is driven by behavioral, social, economic, and cultural factors. Although our knowledge on these liver flukes and available techniques tackling the infections have increased significantly over the past several decades, gaps still exist, which hinder control, let alone elimination (Box 1) (12, 356–358). Nowadays, national surveys are only regularly implemented in the People’s Republic of China, South Korea, and Thailand. Data pertaining to O. viverrini infection in Lao People’s Democratic Republic, Cambodia, southern Vietnam, and Myanmar are inadequate, while data of O. felineus infection are scarce. Moreover, not only prevalence surveys in humans but also data on animal reservoirs and intermediate hosts are needed. Additionally, environmental, social, economic, behavioral, and cultural factors as well as aquaculture influencing transmission should be researched simultaneously, which then could be integrated with prevalence data to establish high-resolution maps through geostatistic techniques (24–26).
Box 1: Proposed key research areas for liver fluke infections.
-
To update the global epidemiology of liver fluke infections
Implementation of well-designed surveys and establishment of surveillance-response systems in endemic areas.
Mapping the definitive distribution of the three main species of liver flukes based on molecular epidemiological surveys.
-
To disentangle the transmission
Quantifying the roles of different species of hosts in transmission, which may vary by prevalence, ecology, and species of liver flukes.
Illuminating the circulation model between human and animal hosts (i.e., full cycle, partial cycle, or separate cycle).
Exploring the potential of interspecies transmission among the three key liver fluke species.
Predicting the impact of climate change on transmission of snails and subsequent change in distribution of liver flukes.
-
To estimate the global burden
Besides liver and biliary system, the relevance of liver flukes to introduce other pathology (e.g., kidney and heart) needs to be determined and quantified.
The carcinogenic potential of O. felineus in cholangiocarcinoma, as well as the association between liver flukes and primary hepatocellular carcinoma, needs to be elucidated.
The association of liver fluke infections and allergy needs scientific inquiry.
The roles of other factors in morbidity, especially co-infection with hepatitis virus, and H. pylori on carcinogenicity need to be explored.
-
To develop new diagnostic tools
Establishment of machine learning for fecal examination and development of products.
Development of sensitive and specific immunological and molecular diagnostic tools.
Development of eDNA techniques for risk evaluation, not only for liver flukes but also for intermediate hosts, especially snails.
-
To develop new drugs
Establishing a clinical development plan for tribendimidine against C. sinensis and O. viverrini, and implementing regulatory clinical trials against O. felineus.
Initiating randomized controlled trials to verify the efficacy of albendazole using praziquantel as comparator.
Exploration on the efficacy of drug combination against liver flukes.
-
To explore sustainable control strategies
Optimization and combination of traditional available measures, in a cost-effective manner.
Further studies on potential new techniques, including fish vaccine and biological control through species competition.
Further mining, validation, and application of the multi-omics findings, for the diagnosis in infection and morbidity (especially cholangiocarcinoma), and discovery of new drug and vaccine targets, as well as the potential development of genetically resistant snails.
Validation and application of a One Health approach integrating measurements targeting human beings, animal reservoirs, two intermediate hosts, and environments for sustainable control.
Although the three species of liver flukes have separate distribution limits, this is not based on systematic evidence from molecular epidemiology. It is still debated whether C. sinensis is endemic in Thailand. The diversity of species in transmitting liver flukes challenges the control, but the roles of different species are unclear. It is of crucial importance to illuminate the precise transmission in humans and the role of animal reservoirs. Currently, only little evidence from genetic research is available, which does not allow to draw a clear conclusion on the interplay between humans and animals, which urges further studies (359). The differential distribution of snail hosts is crucial in the distribution of three species of liver flukes. However, interspecies transmission cannot be completely excluded. Furthermore, climate change is likely to exert an impact on liver flukes and intermediate hosts, thus influencing on transmission.
Although the association of liver fluke infections and damage in liver and biliary systems is well recognized, the global burden of liver fluke infections might still be underestimated because the pathology in other organs and systems is not clear, and the role in allergy remains to be investigated. Whether O. felineus is a carcinogen needs more research. Although co-infection with other pathogens (e.g., hepatitis virus and H. pylori) is common, their interaction is little studied.
Important gaps also still remain in diagnostic and treatment tools. Novel machine learning techniques could free technicians from tedious laboratory examination, but this line of scientific inquiry needs further development and rigorous validation. Thus far, many immunological and molecular techniques have only been tested in the research setting. Samples from infected cases and non-infected individuals are often from different sources, and few studies compared different diagnostic techniques and/or products side by side. Guidelines should be established how to quantify the intensity in immunological and molecular techniques. Moreover, environmental DNA (eDNA) is a highly neglected area in liver flukes (360). This technique will strengthen the risk evaluation and prediction in the future through the detection of liver flukes in water and the existence of suitable intermediate hosts.
A clinical development plan should be discussed for tribendimidine, including the implementation of regulatory trials in O. felineus. Because of the significant differences in the efficacy of albendazole against C. sinensis and O. viverrini infections, further trials are needed to verify the efficacy of albendazole. Drug combination is neglected in the treatment of liver fluke infections, which is also expected to be strengthened in future because of potentially synergistic effects owing to distinct mechanisms from different drugs.
How to combine and optimize the different available measures, including chemotherapy, behavioral change, and environmental control, will determine the cost and effectiveness and help to identify the ideal measures for short-term morbidity control, long-term transmission control, and even interruption. Fish vaccines deserve to be studied in greater detail, while biological control through snail competition potentially increases the sustainability of control of liver fluke infections. There exists high potential to mine and utilize the findings of multi-omics in combating liver flukes. Especially, sensitive and specific cancer biomarkers for liver fluke-related cholangiocarcinoma might be a game changer in screening and early diagnosis. Additionally, further validation of the snail resistance and subsequent decoding of the mechanisms may benefit the development and application of genetically modified snails for sustainable control and even elimination. The One Health approach emphasizes the comprehensive collaboration on health at the human-animal-environment interface (361). The WHO roadmap pointed out the importance that the WHO, the Food and Agriculture Organization of the United Nations, and the World Organization for Animal Health (formerly OIE) collaborate to promote the One Health approach through multisectoral action in clonorchiasis and opisthorchiasis (2). On one hand, mathematical modeling could not only predict the effectiveness and cost but also present the conditions for transmission control and interruption, which could guide the development on sustainable control strategies (362). On the other hand, validation is needed before the application of special One Health approaches, which should take considerations of the differences in transmission determinants in different settings.
During the past decades, considerable progress has been made for many parasitic diseases, some of which are nowadays even eliminated or targeted for elimination. However, control of liver fluke infections lags behind. In some endemic areas, the prevalence even increases due to the availability of and accessibility to freshwater fish. As high neglected diseases, concerted efforts are needed with cooperation and partnership between government departments, the scientific community, and the public and private sectors.
ACKNOWLEDGMENTS
We thank Jin Chen for kindly helping to locate full-length hard-copy versions of some of the articles cited and Ting-Jun Zhu, Liu Liu, and Hao Zhang for kindly providing the pictures.
This work was supported by Shanghai Municipal Health Commission, People’s Republic of China (grant no. 202140208), and National Key Research and Development Program of People’s Republic of China (grant no. 2021YFC2300800 and 2021YFC2300804).
Biographies

Men-Bao Qian heads the Department of Soil-transmitted and Food-borne Parasitic Diseases, in the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research). He studied in Chinese Center for Disease Control and Prevention for his MSc in Pathogen Biology between 2006 and 2009, and then for PhD in Epidemiology and Health Statistics during 2016 and 2019. His team is in charge of the design and implementation of national surveys and surveillance, as well as the development and evaluation of diagnosis and treatment tools, and the exploration of control and elimination strategies, for soil-transmitted helminthiasis and food-borne parasitic diseases.

Jennifer Keiser heads the Helminth Drug Development Unit at the Swiss Tropical and Public Health Institute (Swiss TPH). She is an Associate Professor of Neglected Tropical Diseases at the Faculty of Science of the University of Basel. Prof. Keiser received a PhD in Zoology from the University of Basel in 1999 and was a Postdoctoral Fellow at Princeton University, NJ, USA from 2000 to 2003. Research objectives of her team include in vitro and in vivo evaluation of biological activities of chemical compounds, assay development, preclinical studies such as pharmacokinetics and metabolism, and clinical trials in helminthiasis-endemic countries, particularly in Côte d’Ivoire, Lao People’s Democratic Republic, and Tanzania.

Jürg Utzinger is the Director of the Swiss Tropical and Public Health Institute (Swiss TPH) and Professor of Epidemiology at the University of Basel. He holds an MSc in Environmental Science from ETH Zurich and a PhD in Epidemiology from the University of Basel. He pursued several years of postdoctoral research in demography and epidemiology at Princeton University in the United States of America. Utzinger’s research and teaching interests pertain to the epidemiology and integrated control of neglected tropical diseases and health impact assessments of large footprint projects in low- and middle-income countries. He is engaged in trans-national global health research consortia with ongoing projects in the People’s Republic of China, Côte d’Ivoire, South Africa and Tanzania.

Xiao-Nong Zhou has been Director of the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research) and the World Health Organization (WHO) Collaborating Centre for Tropical Diseases since 2010. He is also serving as Vice Dean, School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine. Prof. Zhou, graduated with a PhD on biology from the University of Copenhagen in 1994, is a leading expert in the research and control of tropical diseases, with over 40 years’ experience on control of parasitic diseases, and his professional works are across the fields of ecology, population biology, and epidemiology of tropical diseases.
Contributor Information
Men-Bao Qian, Email: qianmb@nipd.chinacdc.cn.
Graeme N. Forrest, Rush University, Chicago, Illinois, USA
REFERENCES
- 1. Torgerson PR, Devleesschauwer B, Praet N, Speybroeck N, Willingham AL, Kasuga F, Rokni MB, Zhou XN, Fevre EM, Sripa B, Gargouri N, Fürst T, Budke CM, Carabin H, Kirk MD, Angulo FJ, Havelaar A, de Silva N. 2015. World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis. PLoS Med 12:e1001920. doi: 10.1371/journal.pmed.1001920 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. WHO . Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. World Health Organization, Geneva. Available from: https://www.who.int/publications/i/item/9789240010352. Accessed 23 April 2023 [Google Scholar]
- 3. McConnell JFP. 1875. Remarks on the anatomy and pathological relations of a new species of liver-fluke. Lancet 106:271–274. doi: 10.1016/S0140-6736(02)30525-7 [DOI] [Google Scholar]
- 4. Cox FEG. 2002. History of human parasitology. Clin Microbiol Rev 15:595–612. doi: 10.1128/CMR.15.4.595-612.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Sripa B, Nawa Y, Sithithaworn P, Andrews R, Brindley PJ. 2012. Discovery of human opisthorchiasis: a mysterious history. Parasitol Int 61:3–4. doi: 10.1016/j.parint.2011.08.012 [DOI] [PubMed] [Google Scholar]
- 6. Han ET, Guk SM, Kim JL, Jeong HJ, Kim SN, Chai JY. 2003. Detection of parasite eggs from archaeological excavations in the Republic of Korea. Mem Inst Oswaldo Cruz 98 Suppl 1:123–126. doi: 10.1590/s0074-02762003000900018 [DOI] [PubMed] [Google Scholar]
- 7. Matsui A, Kanehara M, Kanehara M. 2003. Palaeoparasitology in Japan--discovery of toilet features. Mem Inst Oswaldo Cruz 98 Suppl 1:127–136. doi: 10.1590/s0074-02762003000900019 [DOI] [PubMed] [Google Scholar]
- 8. Liu WQ, Liu J, Zhang JH, Long XC, Lei JH, Li YL. 2007. Comparison of ancient and modern Clonorchis sinensis based on ITS1 and ITS2 sequences. Acta Trop 101:91–94. doi: 10.1016/j.actatropica.2006.08.010 [DOI] [PubMed] [Google Scholar]
- 9. Slepchenko SM, Gusev AV, Ivanov SN, Svyatova EO. 2015. Opisthorchiasis in infant remains from the medieval Zeleniy Yar burial ground of XII-XIII centuries AD. Mem Inst Oswaldo Cruz 110:974–980. doi: 10.1590/0074-02760150156 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Slepchenko SM, Kardash OV, Slavinsky VS, Ivanov SN, Sergeyevna RD, Tsybankov AA, Shin DH. 2019. Archaeoparasitological analysis of samples from the cutural layer of Nadym Gorodok dated back to the 14th-late 18th centuries. Korean J Parasitol 57:567–573. doi: 10.3347/kjp.2019.57.6.567 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Kaewkes S. 2003. Taxonomy and biology of liver flukes. Acta Trop 88:177–186. doi: 10.1016/j.actatropica.2003.05.001 [DOI] [PubMed] [Google Scholar]
- 12. Qian MB, Utzinger J, Keiser J, Zhou XN. 2016. Clonorchiasis. Lancet 387:800–810. doi: 10.1016/S0140-6736(15)60313-0 [DOI] [PubMed] [Google Scholar]
- 13. Qian MB, Zhou XN. 2021. Clonorchis sinensis. Trends Parasitol 37:1014–1015. doi: 10.1016/j.pt.2021.05.011 [DOI] [PubMed] [Google Scholar]
- 14. Attwood HD, Chou ST. 1978. The longevity of Clonorchis sinensis. Pathology 10:153–156. doi: 10.3109/00313027809063494 [DOI] [PubMed] [Google Scholar]
- 15. Liang C, Hu XC, Lv ZY, Wu ZD, Yu XB, Xu J, Zheng HQ. 2009. Experimental establishment of life cycle of Clonorchis sinensis. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 27:148–150. [PubMed] [Google Scholar]
- 16. Harinasuta C, Harinasuta T. 1984. Opisthorchis viverrini: life cycle, intermediate hosts, transmission to man and geographical distribution in Thailand. Arzneimittelforschung 34:1164–1167. [PubMed] [Google Scholar]
- 17. Wykoff DE, Ariyaprakai K. 1966. Opisthorchis viverrini in Thailand-egg production in man and laboratory animals. J Parasitol 52:631. doi: 10.2307/3276418 [DOI] [Google Scholar]
- 18. Kim JH, Choi MH, Bae YM, Oh JK, Lim MK, Hong ST. 2011. Correlation between discharged worms and fecal egg counts in human clonorchiasis. PLoS Negl Trop Dis 5:e1339. doi: 10.1371/journal.pntd.0001339 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Centers for Disease Control and Prevention . Clonorchis: resources for health professionals. Available from: https://www.cdc.gov/parasites/clonorchis/health_professionals/index.html. Retrieved 1010 OctOctober 2021. Accessed , 1010 OctOctober 2021
- 20. Touch S, Komalamisra C, Radomyos P, Waikagul J. 2009. Discovery of Opisthorchis viverrini metacercariae in freshwater fish in southern Cambodia. Acta Trop 111:108–113. doi: 10.1016/j.actatropica.2009.03.002 [DOI] [PubMed] [Google Scholar]
- 21. Rachprakhon P, Purivirojkul W. 2021. Very low prevalence of Opisthorchis viverrini s.l. cercariae in Bithynia siamensis siamensis snails from the canal network system in the Bangkok metropolitan region, Thailand. Parasite 28:2. doi: 10.1051/parasite/2020072 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Keiser J, Utzinger J. 2005. Emerging foodborne trematodiasis. Emerg Infect Dis 11:1507–1514. doi: 10.3201/eid1110.050614 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. WHO . 1995. Control of foodborne trematode infections. report of a WHO study group. World Health Organ Tech Rep Ser 849:1–157. [PubMed] [Google Scholar]
- 24. Qian MB. 2019. Behavioral mechanism and intervention strategy on the transmission of clonorchiasis. PhD thesis, Chinese Center for Disease Control and Prevention, Beijing. [Google Scholar]
- 25. Xiao HY, Chai JY, Fang YY, Lai YS. 2023. The spatial-temporal risk profiling of Clonorchis sinensis infection over 50 years implies the effectiveness of control programs in South Korea: a geostatistical modeling study. Lancet Reg Health West Pac 33:100697. doi: 10.1016/j.lanwpc.2023.100697 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Zhao TT, Feng YJ, Doanh PN, Sayasone S, Khieu V, Nithikathkul C, Qian MB, Hao YT, Lai YS. 2021. Model-based spatial-temporal mapping of opisthorchiasis in endemic countries of Southeast Asia. Elife 10:e59755. doi: 10.7554/eLife.59755 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Deng ZH, Fang YY, Zhang QM, Mao Q, Pei FQ, Liu MR. 2020. The control of clonorchiasis in Guangdong province, southern China. Acta Trop 202:105246. doi: 10.1016/j.actatropica.2019.105246 [DOI] [PubMed] [Google Scholar]
- 28. Jiang ZH, Wan XL, Lv GL, Zhang WW, Lin Y, Tang WQ, Wei HY, Ou FQ, Shi YL, Yang YC, Liu J, Chan CHF. 2021. High prevalence of Clonorchis sinensis infection in Guangxi, southern China. Trop Med Health 49:6. doi: 10.1186/s41182-021-00297-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Han S, Zhang X, Chen R, Wen J, Li Y, Shu J, Ling H, Zhang F. 2013. Trends in prevalence of clonorchiasis among patients in Heilongjiang province, northeast China (2009-2012): implications for monitoring and control. PLoS One 8:e80173. doi: 10.1371/journal.pone.0080173 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Gao Y, Li Y, Liu X, Zhang T, Yu G, Wang Y, Shi Y, Chi X, Wang X, Gao X, Wu R, Zhang Y, Hang L, Sun S, Guan Y, Xu Y, Meng J, Liu X, Jiang C, Ma H, Luo L, Yan Q, Yin X, Peng F, Zhi Y, Qu W, Zhang X, Ren T, Liu L, Zhao J, Zhang F, Yakepu A, Pan Y, Xu H, Niu J. 2020. High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China. Sci Rep 10:11749. doi: 10.1038/s41598-020-68684-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Huang X, Kou J, Deng X, Li D, Zhang B, Cheng P, Gong M. 2020. Review of the control of clonorchiasis in Shandong province, China from 1962 to 2015. Int J Infect Dis 96:199–204. doi: 10.1016/j.ijid.2020.04.052 [DOI] [PubMed] [Google Scholar]
- 32. Zhu TJ, Chen YD, Qian MB, Zhu HH, Huang JL, Zhou CH, Zhou XN. 2020. Surveillance of clonorchiasis in China in 2016. Acta Trop 203:105320. doi: 10.1016/j.actatropica.2019.105320 [DOI] [PubMed] [Google Scholar]
- 33. Jeong YI, Shin HE, Lee SE, Cheun HI, Ju JW, Kim JY, Park MY, Cho SH. 2016. Prevalence of Clonorchis sinensis infection among residents along 5 major rivers in the Republic of Korea. Korean J Parasitol 54:215–219. doi: 10.3347/kjp.2016.54.2.215 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Doanh PN, Nawa Y. 2016. Clonorchis sinensis and Opisthorchis spp. in Vietnam: current status and prospects. Trans R Soc Trop Med Hyg 110:13–20. doi: 10.1093/trstmh/trv103 [DOI] [PubMed] [Google Scholar]
- 35. Nguyen TTB, Dermauw V, Dahma H, Bui DT, Le TTH, Phi NTT, Lempereur L, Losson B, Vandenberg O, Do DT, Dorny P. 2020. Prevalence and risk factors associated with Clonorchis sinensis infections in rural communities in northern Vietnam. PLoS Negl Trop Dis 14:e0008483. doi: 10.1371/journal.pntd.0008483 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Bogatov VV, Besprozvannykh VV, Prozorova LA. 2019. Harmful parasitoses on the Russian southern far east under climatic and demographic changes. Dokl Biol Sci 487:108–111. doi: 10.1134/S0012496619040033 [DOI] [PubMed] [Google Scholar]
- 37. Yoshida Y. 2012. Clonorchiasis--a historical review of contributions of Japanese parasitologists. Parasitol Int 61:5–9. doi: 10.1016/j.parint.2011.06.003 [DOI] [PubMed] [Google Scholar]
- 38. Traub RJ, Macaranas J, Mungthin M, Leelayoova S, Cribb T, Murrell KD, Thompson RCA. 2009. A new PCR-based approach indicates the range of Clonorchis sinensis now extends to central Thailand. PLoS Negl Trop Dis 3:e367. doi: 10.1371/journal.pntd.0000367 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Sripa B, Kaewkes S, Intapan PM, Maleewong W, Brindley PJ. 2010. Food-borne trematodiases in Southeast Asia: epidemiology, pathology, clinical manifestation and control. Adv Parasitol 72:305–350. doi: 10.1016/S0065-308X(10)72011-X [DOI] [PubMed] [Google Scholar]
- 40. Buathong S, Leelayoova S, Mungthin M, Ruang-Areerate T, Naaglor T, Suwannahitatorn P, Piyaraj P, Taamasri P, Tan-Ariya P. 2017. Molecular discrimination of Opisthorchis-like eggs from residents in a rural community of central Thailand. PLoS Negl Trop Dis 11:e0006030. doi: 10.1371/journal.pntd.0006030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Wattanawong O, Iamsirithaworn S, Kophachon T, Nak-Ai W, Wisetmora A, Wongsaroj T, Dekumyoy P, Nithikathkul C, Suwannatrai AT, Sripa B. 2021. Current status of helminthiases in Thailand: a cross-sectional, nationwide survey, 2019. Acta Trop 223:106082. doi: 10.1016/j.actatropica.2021.106082 [DOI] [PubMed] [Google Scholar]
- 42. Forrer A, Sayasone S, Vounatsou P, Vonghachack Y, Bouakhasith D, Vogt S, Glaser R, Utzinger J, Akkhavong K, Odermatt P. 2012. Spatial distribution of, and risk factors for, Opisthorchis viverrini infection in southern Lao PDR. PLoS Negl Trop Dis 6:e1481. doi: 10.1371/journal.pntd.0001481 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Eom KS, Yong TS, Sohn WM, Chai JY, Min DY, Rim HJ, Jeon HK, Banouvong V, Insisiengmay B, Phommasack B. 2014. Prevalence of helminthic infections among inhabitants of Lao PDR. Korean J Parasitol 52:51–56. doi: 10.3347/kjp.2014.52.1.51 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Miyamoto K, Kirinoki M, Matsuda H, Hayashi N, Chigusa Y, Sinuon M, Chuor CM, Kitikoon V. 2014. Field survey focused on Opisthorchis viverrini infection in five provinces of Cambodia. Parasitol Int 63:366–373. doi: 10.1016/j.parint.2013.12.003 [DOI] [PubMed] [Google Scholar]
- 45. Khieu V, Fürst T, Miyamoto K, Yong T-S, Chai J-Y, Huy R, Muth S, Odermatt P. 2019. Is Opisthorchis viverrini emerging in Cambodia? Adv Parasitol 103:31–73. doi: 10.1016/bs.apar.2019.02.002 [DOI] [PubMed] [Google Scholar]
- 46. Aung WPP, Htoon TT, Tin HH, Thinn KK, Sanpool O, Jongthawin J, Sadaow L, Phosuk I, Rodpai R, Intapan PM, Maleewong W. 2017. First report and molecular identification of Opisthorchis viverrini infection in human communities from lower Myanmar. PLoS One 12:e0177130. doi: 10.1371/journal.pone.0177130 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Sohn WM, Jung BK, Hong SJ, Lee KH, Park JB, Kim HS, Cho S, Htoon TT, Tin HH, Chai JY. 2019. Low-grade endemicity of opisthorchiasis, Yangon, Myanmar. Emerg Infect Dis 25:1435–1437. doi: 10.3201/eid2507.190495 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Pozio E, Armignacco O, Ferri F, Gomez Morales MA. 2013. Opisthorchis felineus, an emerging infection in Italy and its implication for the European Union. Acta Trop 126:54–62. doi: 10.1016/j.actatropica.2013.01.005 [DOI] [PubMed] [Google Scholar]
- 49. Fedorova OS, Kovshirina YV, Kovshirina AE, Fedotova MM, Deev IA, Petrovskiy FI, Filimonov AV, Dmitrieva AI, Kudyakov LA, Saltykova IV, Odermatt P, Ogorodova LM. 2017. Opisthorchis felineus infection and cholangiocarcinoma in the Russian Federation: a review of medical statistics. Parasitol Int 66:365–371. doi: 10.1016/j.parint.2016.07.010 [DOI] [PubMed] [Google Scholar]
- 50. Fedorova OS, Fedotova MM, Sokolova TS, Golovach EA, Kovshirina YV, Ageeva TS, Kovshirina AE, Kobyakova OS, Ogorodova LM, Odermatt P. 2018. Opisthorchis felineus infection prevalence in Western Siberia: a review of Russian literature. Acta Trop 178:196–204. doi: 10.1016/j.actatropica.2017.11.018 [DOI] [PubMed] [Google Scholar]
- 51. Kotelevska TM, Pryimenko NO, Dubynska GM, Iziumska OM, Bodnar VA. 2018. Opisthorchiasis and viral hepatitis B: clinical cases. Wiad Lek 71:242–245.
- 52. Sultanov A, Abdybekova A, Abdibaeva A, Shapiyeva Z, Yeshmuratov T, Torgerson PR. 2014. Epidemiology of fishborne trematodiasis in Kazakhstan. Acta Trop 138:60–66. doi: 10.1016/j.actatropica.2014.04.030 [DOI] [PubMed] [Google Scholar]
- 53. Skripova LV, Romanenko NA, Be’er SA, Beznos TV, Gitsu GA, Novosil’tsev GI, Gorbatkova IE, Kvacheniuk SK, Kolesinskaia II, Lysenko TN. 1991. The detection of opisthorchiasis foci in Byelorussia. Med Parazitol (Mosk):37–40. [PubMed] [Google Scholar]
- 54. Traverso A, Repetto E, Magnani S, Meloni T, Natrella M, Marchisio P, Giacomazzi C, Bernardi P, Gatti S, Gomez Morales MA, Pozio E. 2012. A large outbreak of Opisthorchis felineus in Italy suggests that opisthorchiasis develops as a febrile eosinophilic syndrome with cholestasis rather than a hepatitis-like syndrome. Eur J Clin Microbiol Infect Dis 31:1089–1093. doi: 10.1007/s10096-011-1411-y [DOI] [PubMed] [Google Scholar]
- 55. Tselepatiotis E, Mantadakis E, Papoulis S, Vassalou E, Kotsakis P, Samonis G. 2003. A case of Opisthorchis felineus infestation in a pilot from Greece. Infection 31:430–432. doi: 10.1007/s15010-003-3225-z [DOI] [PubMed] [Google Scholar]
- 56. Yossepowitch O, Gotesman T, Assous M, Marva E, Zimlichman R, Dan M. 2004. Opisthorchiasis from imported raw fish. Emerg Infect Dis 10:2122–2126. doi: 10.3201/eid1012.040410 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Joo H, Maskery BA, Alpern JD, Chancey RJ, Weinberg M, Stauffer WM. 2022. Low treatment rates of parasitic diseases with standard-of-care prescription drugs in the United States, 2013-2019. Am J Trop Med Hyg 107:780–784. doi: 10.4269/ajtmh.22-0291 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Sun J, Xin H, Jiang Z, Qian M, Duan K, Chen Y, Li S, Li W, Huang S, Gan X, Yang Y, Li Z. 2020. High endemicity of Clonorchis sinensis infection in Binyang county, southern China. Plos Negl Trop Dis 14:e0008540. doi: 10.1371/journal.pntd.0008540 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Pengput A, Schwartz DG. 2020. Risk factors for Opisthorchis viverrini infection: a systematic review. J Infect Public Health 13:1265–1273. doi: 10.1016/j.jiph.2020.05.028 [DOI] [PubMed] [Google Scholar]
- 60. Qian MB, Jiang ZH, Zhou CH, Ge T, Wang X, Zhou XN. 2020. Familial assimilation in transmission of raw-freshwater fish-eating practice leading to clonorchiasis. PLoS Negl Trop Dis 14:e0008263. doi: 10.1371/journal.pntd.0008263 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Qian MB, Chen YD, Liang S, Yang GJ, Zhou XN. 2012. The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma. Infect Dis Poverty 1:4. doi: 10.1186/2049-9957-1-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Xayaseng V, Phongluxa K, van Eeuwijk P, Akkhavong K, Odermatt P. 2013. Raw fish consumption in liver fluke endemic areas in rural southern Laos. Acta Trop 127:105–111. doi: 10.1016/j.actatropica.2013.03.016 [DOI] [PubMed] [Google Scholar]
- 63. Wang YC, Grundy-Warr C, Namsanor J, Kenney-Lazar M, Tang CJY, Goh LYW, Chong YC, Sithithaworn P, Ngonkum S, Khuntikeo N. 2021. Masculinity and misinformation: social dynamics of liver fluke infection risk in Thailand. Parasitol Int 84:102382. doi: 10.1016/j.parint.2021.102382 [DOI] [PubMed] [Google Scholar]
- 64. Phan VT, Ersbøll AK, Do DT, Dalsgaard A. 2011. Raw-fish-eating behavior and fishborne zoonotic trematode infection in people of northern Vietnam. Foodborne Pathog Dis 8:255–260. doi: 10.1089/fpd.2010.0670 [DOI] [PubMed] [Google Scholar]
- 65. Qian MB, Chen YD, Fang YY, Tan T, Zhu TJ, Zhou CH, Wang GF, Xu LQ, Zhou XN. 2013. Epidemiological profile of Clonorchis sinensis infection in one community, Guangdong, People’s Republic of China. Parasit Vectors 6:194. doi: 10.1186/1756-3305-6-194 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Lee SE, Shin HE, Lee MR, Kim YH, Cho SH, Ju JW. 2020. Risk factors of Clonorchis sinensis human infections in endemic areas, Haman-Gun, Republic of Korea: a case-control study. Korean J Parasitol 58:647–652. doi: 10.3347/kjp.2020.58.6.647 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Suwannahitatorn P, Webster J, Riley S, Mungthin M, Donnelly CA. 2019. Uncooked fish consumption among those at risk of Opisthorchis viverrini infection in central Thailand. PLoS One 14:e0211540. doi: 10.1371/journal.pone.0211540 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Fedorova OS, Fedotova MM, Zvonareva OI, Mazeina SV, Kovshirina YV, Sokolova TS, Golovach EA, Kovshirina AE, Konovalova UV, Kolomeets IL, Gutor SS, Petrov VA, Hattendorf J, Ogorodova LM, Odermatt P. 2020. Opisthorchis felineus infection, risks, and morbidity in rural Western Siberia, Russian Federation. PLoS Negl Trop Dis 14:e0008421. doi: 10.1371/journal.pntd.0008421 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Saenna P, Hurst C, Echaubard P, Wilcox BA, Sripa B. 2017. Fish sharing as a risk factor for Opisthorchis viverrini infection: evidence from two villages in north-eastern Thailand. Infect Dis Poverty 6:66. doi: 10.1186/s40249-017-0281-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Vinh HQ, Phimpraphai W, Tangkawattana S, Smith JF, Kaewkes S, Dung DT, Duong TT, Sripa B. 2017. Risk factors for Clonorchis sinensis infection transmission in humans in northern Vietnam: a descriptive and social network analysis study. Parasitol Int 66:74–82. doi: 10.1016/j.parint.2016.11.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Araki H, Ong KIC, Lorphachan L, Soundala P, Iwagami M, Shibanuma A, Hongvanthong B, Brey PT, Kano S, Jimba M. 2018. Mothers' Opisthorchis viverrini infection status and raw fish dish consumption in Lao People’s Democratic Republic: determinants of child infection status. Trop Med Health 46:29. doi: 10.1186/s41182-018-0112-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Qian MB, Li HM, Jiang ZH, Yang YC, Lu MF, Wei K, Wei SL, Chen Y, Zhou CH, Chen YD, Zhou XN. 2021. Severe hepatobiliary morbidity is associated with Clonorchis sinensis infection: the evidence from a cross-sectional community study. PLoS Negl Trop Dis 15:e0009116. doi: 10.1371/journal.pntd.0009116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Upatham ES, Viyanant V, Brockelman WY, Kurathong S, Lee P, Kraengraeng R. 1988. Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy. Int J Parasitol 18:643–649. doi: 10.1016/0020-7519(88)90099-9 [DOI] [PubMed] [Google Scholar]
- 74. Prakobwong S, Suwannatrai K. 2020. Reduction of reinfection rates with Opisthorchis viverrini through a three-year management program in endemic areas of northeastern Thailand. Korean J Parasitol 58:527–535. doi: 10.3347/kjp.2020.58.5.527 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Li Z, Xin H, Qian MB, Sun J, Yang Y, Chen Y, Yu J, Chen Y, Huang Z, Hay SI, Jiang Z, Li SZ. 2022. Clonorchis sinensis reinfection rate and reinfection determinants: a prospective cohort study in Hengxian county, Guangxi, China. J Infect Dis 225:481–491. doi: 10.1093/infdis/jiab403 [DOI] [PubMed] [Google Scholar]
- 76. Thinkhamrop K, Khuntikeo N, Sithithaworn P, Thinkhamrop W, Wangdi K, Kelly MJ, Suwannatrai AT, Gray DJ. 2019. Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand. Infect Dis Poverty 8:18. doi: 10.1186/s40249-019-0529-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, Fang YY. 2005. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 5:31–41. doi: 10.1016/S1473-3099(04)01252-6 [DOI] [PubMed] [Google Scholar]
- 78. Nguyen HM, Van HH, Ho LT, Tatonova YV, Madsen H. 2021. Are Melanoides tuberculata and Tarebia granifera (Gastropoda, Thiaridae), suitable first intermediate hosts of Clonorchis sinensis in Vietnam? PLoS Negl Trop Dis 15:e0009093. doi: 10.1371/journal.pntd.0009093 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Madsen H, Hung NM. 2014. An overview of freshwater snails in Asia with main focus on Vietnam. Acta Trop 140:105–117. doi: 10.1016/j.actatropica.2014.08.005 [DOI] [PubMed] [Google Scholar]
- 80. Nguyen PTX, Van Hoang H, Dinh HTK, Dorny P, Losson B, Bui DT, Lempereur L. 2021. Insights on foodborne zoonotic trematodes in freshwater snails in north and central Vietnam. Parasitol Res 120:949–962. doi: 10.1007/s00436-020-07027-1 [DOI] [PubMed] [Google Scholar]
- 81. Petney T, Sithithaworn P, Andrews R, Kiatsopit N, Tesana S, Grundy-Warr C, Ziegler A. 2012. The ecology of the Bithynia first intermediate hosts of Opisthorchis viverrini. Parasitol Int 61:38–45. doi: 10.1016/j.parint.2011.07.019 [DOI] [PubMed] [Google Scholar]
- 82. Yurlova NI, Yadrenkina EN, Rastyazhenko NM, Serbina EА, Glupov VV. 2017. Opisthorchiasis in Western Siberia: epidemiology and distribution in human, fish, snail, and animal populations. Parasitol Int 66:355–364. doi: 10.1016/j.parint.2016.11.017 [DOI] [PubMed] [Google Scholar]
- 83. Strong EE, Gargominy O, Ponder WF, Bouchet P. 2008. Global diversity of gastropods (Gastropoda; Mollusca) in freshwater. Hydrobiologia 595:149–166. doi: 10.1007/s10750-007-9012-6 [DOI] [Google Scholar]
- 84. Li BZ, Wang CX, Li DY, Liu TC, Deng LJ, Liu YZ. 1983. Ecological study on the Parafossarulus striatulus, the first intermediate host of Clonorchis sinensis in Liaoning province, China. Dong Wu Xue Za Zhi 18:3–6. [Google Scholar]
- 85. Ngern-klun R, Sukontason KL, Tesana S, Sripakdee D, Irvine KN, Sukontason K. 2006. Field investigation of Bithynia funiculata, intermediate host of Opisthorchis viverrini in northern Thailand. Southeast Asian J Trop Med Public Health 37:662–672. [PubMed] [Google Scholar]
- 86. Suwannatrai A, Suwannatrai K, Haruay S, Piratae S, Thammasiri C, Khampoosa P, Kulsantiwong J, Prasopdee S, Tarbsripair P, Suwanwerakamtorn R, Sukchan S, Boonmars T, Malone JB, Kearney MT, Tesana S. 2011. Effect of soil surface salt on the density and distribution of the snail Bithynia siamensis goniomphalos in northeast Thailand. Geospat Health 5:183–190. doi: 10.4081/gh.2011.170 [DOI] [PubMed] [Google Scholar]
- 87. Kim CS, Echaubard P, Suwannatrai A, Kaewkes S, Wilcox BA, Sripa B. 2016. Seasonal and spatial environmental influence on Opisthorchis viverrini intermediate hosts, abundance, and distribution: insights on transmission dynamics and sustainable control. PLoS Negl Trop Dis 10:e0005121. doi: 10.1371/journal.pntd.0005121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Chaiyasaeng M, Pechdee P, Sereewong C, Suwannatrai A, Laha T, Tesana S. 2019. Effects of aestivation on survival of Bithynia siamensis goniomphalos snails and the infection of Opisthorchis viverrini in the irrigation area of wet- and dry-season rice paddy. Acta Trop 192:55–60. doi: 10.1016/j.actatropica.2019.01.014 [DOI] [PubMed] [Google Scholar]
- 89. Brockelman WY, Upatham ES, Viyanant V, Ardsungnoen S, Chantanawat R. 1986. Field studies on the transmission of the human liver fluke, Opisthorchis viverrini, in northeast Thailand: population changes of the snail intermediate host. Int J Parasitol 16:545–552. doi: 10.1016/0020-7519(86)90091-3 [DOI] [PubMed] [Google Scholar]
- 90. Kiatsopit N, Sithithaworn P, Saijuntha W, Boonmars T, Tesana S, Sithithaworn J, Petney TN, Andrews RH. 2012. Exceptionally high prevalence of infection of Bithynia siamensis goniomphalos with Opisthorchis viverrini cercariae in different wetlands in Thailand and Lao PDR. Am J Trop Med Hyg 86:464–469. doi: 10.4269/ajtmh.2012.11-0217 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Chen S, Chen S, Wu F, Chen S, Ke S, Chen S, Pan Z. 1997. Epidemiological survey on clonorchiasis sinensis in Yangxin county of Hubei province of PR China. Southeast Asian J Trop Med Public Health 28 Suppl 1:51–53. [PubMed] [Google Scholar]
- 92. Kopolrat K, Sithithaworn P, Kiatsopit N, Namsanor J, Laoprom N, Tesana S, Andrews RH, Petney TN. 2020. Influence of water irrigation schemes and seasonality on transmission dynamics of Opisthorchis viverrini in the snail intermediate host, Bithynia siamensis goniomphalos in rice paddy fields in northeast Thailand. Am J Trop Med Hyg 103:276–286. doi: 10.4269/ajtmh.19-0290 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Kiatsopit N, Sithithaworn P, Kopolrat K, Andrews RH, Petney TN. 2014. Seasonal cercarial emergence patterns of Opisthorchis viverrini infecting Bithynia siamensis goniomphalos from Vientiane province, Lao PDR. Parasit Vectors 7:551. doi: 10.1186/s13071-014-0551-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Namsanor J, Sithithaworn P, Kopolrat K, Kiatsopit N, Pitaksakulrat O, Tesana S, Andrews RH, Petney TN. 2015. Seasonal transmission of Opisthorchis viverrini sensu lato and a lecithodendriid trematode species in Bithynia siamensis goniomphalos snails in northeast Thailand. Am J Trop Med Hyg 93:87–93. doi: 10.4269/ajtmh.14-0639 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Li BZ, Wang CX, Li DY, Liu TC, Yu XH. 1986. Seasonal and dynamic observation on Parafossarulus striatulus infecting Clonorchis sinensis. Zhongguo Yi Ke Da Xue Xue Bao 15:47–48. [Google Scholar]
- 96. Echaubard P, León T, Suwanatrai K, Chaiyos J, Kim CS, Mallory FF, Kaewkes S, Spear RC, Sripa B. 2017. Experimental and modelling investigations of Opisthorchis viverrini miracidia transmission over time and across temperatures: implications for control. Int J Parasitol 47:257–270. doi: 10.1016/j.ijpara.2016.10.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Prasopdee S, Kulsantiwong J, Piratae S, Khampoosa P, Thammasiri C, Suwannatrai A, Laha T, Grams R, Loukas A, Tesana S. 2015. Temperature dependence of Opisthorchis viverrini infection in first intermediate host snail, Bithynia siamensis goniomphalos . Acta Trop 141:112–117. doi: 10.1016/j.actatropica.2013.10.011 [DOI] [PubMed] [Google Scholar]
- 98. Laoprom N, Kiatsopit N, Sithithaworn P, Kopolrat K, Namsanor J, Andrews RH, Petney TN. 2016. Cercarial emergence patterns for Opisthorchis viverrini sensu lato infecting Bithynia siamensis goniomphalos from Sakon Nakhon province, Thailand. Parasitol Res 115:3313–3321. doi: 10.1007/s00436-016-5089-z [DOI] [PubMed] [Google Scholar]
- 99. Chanawong A, Waikagul J. 1991. Laboratory studies on host-parasite relationship of Bithynia snails and the liver fluke, Opisthorchis viverrini . Southeast Asian J Trop Med Public Health 22:235–239. [PubMed] [Google Scholar]
- 100. Phongsasakulchoti P, Sri-aroon P, Kerdpuech Y. 2005. Emergence of Opisthorchis viverrini cercariae from naturally infected Bithynia (digoniostoma) siamensis goniomphalos. Southeast Asian J Trop Med Public Health 36 Suppl 4:189–191. [PubMed] [Google Scholar]
- 101. Kaewkes S, Kaewkes W, Boonmars T, Sripa B. 2012. Effect of light intensity on Opisthorchis viverrini cercarial shedding levels from Bithynia snails--a preliminary study. Parasitol Int 61:46–48. doi: 10.1016/j.parint.2011.08.015 [DOI] [PubMed] [Google Scholar]
- 102. Mordvinov VA, Yurlova NI, Ogorodova LM, Katokhin AV. 2012. Opisthorchis felineus and Metorchis bilis are the main agents of liver fluke infection of humans in Russia. Parasitol Int 61:25–31. doi: 10.1016/j.parint.2011.07.021 [DOI] [PubMed] [Google Scholar]
- 103. Petney TN, Andrews RH, Saijuntha W, Tesana S, Prasopdee S, Kiatsopit N, Sithithaworn P. 2018. Taxonomy, ecology and population genetics of Opisthorchis viverrini and its intermediate hosts. Adv Parasitol 101:1–39. doi: 10.1016/bs.apar.2018.05.001 [DOI] [PubMed] [Google Scholar]
- 104. Zhang Y, Gong QL, Lv QB, Qiu YY, Wang YC, Qiu HY, Guo XR, Gao JF, Chang QC, Wang CR. 2020. Prevalence of Clonorchis sinensis infection in fish in South-East Asia: a systematic review and meta-analysis. J Fish Dis 43:1409–1418. doi: 10.1111/jfd.13245 [DOI] [PubMed] [Google Scholar]
- 105. Tang CC, Lin YK, Wang PC, Chen PH, Tang CT, Chen TS, Lin CT, Huang CK, Chen CF, Chen SH. 1963. Clonorchiasis in south Fukien with special reference to the discovery of crayfishes as second intermediate host. Chin Med J 82:545–562. [PubMed] [Google Scholar]
- 106. Chen D, Chen J, Huang J, Chen X, Feng D, Liang B, Che Y, Liu X, Zhu C, Li X, Shen H. 2010. Epidemiological investigation of Clonorchis sinensis infection in freshwater fishes in the Pearl River Delta. Parasitol Res 107:835–839. doi: 10.1007/s00436-010-1936-5 [DOI] [PubMed] [Google Scholar]
- 107. Zhang Y, Chang QC, Zhang Y, Na L, Wang WT, Xu WW, Gao DZ, Liu ZX, Wang CR, Zhu XQ. 2014. Prevalence of Clonorchis sinensis infection in freshwater fishes in northeastern China. Vet Parasitol 204:209–213. doi: 10.1016/j.vetpar.2014.05.007 [DOI] [PubMed] [Google Scholar]
- 108. Sohn WM. 2022. Infection characteristics of Clonorchis sinensis metacercariae in fish from Republic of Korea. Korean J Parasitol 60:79–96. doi: 10.3347/kjp.2022.60.2.79 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109. Donthaisong C, Arunsan P, Suwannatrai K, Prasopdee S, Kulsantiwong J, Wongmaneeprateep S, Suwannatrai A, Tesana S. 2014. Experimental infection of Opisthorchis viverrini cercariae to the cyprinid fish, Barbonymus gonionotus. Acta Trop 136:118–122. doi: 10.1016/j.actatropica.2014.04.022 [DOI] [PubMed] [Google Scholar]
- 110. Namsanor J, Kiatsopit N, Laha T, Andrews RH, Petney TN, Sithithaworn P. 2020. Infection dynamics of Opisthorchis viverrini metacercariae in cyprinid fishes from two endemic areas in Thailand and Lao PDR. Am J Trop Med Hyg 102:110–116. doi: 10.4269/ajtmh.19-0432 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Boerlage AS, Graat EAM, Verreth JA, de Jong MCM. 2011. Effect of fish size on transmission of fish-borne trematodes (heterophyidae) to common carps (Cyprinus carpio) and implications for intervention. Aquaculture 321:179–184. doi: 10.1016/j.aquaculture.2011.09.005 [DOI] [Google Scholar]
- 112. Donthaisong C, Arunsan P, Suwannatrai K, Prasopdee S, Kulsantiwong J, Wongmaneeprateep S, Suwannatrai A, Tesana S. 2016. Infectivity and development of Opisthorchis viverrini metacercariae in immunosuppressed Barbonymus gonionotus fingerlings (Cyprinidae). Acta Trop 162:107–113. doi: 10.1016/j.actatropica.2016.06.022 [DOI] [PubMed] [Google Scholar]
- 113. Zhang F, Wang J, Li J, Zeng Y. 2021. The selectivity for the second intermediate host (fish) of Clonorchis sinensis in the Jialing River basin, China—from the perspective of fish ecological viewpoint. Biologia 76:91–100. doi: 10.2478/s11756-020-00502-1 [DOI] [Google Scholar]
- 114. Sithithaworn P, Pipitgool V, Srisawangwong T, Elkins DB, Haswell-Elkins MR. 1997. Seasonal variation of Opisthorchis viverrini infection in cyprinoid fish in north-east Thailand: implications for parasite control and food safety. Bull World Health Organ 75:125–131. [PMC free article] [PubMed] [Google Scholar]
- 115. Kopolrat K, Sithithaworn P, Kiatsopit N, Pitaksakulrat O, Tesana S, Andrews RH, Petney TN. 2016. Comparison of infectivity, metacercarial burden and host mortality induced by Opisthorchis viverrini sensu lato cercariae from Lao PDR compared with Thailand in cyprinid fish, Barbonymus gonionotus. Trans R Soc Trop Med Hyg 110:46–54. doi: 10.1093/trstmh/trv102 [DOI] [PubMed] [Google Scholar]
- 116. Lin R, Li X, Lan C, Yu S, Kawanaka M. 2005. Investigation on the epidemiological factors of Clonorchis sinensis infection in an area of south China. Southeast Asian J Trop Med Public Health 36:1114–1117. [PubMed] [Google Scholar]
- 117. Lin RQ, Tang JD, Zhou DH, Song HQ, Huang SY, Chen JX, Chen MX, Zhang H, Zhu XQ, Zhou XN. 2011. Prevalence of Clonorchis sinensis infection in dogs and cats in subtropical southern China. Parasit Vectors 4:180. doi: 10.1186/1756-3305-4-180 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118. Aunpromma S, Kanjampa P, Papirom P, Tangkawattana S, Tangkawattana P, Tesana S, Boonmars T, Suwannatrai A, Uopsai S, Sukon P, Sripa B. 2016. Prevlence and risk factors for Opisthorchis viverrini infection among cats and dogs in six districts surrounding the Ubolratana dam, an endemic area for human opisthorchiasis in northeastern Thailand. Southeast Asian J Trop Med Public Health 47:1153–1159. [PubMed] [Google Scholar]
- 119. Vonghachack Y, Odermatt P, Taisayyavong K, Phounsavath S, Akkhavong K, Sayasone S. 2017. Transmission of Opisthorchis viverrini, Schistosoma mekongi and soil-transmitted helminthes on the Mekong Islands, southern Lao PDR. Infect Dis Poverty 6:131. doi: 10.1186/s40249-017-0343-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120. Tatyana VM, Anna VI, Alexander VT. 2018. Parasites of stray and client-owned domestic cats in urban areas in Russia during 2000-2015 years. Trop Biomed 35:267–279. [PubMed] [Google Scholar]
- 121. Nguyen HM, Tatonova YV, Madsen H. 2018. Infections by hepatic trematodes in cats from slaughterhouses in Vietnam. J Parasitol 104:306–309. doi: 10.1645/18-5 [DOI] [PubMed] [Google Scholar]
- 122. Dao TH, Nguyen TG, Victor B, Gabriël S, Dorny P. 2014. Opisthorchis viverrini-like liver fluke in birds from Vietnam: morphological variability and rDNA/mtDNA sequence confirmation. J Helminthol 88:441–446. doi: 10.1017/S0022149X13000400 [DOI] [PubMed] [Google Scholar]
- 123. Dao TTH, Abatih EN, Nguyen TTG, Tran HTL, Gabriël S, Smit S, Le PN, Dorny P. 2016. Prevalence of Opisthorchis viverrini-like fluke infection in ducks in Binh Dinh province, central Vietnam. Korean J Parasitol 54:357–361. doi: 10.3347/kjp.2016.54.3.357 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124. Dao TTH, Nguyen TTG, Gabriel S, Bui KL, Dorny P, Le TH. 2017. Updated molecular phylogenetic data for Opisthorchis spp. (Trematoda: Opisthorchioidea) from ducks in Vietnam. Parasit Vectors 10:575. doi: 10.1186/s13071-017-2514-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125. Qian MB, Chen YD, Fang YY, Xu LQ, Zhu TJ, Tan T, Zhou CH, Wang GF, Jia TW, Yang GJ, Zhou XN. 2011. Disability weight of Clonorchis sinensis infection: captured from community study and model simulation. PLoS Negl Trop Dis 5:e1377. doi: 10.1371/journal.pntd.0001377 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126. Kim MS, Lee JS, Rim HJ. 1982. Studies on the clinical aspects of clonorchiasis in Korea. Korea Univ Med J 19:107–121. [Google Scholar]
- 127. Upatham ES, Viyanant V, Kurathong S, Rojborwonwitaya J, Brockelman WY, Ardsungnoen S, Lee P, Vajrasthira S. 1984. Relationship between prevalence and intensity of Opisthorchis viverrini infection, and clinical symptoms and signs in a rural community in north-east Thailand. Bull World Health Organ 62:451–461. [PMC free article] [PubMed] [Google Scholar]
- 128. Elkins DB, Mairiang E, Sithithaworn P, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, Haswell-Elkins MR. 1996. Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans. Am J Trop Med Hyg 55:295–301. doi: 10.4269/ajtmh.1996.55.295 [DOI] [PubMed] [Google Scholar]
- 129. Mairiang E, Laha T, Bethony JM, Thinkhamrop B, Kaewkes S, Sithithaworn P, Tesana S, Loukas A, Brindley PJ, Sripa B. 2012. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int 61:208–211. doi: 10.1016/j.parint.2011.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130. Ayé Soukhathammavong P, Rajpho V, Phongluxa K, Vonghachack Y, Hattendorf J, Hongvanthong B, Rasaphon O, Sripa B, Akkhavong K, Hatz C, Odermatt P. 2015. Subtle to severe hepatobiliary morbidity in Opisthorchis viverrini endemic settings in southern Laos. Acta Trop 141:303–309. doi: 10.1016/j.actatropica.2014.09.014 [DOI] [PubMed] [Google Scholar]
- 131. Chen ZZ, Fang YY, Zhang QM, Zhang XC. 1997. The relationship between Clonorchis sinensis infection and acute cholangitis-a survey of Clonorchis sinensis epidemic areas and analysis of clinical data. Zhongguo Ji Sheng Chong Bing Fang Zhi Za Zhi 10:31–33. [Google Scholar]
- 132. Xie W, Deng Y, Chen S, Yang Q. 2019. Association between eosinophil count and cholelithiasis among a population with Clonorchis sinensis infection in Foshan city, China. J Helminthol 94:e107. doi: 10.1017/S0022149X19001019 [DOI] [PubMed] [Google Scholar]
- 133. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, Choi DW, Jang KT, Lee NY, Kim S, Hong ST. 2008. Gallstones and Clonorchis sinensis infection: a hospital-based case-control study in Korea. J Gastroenterol Hepatol 23:e399–404. doi: 10.1111/j.1440-1746.2007.05242.x [DOI] [PubMed] [Google Scholar]
- 134. Sripa B, Kanla P, Sinawat P, Haswell-Elkins MR. 2004. Opisthorchiasis-associated biliary stones: light and scanning electron microscopic study. World J Gastroenterol 10:3318–3321. doi: 10.3748/wjg.v10.i22.3318 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135. Qiao T, Ma R, Luo X, Luo Z, Zheng P. 2012. Cholecystolithiasis is associated with Clonorchis sinensis infection. PLoS One 7:e42471. doi: 10.1371/journal.pone.0042471 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136. Saichua P, Sithithaworn P, Jariwala AR, Deimert DJ, Sithithaworn J, Sripa B, Laha T, Mairiang E, Pairojkul C, Periago MV, Khuntikeo N, Mulvenna J, Bethony JM. 2013. Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis. PLoS Negl Trop Dis 7:e2228. doi: 10.1371/journal.pntd.0002228 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137. Xie W, Deng Y, Chen S, Wu Y, Li Y, Yang Q. 2020. Association between renal function and co-infection with Clonorchis sinensis and Helicobacter pylori: a cross-sectional study. BMC Infect Dis 20:868. doi: 10.1186/s12879-020-05616-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138. Kapushchak YK, Zaparina OG, Mordvinov VA, Pakharukova MY. 2022. Time-dependent renal pathologies associated with the liver fluke infection, opisthorchiasis felinea. Acta Trop 228:106282. doi: 10.1016/j.actatropica.2021.106282 [DOI] [PubMed] [Google Scholar]
- 139. Tonsawan P, Intarak S, Sripa B, Puapairoj A, Sripa M, Sithithaworn P, Anutrakulchai S. 2022. Association between Opisthorchis viverrini infection and glomerular disease in Thailand. Am J Nephrol 53:199–206. doi: 10.1159/000521780 [DOI] [PubMed] [Google Scholar]
- 140. Zhu SH, Zhong XS, Luo ZY. 1983. Clonorchiasis and developmental disorder in the children (dwarfism). Xin Yi Xue 14:71–72. [Google Scholar]
- 141. Phathammavong O, Moazzam A, Xaysomphoo D, Phengsavanh A, Kuroiwa C. 2007. Parasitic infestation and nutritional status among schoolchildren in Vientiane, Lao PDR. J Paediatr Child Health 43:689–694. doi: 10.1111/j.1440-1754.2007.01192.x [DOI] [PubMed] [Google Scholar]
- 142. Sayasone S, Utzinger J, Akkhavong K, Odermatt P. 2015. Multiparasitism and intensity of helminth infections in relation to symptoms and nutritional status among children: a cross-sectional study in southern Lao People’s Democratic Republic. Acta Trop 141:322–331. doi: 10.1016/j.actatropica.2014.09.015 [DOI] [PubMed] [Google Scholar]
- 143. IARC monographs on the evaluation of carcinogenic risks to humans. volume 61. 1994. In Schistosomes, liver flukes and Helicobacter pylori. International Agency for Research on Cancer. [PMC free article] [PubMed] [Google Scholar]
- 144. Møller H, Heseltine E, Vainio H. 1995. Working group report on schistosomes, liver flukes and Helicobacter pylori. Int J Cancer 60:587–589. doi: 10.1002/ijc.2910600502 [DOI] [PubMed] [Google Scholar]
- 145. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi FE, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens--Part B: biological agents. Lancet Oncol 10:321–322. doi: 10.1016/S1470-2045(09)70096-8 [DOI] [PubMed] [Google Scholar]
- 146. IARC monographs on the evaluation of carcinogenic risks to humans. volume 100. 2011. In A review of human carcinogens. Part B: biological agents. International Agency for Research on Cancer. [Google Scholar]
- 147. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, Jang KT, Lee NY, Kim S, Hong ST. 2006. Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol 44:1066–1073. doi: 10.1016/j.jhep.2005.11.040 [DOI] [PubMed] [Google Scholar]
- 148. Haswell-Elkins MR, Mairiang E, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, Sithithaworn P, Elkins DB. 1994. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 59:505–509. doi: 10.1002/ijc.2910590412 [DOI] [PubMed] [Google Scholar]
- 149. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, Lee SK, Seo DW, Kim MH, Suh DJ. 2008. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 103:1716–1720. doi: 10.1111/j.1572-0241.2008.01796.x [DOI] [PubMed] [Google Scholar]
- 150. Honjo S, Srivatanakul P, Sriplung H, Kikukawa H, Hanai S, Uchida K, Todoroki T, Jedpiyawongse A, Kittiwatanachot P, Sripa B, Deerasamee S, Miwa M. 2005. Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer 117:854–860. doi: 10.1002/ijc.21146 [DOI] [PubMed] [Google Scholar]
- 151. Fürst T, Keiser J, Utzinger J. 2012. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 12:210–221. doi: 10.1016/S1473-3099(11)70294-8 [DOI] [PubMed] [Google Scholar]
- 152. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST. 2010. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 101:579–585. doi: 10.1111/j.1349-7006.2009.01458.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153. Kovshirina YV, Fedorova OS, Vtorushin SV, Kovshirina AE, Ivanov SD, Chizhikov AV, Onishchenko SV, Ogorodova LM, Odermatt P. 2019. Case report: two cases of cholangiocarcinoma in patients with Opisthorchis felineus infection in Western Siberia, Russian Federation. Am J Trop Med Hyg 100:599–603. doi: 10.4269/ajtmh.18-0652 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154. Fedorova OS, Kovshirina AE, Kovshirina YV, Hattendorf J, Onishchenko SV, Katanakhova LL, Taslicki SS, Chizhikov AV, Tataurov IA, Vtorushin SV, Sripa B, Ogorodova LM, Odermatt P. 2023. Opisthorchis felineus infection is a risk factor for cholangiocarcinoma in Western Siberia: a hospital-based case-control study. Clin Infect Dis 76:e1392–e1398. doi: 10.1093/cid/ciac497 [DOI] [PubMed] [Google Scholar]
- 155. Tan SK, Qiu XQ, Yu HP, Zeng XY, Zhao YN, Hu L. 2008. Evaluation of the risk of clonorchiasis inducing primary hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 16:114–116. [PubMed] [Google Scholar]
- 156. Kim YH. 1999. Pancreatitis in association with Clonorchis sinensis infestation: CT evaluation. AJR Am J Roentgenol 172:1293–1296. doi: 10.2214/ajr.172.5.10227505 [DOI] [PubMed] [Google Scholar]
- 157. Reddy AK, Chakrabarty M, Liu Y, Cohen SH, Maniar AH. 2021. Case report: Clonorchis sinensis infection associated with eosinophilic pneumonia. Am J Trop Med Hyg 104:2065–2068. doi: 10.4269/ajtmh.20-0632 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 158. Kim YH. 2003. Carcinoma of the gallbladder associated with clonorchiasis: clinicopathologic and CT evaluation. Abdom Imaging 28:83–86. doi: 10.1007/s00261-001-0155-z [DOI] [PubMed] [Google Scholar]
- 159. Bychkov VG, Zolotukhin VM, Khadieva ED, Kulikova SV, Petrov IM, Berdinskih SG, Lazarev SD, Morozova LF, Morozov EN. 2019. Hypereosinophilic syndrome, cardiomyopathies, and sudden cardiac death in superinvasive opisthorchiasis. Cardiol Res Pract 2019:4836948. doi: 10.1155/2019/4836948 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160. Nepomnyashchikh LM, Aidagulova SV, Senchukova SR, Demidova EI. 2002. Allergic dermatoses associated with chronic opisthorchiasis during antihelminthic therapy. Bull Exp Biol Med 134:494–499. doi: 10.1023/A:1022610902337 [DOI] [PubMed] [Google Scholar]
- 161. Ogorodova LM, Freidin MB, Sazonov AE, Fedorova OS, Gerbek IE, Cherevko NA, Lebedeva NY. 2007. A pilot screening of prevalence of atopic states and opisthorchosis and their relationship in people of Tomsk Oblast. Parasitol Res 101:1165–1168. doi: 10.1007/s00436-007-0588-6 [DOI] [PubMed] [Google Scholar]
- 162. Phathammavong O, Ali M, Phengsavanh A, Xaysomphou D, Odajima H, Nishima S, Kuroiwa C. 2008. Prevalence and potential risk factors of rhinitis and atopic eczema among schoolchildren in Vientiane capital, Lao PDR: ISAAC questionnaire. Biosci Trends 2:193–199. [PubMed] [Google Scholar]
- 163. Ciprandi G, Cavallucci E, Cuccurullo F, Di Gioacchino M. 2008. Helminthic infection as a factor in new-onset coffee allergy in a father and daughter. J Allergy Clin Immunol 121:773–774. doi: 10.1016/j.jaci.2007.09.050 [DOI] [PubMed] [Google Scholar]
- 164. Choi MH, Chang YS, Lim MK, Bae YM, Hong ST, Oh JK, Yun EH, Bae MJ, Kwon HS, Lee SM, Park HW, Min KU, Kim YY, Cho SH. 2011. Clonorchis sinensis infection is positively associated with atopy in endemic area. Clin Exp Allergy 41:697–705. doi: 10.1111/j.1365-2222.2011.03746.x [DOI] [PubMed] [Google Scholar]
- 165. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad LJ, Assadi R, Bhala N, Cowie B, Forouzanfour MH, Groeger J, Hanafiah KM, Jacobsen KH, James SL, MacLachlan J, Malekzadeh R, Martin NK, Mokdad AA, Mokdad AH, Murray CJL, Plass D, Rana S, Rein DB, Richardus JH, Sanabria J, Saylan M, Shahraz S, So S, Vlassov VV, Weiderpass E, Wiersma ST, Younis M, Yu C, El Sayed Zaki M, Cooke GS. 2016. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 388:1081–1088. doi: 10.1016/S0140-6736(16)30579-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166. Li W, Dong H, Huang Y, Chen T, Kong X, Sun H, Yu X, Xu J. 2016. Clonorchis sinensis co-infection could affect the disease state and treatment response of HBV patients. PLoS Negl Trop Dis 10:e0004806. doi: 10.1371/journal.pntd.0004806 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167. Deenonpoe R, Mairiang E, Mairiang P, Pairojkul C, Chamgramol Y, Rinaldi G, Loukas A, Brindley PJ, Sripa B. 2017. Elevated prevalence of helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease. Sci Rep 7:42744. doi: 10.1038/srep42744 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168. Phung HTT, Deenonpoe R, Suttiprapa S, Mairiang E, Edwards SW, Sripa B. 2022. Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis. Helicobacter 27:e12897. doi: 10.1111/hel.12897 [DOI] [PubMed] [Google Scholar]
- 169. Sripa B, Deenonpoe R, Brindley PJ. 2017. Co-infections with liver fluke and helicobacter species: a paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma? Parasitol Int 66:383–389. doi: 10.1016/j.parint.2016.11.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170. Sayasone S, Rasphone O, Vanmany M, Vounatsou P, Utzinger J, Tanner M, Akkhavong K, Hatz C, Odermatt P. 2012. Severe morbidity due to Opisthorchis viverrini and Schistosoma mekongi infection in Lao People’s Democratic Republic. Clin Infect Dis 55:e54–e57. doi: 10.1093/cid/cis528 [DOI] [PubMed] [Google Scholar]
- 171. Songserm N, Promthet S, Sithithaworn P, Pientong C, Ekalaksananan T, Chopjitt P, Parkin DM. 2012. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol 36:e89–94. doi: 10.1016/j.canep.2011.11.007 [DOI] [PubMed] [Google Scholar]
- 172. Sriraj P, Aukkanimart R, Boonmars T, Juasook A, Sudsarn P, Wonkchalee N, Pairojkul C, Waraasawapati S, Laummaunwai P, Boonjaraspinyo S. 2013. Does a combination of opisthorchiasis and ethyl alcohol consumption enhance early cholangiofibrosis, the risk of cholangiocarcinoma? Parasitol Res 112:2971–2981. doi: 10.1007/s00436-013-3469-1 [DOI] [PubMed] [Google Scholar]
- 173. Sriraj P, Boonmars T, Aukkanimart R, Songsri J, Sripan P, Ratanasuwan P, Boonjaraspinyo S, Wongchalee N, Laummaunwai P. 2016. A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development. Parasitol Res 115:3843–3852. doi: 10.1007/s00436-016-5148-5 [DOI] [PubMed] [Google Scholar]
- 174. Shao Y, Dong JH, Wang SG, Bie P, Yang ZY, Wang KZ, He ZP. 2008. The application of donor livers with Clonorchis sinensis in liver transplantation (a report of three cases). Xuzhou Yi Xue Yuan Xue Bao 28:335–337. [Google Scholar]
- 175. Capobianco I, Frank M, Königsrainer A, Sipos B, Menzel M, Sturm E, Nadalin S. 2015. Liver fluke-infested graft used for living-donor liver transplantation: case report and review of the literature. Transpl Infect Dis 17:880–885. doi: 10.1111/tid.12463 [DOI] [PubMed] [Google Scholar]
- 176. Zhu ZJ, Shen ZY, Gao W, Zheng H, Deng YL, Pan C, Sun LY, Zeng ZG, Sun JS. 2010. Feasibility of using a liver infected with Clonorchis sinensis for liver transplantation: fourteen cases. Liver Transpl 16:1440–1442. doi: 10.1002/lt.22147 [DOI] [PubMed] [Google Scholar]
- 177. Kotton CN, Hurtado RM. 2010. Not just a fluke: expanding the organ supply. Liver Transpl 16:1343–1344. doi: 10.1002/lt.22178 [DOI] [PubMed] [Google Scholar]
- 178. Hwang YJ, Kim YI, Yun YK, Kim JW. 2000. Use of liver graft infested with Clonorchis sinensis for living related liver transplantation: a case report. Transplant Proc 32:2182–2183. doi: 10.1016/s0041-1345(00)01625-0 [DOI] [PubMed] [Google Scholar]
- 179. Lee KW, Joh JW, Kim SJ, Park JH, Chon SE, Choi SH, Heo JS, Song JH, Kim SM, Peck KR, Kim YI, Lee BB, Lee SK. 2003. Living donor liver transplantation using graft infested with Clonorchis sinensis: two cases. Transplant Proc 35:66–67. doi: 10.1016/s0041-1345(02)03955-6 [DOI] [PubMed] [Google Scholar]
- 180. Yeung CK, Ho JK, Lau WY, Lee KH, Li AK. 1996. The use of liver grafts infested with Clonorchis sinensis for orthotopic liver transplantation. Postgrad Med J 72:427–428. doi: 10.1136/pgmj.72.849.427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 181. Saijuntha W, Duenngai K, Tangkawattana S, Petney TN, Andrews RH, Sithithaworn P. 2018. Recent advances in the diagnosis and detection of Opisthorchis viverrini sensu lato in human and intermediate hosts for use in control and elimination programs. Adv Parasitol 101:177–214. doi: 10.1016/bs.apar.2018.05.007 [DOI] [PubMed] [Google Scholar]
- 182. Hong ST, Choi MH, Kim CH, Chung BS, Ji Z. 2003. The Kato-Katz method is reliable for diagnosis of Clonorchis sinensis infection. Diagn Microbiol Infect Dis 47:345–347. doi: 10.1016/s0732-8893(03)00113-5 [DOI] [PubMed] [Google Scholar]
- 183. Charoensuk L, Subrungruang I, Mungthin M, Pinlaor S, Suwannahitatorn P. 2019. Comparison of stool examination techniques to detect Opisthorchis viverrini in low intensity infection. Acta Trop 191:13–16. doi: 10.1016/j.actatropica.2018.12.018 [DOI] [PubMed] [Google Scholar]
- 184. Sayasone S, Utzinger J, Akkhavong K, Odermatt P. 2015. Repeated stool sampling and use of multiple techniques enhance the sensitivity of helminth diagnosis: a cross-sectional survey in southern Lao People’s Democratic Republic. Acta Trop 141:315–321. doi: 10.1016/j.actatropica.2014.09.004 [DOI] [PubMed] [Google Scholar]
- 185. Qian MB, Yap P, Yang YC, Liang H, Jiang ZH, Li W, Utzinger J, Zhou XN, Keiser J. 2013. Accuracy of the Kato-Katz method and formalin-ether concentration technique for the diagnosis of Clonorchis sinensis, and implication for assessing drug efficacy. Parasit Vectors 6:314. doi: 10.1186/1756-3305-6-314 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186. Qian MB, Zhuang SF, Zhu SQ, Deng XM, Li ZX, Zhou XN. 2019. Improving diagnostic performance of the Kato-Katz method for Clonorchis sinensis infection through multiple samples. Parasit Vectors 12:336. doi: 10.1186/s13071-019-3594-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187. Lee YJ, Won EJ, Cho YC, Kim SH, Shin MG, Shin JH. 2021. Utility of an automatic vision-based examination system (AVE-562) for the detection of Clonorchis sinensis eggs in stool. Ann Lab Med 41:221–224. doi: 10.3343/alm.2021.41.2.221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 188. Joo KR, Bang SJ. 2005. A bile based study of Clonorchis sinensis infections in patients with biliary tract diseases in Ulsan, Korea. Yonsei Med J 46:794–798. doi: 10.3349/ymj.2005.46.6.794 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189. Qiao T, Ma R, Luo X, Zheng P, Luo Z, Yang L. 2013. Microscopic examination of gallbladder stones improves rate of detection of Clonorchis sinensis infection. J Clin Microbiol 51:2551–2555. doi: 10.1128/JCM.00946-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190. Ditrich O, Giboda M, Scholz T, Beer SA. 1992. Comparative morphology of eggs of the haplorchiinae (Trematoda: Heterophyidae) and some other medically important heterophyid and opisthorchiid flukes. Folia Parasitol (Praha) 39:123–132. [PubMed] [Google Scholar]
- 191. Lee JJ, Jung BK, Lim H, Lee MY, Choi SY, Shin EH, Chai JY. 2012. Comparative morphology of minute intestinal fluke eggs that can occur in human stools in the Republic of Korea. Korean J Parasitol 50:207–213. doi: 10.3347/kjp.2012.50.3.207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 192. Liu X, Zhu G, Cai C, Lv Z, Li J. 2019. Clonorchiasis sinensis detected by laparoscopic exploration of biliary tracts in two patients with obstructive jaundice. BMC Infect Dis 19:33. doi: 10.1186/s12879-019-3679-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 193. Yunina D, Golfeyz S, Cheung D, Mathison BA, Landa M, Niknam N, Khodorskiy DO, Pittman ME. 2022. Liver flukes diagnosed by ERCP in a local immigrant community. Gastrointest Endosc 96:1058–1061. doi: 10.1016/j.gie.2022.07.028 [DOI] [PubMed] [Google Scholar]
- 194. Sato M, Pongvongsa T, Sanguankiat S, Yoonuan T, Kobayashi J, Boupha B, Nishimoto F, Moji K, Sato MO, Waikagul J. 2015. Patterns of trematode infections of Opisthorchis viverrini (Opisthorchiidae) and Haplorchis taichui (Heterophyidae) in human populations from two villages in Savannakhet province, Lao PDR. J Helminthol 89:439–445. doi: 10.1017/S0022149X14000261 [DOI] [PubMed] [Google Scholar]
- 195. Choi MH, Park IC, Li S, Hong ST. 2003. Excretory-secretory antigen is better than crude antigen for the serodiagnosis of clonorchiasis by ELISA. Korean J Parasitol 41:35–39. doi: 10.3347/kjp.2003.41.1.35 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196. Li HM, Qian MB, Yang YC, Jiang ZH, Wei K, Chen JX, Chen JH, Chen YD, Zhou XN. 2018. Performance evaluation of existing immunoassays for Clonorchis sinensis infection in China. Parasit Vectors 11:35. doi: 10.1186/s13071-018-2612-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 197. Cho PY, Lee JY, Kim TI, Song JH, Hong SJ, Yoo WG, Tsuboi T, Ha KS, Jung JW, Takeo S, Han ET, Sripa B, Hong ST, Chai JY, Nam HW, Pak JH, Kim TS. 2020. Serodiagnostic antigens of Clonorchis sinensis identified and evaluated by high-throughput proteogenomics. PLoS Negl Trop Dis 14:e0008998. doi: 10.1371/journal.pntd.0008998 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 198. Phupiewkham W, Sadaow L, Sanpool O, Rodpai R, Yamasaki H, Ittiprasert W, Mann VH, Brindley PJ, Maleewong W, Intapan PM. 2021. Comparative assessment of immunochromatographic test kits using somatic antigens from adult Opisthorchis viverrini and IgG and IgG4 conjugates for serodiagnosis of human opisthorchiasis. Parasitol Res 120:2839–2846. doi: 10.1007/s00436-021-07224-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 199. Kim YJ, Lee SM, Choi GE, Hwang SH, Kim HH, Lee EY, Chang CL. 2010. Performance of an enzyme-linked immunosorbent assay for detection of Clonorchis sinensis infestation in high- and low-risk groups. J Clin Microbiol 48:2365–2367. doi: 10.1128/JCM.02506-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 200. Cheng N, Xu XN, Zhou Y, Dong YT, Bao YF, Xu B, Hu W, Feng Z. 2018. Cs1, a Clonorchis sinensis-derived serodiagnostic antigen containing tandem repeats and a signal peptide. PLoS Negl Trop Dis 12:e0006683. doi: 10.1371/journal.pntd.0006683 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 201. Sadaow L, Sanpool O, Rodpai R, Yamasaki H, Ittiprasert W, Mann VH, Brindley PJ, Maleewong W, Intapan PM. 2019. Development of an immunochromatographic point-of-care test for serodiagnosis of opisthorchiasis and clonorchiasis. Am J Trop Med Hyg 101:1156–1160. doi: 10.4269/ajtmh.19-0446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 202. Gómez-Morales MA, Ludovisi A, Amati M, Pozio E. 2013. Validation of an excretory/secretory antigen based-ELISA for the diagnosis of Opisthorchis felineus infection in humans from low trematode endemic areas. PLoS One 8:e62267. doi: 10.1371/journal.pone.0062267 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 203. Li Y, Huang Y, Hu X, Liu X, Ma C, Zhao J, Wu Z, Xu J, Yu X. 2012. 41.5-kDa cathepsin L protease from Clonorchis sinensis: expression, characterization, and serological reactivity of one excretory-secretory antigen. Parasitol Res 111:673–680. doi: 10.1007/s00436-012-2885-y [DOI] [PubMed] [Google Scholar]
- 204. Kim JG, Ahn CS, Sripa B, Eom KS, Kang I, Sohn WM, Nawa Y, Kong Y. 2019. Clonorchis sinensis omega-class glutathione transferases are reliable biomarkers for serodiagnosis of clonorchiasis and opisthorchiasis. Clin Microbiol Infect 25:109. doi: 10.1016/j.cmi.2018.03.042 [DOI] [PubMed] [Google Scholar]
- 205. Li S, Shin JG, Cho PY, Kim TI, Hong ST, Hong SJ. 2011. Multiple recombinant antigens of Clonorchis sinensis for serodiagnosis of human clonorchiasis. Parasitol Res 108:1295–1302. doi: 10.1007/s00436-010-2179-1 [DOI] [PubMed] [Google Scholar]
- 206. Chaiyarit P, Sithithaworn P, Thuwajit C, Yongvanit P. 2011. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients. Clin Oral Investig 15:477–483. doi: 10.1007/s00784-010-0421-y [DOI] [PubMed] [Google Scholar]
- 207. Nie G, Wang T, Lu S, Liu W, Li Y, Lei J. 2014. Detection of Clonorchis sinensis circulating antigen in sera from Chinese patients by immunomagnetic bead ELISA based on IgY. PLoS One 9:e113208. doi: 10.1371/journal.pone.0113208 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 208. Teimoori S, Arimatsu Y, Laha T, Kaewkes S, Sereerak P, Sripa M, Tangkawattana S, Brindley PJ, Sripa B. 2017. Chicken IgY-based coproantigen capture ELISA for diagnosis of human opisthorchiasis. Parasitol Int 66:443–447. doi: 10.1016/j.parint.2015.10.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 209. Worasith C, Wangboon C, Duenngai K, Kiatsopit N, Kopolrat K, Techasen A, Sithithaworn J, Khuntikeo N, Loilome W, Namwat N, Yongvanit P, Carlton EJ, Sithithaworn P. 2019. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in northeast Thailand. PLoS Negl Trop Dis 13:e0007186. doi: 10.1371/journal.pntd.0007186 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 210. Worasith C, Kamamia C, Yakovleva A, Duenngai K, Wangboon C, Sithithaworn J, Watwiengkam N, Namwat N, Techasen A, Loilome W, Yongvanit P, Loukas A, Sithithaworn P, Bethony JM. 2015. Advances in the diagnosis of human opisthorchiasis: development of Opisthorchis viverrini antigen detection in urine. PLoS Negl Trop Dis 9:e0004157. doi: 10.1371/journal.pntd.0004157 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 211. Watwiengkam N, Sithithaworn J, Duenngai K, Sripa B, Laha T, Johansen MV, Sithithaworn P. 2013. Improved performance and quantitative detection of copro-antigens by a monoclonal antibody based ELISA to diagnose human opisthorchiasis. Acta Trop 128:659–665. doi: 10.1016/j.actatropica.2013.09.012 [DOI] [PubMed] [Google Scholar]
- 212. Worasith C, Wongphutorn P, Homwong C, Kopolrat KY, Techasen A, Thanan R, Eamudomkarn C, Wangboon C, Khuntikeo N, Loilome W, Sithithaworn J, Crellen T, Sithithaworn P. 2022. Effects of day-to-day variation of Opisthorchis viverrini antigen in urine on the accuracy of diagnosing opisthorchiasis in northeast Thailand. PLoS One 17:e0271553. doi: 10.1371/journal.pone.0271553 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 213. Worasith C, Wongphutorn P, Kopolrat KY, Homwong C, Techasen A, Thanan R, Wangboon C, Eamudomkarn C, Sithithaworn J, Crellen T, Sithithaworn P. 2022. Long-term persistence of Opisthorchis viverrini antigen in urine: a prospective study in northeast Thailand. Am J Trop Med Hyg 108:356–358. doi: 10.4269/ajtmh.22-0478 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 214. Worasith C, Wangboon C, Kopolrat KY, Homwong C, Sithithaworn J, Techasen A, Thanan R, Khuntikeo N, Sithithaworn P. 2020. Application of urine antigen assay to evaluate outcomes of praziquantel treatment and reinfection in opisthorchiasis in northeast Thailand. Trans R Soc Trop Med Hyg 114:751–761. doi: 10.1093/trstmh/traa057 [DOI] [PubMed] [Google Scholar]
- 215. Taron W, Jamnongkan W, Techasen A, Phetcharaburanin J, Namwat N, Sithithaworn P, Khuntikeo N, Mukdasai S, Sayasone S, Loilome W, Ngeontae W. 2020. Aunps-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine. Talanta 209:120592. doi: 10.1016/j.talanta.2019.120592 [DOI] [PubMed] [Google Scholar]
- 216. Taron W, Jamnongkan W, Phetcharaburanin J, Klanrit P, Namwat N, Techasen A, Sithithaworn P, Khuntikeo N, Boonmars T, Loilome W, Ngeontae W. 2021. A fluorescence AuNPS-LISA: a new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples. Spectrochim Acta A Mol Biomol Spectrosc 254:119633. doi: 10.1016/j.saa.2021.119633 [DOI] [PubMed] [Google Scholar]
- 217. Taron W, Phooplub K, Sanchimplee S, Piyanamvanich K, Jamnongkan W, Techasen A, Phetcharaburanin J, Klanrit P, Namwat N, Khuntikeo N, Boonmars T, Sithithaworn P, Ouiganon S, Kanatharana P, Thavarungkul P, Buranachai C, Loilome W, Ngeontae W. 2021. Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples. Sensors and Actuators: B Chemical 348:130705. doi: 10.1016/j.snb.2021.130705 [DOI] [Google Scholar]
- 218. Müller B, Schmidt J, Mehlhorn H. 2007. PCR diagnosis of infections with different species of Opisthorchiidae using a rapid clean-up procedure for stool samples and specific primers. Parasitol Res 100:905–909. doi: 10.1007/s00436-006-0321-x [DOI] [PubMed] [Google Scholar]
- 219. Huang SY, Tang JD, Song HQ, Fu BQ, Xu MJ, Hu XC, Zhang H, Weng YB, Lin RQ, Zhu XQ. 2012. A specific PCR assay for the diagnosis of Clonorchis sinensis infection in humans, cats and fishes. Parasitol Int 61:187–190. doi: 10.1016/j.parint.2011.07.010 [DOI] [PubMed] [Google Scholar]
- 220. Meng X, Jian-Hai Y, Sheng-Kui C, Jian-Ping C, Xiao-Fan Z, Yu-Juan S. 2019. Comparison of efficiency of Kato-Katz technique and PCR assay for detecting Clonorchis sinensis infection. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 31:165–168. doi: 10.16250/j.32.1374.2018233 [DOI] [PubMed] [Google Scholar]
- 221. Pumpa S, Phadungsil W, Grams R, Martviset P, Ruang-Areerate T, Mungthin M, Geadkaew-Krenc A. 2021. Improvement of a PCR-based method for the detection of Opisthorchis viverrini eggs in human stool samples by targeting internal transcribed spacer-2 (ITS-2), cytochrome oxidase subunit 1 (cox1), and cytochrome b (cyb). J Parasit Dis 45:474–478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 222. Tantrawatpan C, Intapan PM, Thanchomnang T, Sanpool O, Janwan P, Lulitanond V, Sadaow L, Maleewong W. 2014. Development of a PCR assay and pyrosequencing for identification of important human fish-borne trematodes and its potential use for detection in fecal specimens. Parasit Vectors 7:88. doi: 10.1186/1756-3305-7-88 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 223. Buathong S, Leelayoova S, Mungthin M, Naaglor T, Taamasri P, Suwannahitatorn P, Tan-Ariya P. 2015. Development and evaluation of PCR methods based on cytochrome c oxidase subunit one (cox1) and NADH dehydrogenase subunit one gene (nad1) to detect Opisthorchis viverrini in human fecal samples. Parasitol Res 114:3547–3549. doi: 10.1007/s00436-015-4640-7 [DOI] [PubMed] [Google Scholar]
- 224. Rahman SMM, Song HB, Jin Y, Oh JK, Lim MK, Hong ST, Choi MH. 2017. Application of a loop-mediated isothermal amplification (LAMP) assay targeting cox1 gene for the detection of Clonorchis sinensis in human fecal samples. PLoS Negl Trop Dis 11:e0005995. doi: 10.1371/journal.pntd.0005995 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 225. Smagulova A, Katokhin A, Mambetpayeva B, Kulmaganbetova N, Kiyan V. 2021. A multiplex PCR assay for the differential detection of Opisthorchis felineus and Metorchis bilis. Georgian Med News:176–182. [PubMed] [Google Scholar]
- 226. Phadungsil W, Pumpa S, Sirisabhabhorn K, Geadkaew-Krenc A, Grams R, Mungthin M, Ruang-Areerate T, Adisakwattana P, Labbunruang N, Martviset P. 2021. Efficiency of the stool-PCR test targeting NADH dehydrogenase (nad) subunits for detection of Opisthorchis viverrini eggs. J Trop Med 2021:3957545. doi: 10.1155/2021/3957545 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 227. Cho PY, Na B-K, Mi Choi K, Kim JS, Cho S-H, Lee W-J, Lim S-B, Cha SH, Park Y-K, Pak JH, Lee H-W, Hong S-J, Kim T-S. 2013. Development of a polymerase chain reaction applicable to rapid and sensitive detection of Clonorchis sinensis eggs in human stool samples . Pathog Glob Health 107:253–259. doi: 10.1179/2047773213Y.0000000099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 228. Wongratanacheewin S, Pumidonming W, Sermswan RW, Pipitgool V, Maleewong W. 2002. Detection of Opisthorchis viverrini in human stool specimens by PCR. J Clin Microbiol 40:3879–3880. doi: 10.1128/JCM.40.10.3879-3880.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 229. Stensvold CR, Saijuntha W, Sithithaworn P, Wongratanacheewin S, Strandgaard H, Ørnbjerg N, Johansen MV. 2006. Evaluation of PCR based coprodiagnosis of human opisthorchiasis. Acta Trop 97:26–30. doi: 10.1016/j.actatropica.2005.08.008 [DOI] [PubMed] [Google Scholar]
- 230. Duenngai K, Sithithaworn P, Rudrappa UK, Iddya K, Laha T, Stensvold CR, Strandgaard H, Johansen MV. 2008. Improvement of PCR for detection of Opisthorchis viverrini DNA in human stool samples. J Clin Microbiol 46:366–368. doi: 10.1128/JCM.01323-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 231. Le TH, Van De N, Blair D, Sithithaworn P, McManus DP. 2006. Clonorchis sinensis and Opisthorchis viverrini: development of a mitochondrial-based multiplex PCR for their identification and discrimination. Exp Parasitol 112:109–114. doi: 10.1016/j.exppara.2005.09.012 [DOI] [PubMed] [Google Scholar]
- 232. Wongsawad C, Wongsawad P. 2012. Opisthorchis viverrini and Haplorchis taichui: development of a multiplex PCR assay for their detection and differentiation using specific primers derived from HAT-RAPD. Exp Parasitol 132:237–242. doi: 10.1016/j.exppara.2012.07.007 [DOI] [PubMed] [Google Scholar]
- 233. Kim E-M, Verweij JJ, Jalili A, van Lieshout L, Choi M-H, Bae YM, Lim MK, Hong S-T. 2009. Detection of Clonorchis sinensis in stool samples using real-time PCR. Ann Trop Med Parasitol 103:513–518. doi: 10.1179/136485909X451834 [DOI] [PubMed] [Google Scholar]
- 234. Cai XQ, Yu HQ, Bai JS, Tang JD, Hu XC, Chen DH, Zhang RL, Chen MX, Ai L, Zhu XQ. 2012. Development of a TaqMan based real-time PCR assay for detection of Clonorchis sinensis DNA in human stool samples and fishes. Parasitol Int 61:183–186. doi: 10.1016/j.parint.2011.06.010 [DOI] [PubMed] [Google Scholar]
- 235. Le TH, Nguyen NTB, Truong NH, De NV. 2012. Development of mitochondrial loop-mediated isothermal amplification for detection of the small liver fluke Opisthorchis viverrini (Opisthorchiidae; Trematoda; Platyhelminthes). J Clin Microbiol 50:1178–1184. doi: 10.1128/JCM.06277-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 236. Arimatsu Y, Kaewkes S, Laha T, Hong SJ, Sripa B. 2012. Rapid detection of Opisthorchis viverrini copro-DNA using loop-mediated isothermal amplification (LAMP). Parasitol Int 61:178–182. doi: 10.1016/j.parint.2011.08.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 237. Intapan PM, Thanchomnang T, Lulitanond V, Pongsaskulchoti P, Maleewong W. 2008. Detection of Opisthorchis viverrini in infected bithynid snails by real-time fluorescence resonance energy transfer PCR-based method and melting curve analysis. Parasitol Res 103:649–655. doi: 10.1007/s00436-008-1026-0 [DOI] [PubMed] [Google Scholar]
- 238. Chen Y, Wen T, Lai DH, Wen YZ, Wu ZD, Yang TB, Yu XB, Hide G, Lun ZR. 2013. Development and evaluation of loop-mediated isothermal amplification (LAMP) for rapid detection of Clonorchis sinensis from its first intermediate hosts, freshwater snails . Parasitology 140:1377–1383. doi: 10.1017/S0031182013000498 [DOI] [PubMed] [Google Scholar]
- 239. Cai XQ, Xu MJ, Wang YH, Qiu DY, Liu GX, Lin A, Tang JD, Zhang RL, Zhu XQ. 2010. Sensitive and rapid detection of Clonorchis sinensis infection in fish by loop-mediated isothermal amplification (LAMP). Parasitol Res 106:1379–1383. doi: 10.1007/s00436-010-1812-3 [DOI] [PubMed] [Google Scholar]
- 240. Cai XQ, Yu HQ, Li R, Yue QY, Liu GH, Bai JS, Deng Y, Qiu DY, Zhu XQ. 2014. Rapid detection and differentiation of Clonorchis sinensis and Opisthorchis viverrini using real-time PCR and high resolution melting analysis. The Scientific World Journal 2014:893981. doi: 10.1155/2014/893981 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 241. Caffara M, Serracca L, Gustinelli A, Vencia W, Rossini I, Prearo M, Fioravanti ML. 2017. Development and validation of species-specific molecular diagnostic tool for Opisthorchis felineus (Digenea, Opisthorchiidae) metacercariae. Int J Food Microbiol 242:98–100. doi: 10.1016/j.ijfoodmicro.2016.11.024 [DOI] [PubMed] [Google Scholar]
- 242. Sri-Aroon P, Intapan PM, Lohachit C, Phongsasakulchoti P, Thanchomnang T, Lulitanond V, Hiscox A, Phompida S, Sananikhom P, Maleewong W, Brey PT. 2011. Molecular evidence of Opisthorchis viverrini in infected bithyniid snails in the Lao People’s Democratic Republic by specific hybridization probe-based real-time fluorescence resonance energy transfer PCR method. Parasitol Res 108:973–978. doi: 10.1007/s00436-010-2140-3 [DOI] [PubMed] [Google Scholar]
- 243. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, Cho HJ, Kim KA, Choi SY. 2009. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29:683–700. doi: 10.1148/rg.293085729 [DOI] [PubMed] [Google Scholar]
- 244. Choi BI, Han JK, Hong ST, Lee KH. 2004. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev 17:540–552. doi: 10.1128/CMR.17.3.540-552.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 245. Jeong YY, Kang HK, Kim JW, Yoon W, Chung TW, Ko SW. 2004. MR imaging findings of clonorchiasis. Korean J Radiol 5:25–30. doi: 10.3348/kjr.2004.5.1.25 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 246. Lim JH. 1990. Radiologic findings of clonorchiasis. AJR Am J Roentgenol 155:1001–1008. doi: 10.2214/ajr.155.5.2120925 [DOI] [PubMed] [Google Scholar]
- 247. Li XL, Zhi FC, Huang BY, Yang LC, Xu TL, Wang FQ, Liang BY, Fu Z. 2005. Comparison study on diagnostic value of ERCP, US and CT on clonorchiasis and clonorchiasis-related cholangiopancreatic diseases. Zhonghua Xiao Hua Za Zhi 25:583–585. [Google Scholar]
- 248. Xu QH, Zhu GX, Liang MZ. 2003. Ultrasound diagnosis and differential diagnosis value of chonorchiasis. Guangzhou Yi Yao 34:49–51. [Google Scholar]
- 249. Lo WK, Yu SM, Chan JC. 2018. Characteristic imaging features of clonorchiasis. Hong Kong Med J 24:206. doi: 10.12809/hkmj166198 [DOI] [PubMed] [Google Scholar]
- 250. Choi D, Hong ST, Lim JH, Cho SY, Rim HJ, Ji Z, Yuan R, Wang S. 2004. Sonographic findings of active Clonorchis sinensis infection. J Clin Ultrasound 32:17–23. doi: 10.1002/jcu.10216 [DOI] [PubMed] [Google Scholar]
- 251. Choi MS, Choi D, Choi MH, Ji Z, Li Z, Cho SY, Hong KS, Rim HJ, Hong ST. 2005. Correlation between sonographic findings and infection intensity in clonorchiasis. Am J Trop Med Hyg 73:1139–1144. doi: 10.4269/ajtmh.2005.73.1139 [DOI] [PubMed] [Google Scholar]
- 252. Mairiang E, Laha T, Kaewkes S, Loukas A, Bethony J, Brindley PJ, Sripa B. 2021. Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study. Acta Trop 217:105853. doi: 10.1016/j.actatropica.2021.105853 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 253. Choi D, Jeon YH, Lee GC, Choi MH, Hong ST. 2009. Changes in sonographic findings after treatment of patients with clonorchiasis in a heavy endemic area. Korean J Parasitol 47:19–23. doi: 10.3347/kjp.2009.47.1.19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 254. Chai JY. 2013. Praziquantel treatment in trematode and cestode infections: an update. Infect Chemother 45:32–43. doi: 10.3947/ic.2013.45.1.32 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 255. Chan JD, Zarowiecki M, Marchant JS. 2013. Ca²⁺ channels and praziquantel: a view from the free world. Parasitol Int 62:619–628. doi: 10.1016/j.parint.2012.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 256. WHO . Foodborne trematode infections. Geneva: World Health Organization. Available from: https://www.who.int/news-room/fact-sheets/detail/foodborne-trematode-infections. Accessed 15 April 2022
- 257. Qian MB, Patel C, Palmeirim MS, Wang X, Schindler C, Utzinger J, Zhou XN, Keiser J. 2022. Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis. Lancet Microbe 3:e616–e624. doi: 10.1016/S2666-5247(22)00026-X [DOI] [PubMed] [Google Scholar]
- 258. Rim HJ, Lee YM, Lee JS, Joo KH. 1982. Therapeutic field trial with praziquantel (Biltricide(R)) in a rural population infected with Clonorchis sinensis. Korean J Parasitol 20:1–8. doi: 10.3347/kjp.1982.20.1.1 [DOI] [PubMed] [Google Scholar]
- 259. Lee SH. 1984. Large scale treatment of Clonorchis sinensis infections with praziquantel under field conditions. Arzneimittelforschung 34:1227–1230. [PubMed] [Google Scholar]
- 260. Soukhathammavong P, Odermatt P, Sayasone S, Vonghachack Y, Vounatsou P, Hatz C, Akkhavong K, Keiser J. 2011. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infect Dis 11:110–118. doi: 10.1016/S1473-3099(10)70250-4 [DOI] [PubMed] [Google Scholar]
- 261. Lovis L, Mak TK, Phongluxa K, Ayé Soukhathammavong P, Vonghachack Y, Keiser J, Vounatsou P, Tanner M, Hatz C, Utzinger J, Odermatt P, Akkhavong K. 2012. Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial. PLoS Negl Trop Dis 6:e1726. doi: 10.1371/journal.pntd.0001726 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 262. Qian MB, Yap P, Yang YC, Liang H, Jiang ZH, Li W, Tan YG, Zhou H, Utzinger J, Zhou XN, Keiser J. 2013. Efficacy and safety of tribendimidine against Clonorchis sinensis. Clin Infect Dis 56:e76–e82. doi: 10.1093/cid/cis1011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 263. Sayasone S, Meister I, Andrews JR, Odermatt P, Vonghachack Y, Xayavong S, Senggnam K, Phongluxa K, Hattendorf J, Bogoch II, Keiser J. 2017. Efficacy and safety of praziquantel against light infections of Opisthorchis viverrini: a randomized parallel single-blind dose-ranging trial. Clin Infect Dis 64:451–458. doi: 10.1093/cid/ciw785 [DOI] [PubMed] [Google Scholar]
- 264. Kim CH, Lee JK, Chung BS, Li S, Choi MH, Hong ST. 2011. Influencing factors for cure of clonorchiasis by praziquantel therapy: infection burden and CYP3A5 gene polymorphism. Korean J Parasitol 49:45–49. doi: 10.3347/kjp.2011.49.1.45 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 265. Wang XG, Liu YH, Yan XH. 1992. A comparative trial of levo-praziquantel and praziquantel in the treatment of human Clonorchis sinensis infection. Zhonghua Nei Ke Za Zhi 31:233–235. [PubMed] [Google Scholar]
- 266. Chai JY, Jung BK, Hong SJ. 2021. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: an update. Korean J Parasitol 59:189–225. doi: 10.3347/kjp.2021.59.3.189 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 267. Lacey E. 1990. Mode of action of benzimidazoles. Parasitol Today 6:112–115. doi: 10.1016/0169-4758(90)90227-u [DOI] [PubMed] [Google Scholar]
- 268. Huang J, Wei Q, Wu FQ, Tan BJ. 1992. Efficacy of albendazole in treatment of clonorchiasis. Zhongguo Ji Sheng Chong Bing Fang Zhi Za Zhi 5:266. [Google Scholar]
- 269. Liu YH, Wang XG, Gao P, Qian MX. 1991. Experimental and clinical trial of albendazole in the treatment of clonorchiasis sinensis. Chin Med J (Engl) 104:27–31. [PubMed] [Google Scholar]
- 270. Pungpark S, Bunnag D, Harinasuta T. 1984. Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections. Southeast Asian J Trop Med Public Health 15:44–50. [PubMed] [Google Scholar]
- 271. Soukhathammavong PA, Sayasone S, Phongluxa K, Xayaseng V, Utzinger J, Vounatsou P, Hatz C, Akkhavong K, Keiser J, Odermatt P. 2012. Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR. PLoS Negl Trop Dis 6:e1417. doi: 10.1371/journal.pntd.0001417 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 272. Xu LL, Jiang B, Duan JH, Zhuang SF, Liu YC, Zhu SQ, Zhang LP, Zhang HB, Xiao SH, Zhou XN. 2014. Efficacy and safety of praziquantel, tribendimidine and mebendazole in patients with co-infection of Clonorchis sinensis and other helminths. PLoS Negl Trop Dis 8:e3046. doi: 10.1371/journal.pntd.0003046 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 273. Xiao SH, Utzinger J, Tanner M, Keiser J, Xue J. 2013. Advances with the Chinese anthelminthic drug tribendimidine in clinical trials and laboratory investigations. Acta Trop 126:115–126. doi: 10.1016/j.actatropica.2013.01.009 [DOI] [PubMed] [Google Scholar]
- 274. Yufen W, Xinru L, Jian X, Zhihua J, Yu C, Mingyong L, Haobing Z. 2022. Metabolome alterations in Clonorchis sinensis after treatment with tribendimidine and praziquante in vivo. Acta Trop 230:106330. doi: 10.1016/j.actatropica.2022.106330 [DOI] [PubMed] [Google Scholar]
- 275. Sayasone S, Keiser J, Meister I, Vonghachack Y, Xayavong S, Senggnam K, Phongluxa K, Hattendorf J, Odermatt P. 2018. Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial. Lancet Infect Dis 18:155–161. doi: 10.1016/S1473-3099(17)30624-2 [DOI] [PubMed] [Google Scholar]
- 276. Pakharukova MY, Samsonov VA, Serbina EA, Mordvinov VA. 2019. A study of tribendimidine effects in vitro and in vivo on the liver fluke Opisthorchis felineus. Parasit Vectors 12:23. doi: 10.1186/s13071-019-3288-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 277. Feng Q, Luo L, Xia SL, Zhang RH, Wu HD, Fan MG, Chen XH. 2006. Compare the efficacy of two antiparasitic drugs against clonorchiasis. Re Dai Yi Xue Za Zhi 6:1291–1292. [Google Scholar]
- 278. Rim HJ, Lyu KS, Lee JS, Joo KH. 1981. Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) against Clonorchis sinensis infection in man. Ann Trop Med Parasitol 75:27–33. doi: 10.1080/00034983.1981.11687405 [DOI] [PubMed] [Google Scholar]
- 279. Shen C, Choi MH, Bae YM, Yu G, Wang S, Hong ST. 2007. A case of anaphylactic reaction to praziquantel treatment. Am J Trop Med Hyg 76:603–605. [PubMed] [Google Scholar]
- 280. Lee JM, Lim HS, Hong ST. 2011. Hypersensitive reaction to praziquantel in a clonorchiasis patient. Korean J Parasitol 49:273–275. doi: 10.3347/kjp.2011.49.3.273 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 281. Hong ST, Rim HJ, Min DY, Li X, Xu J, Feng Z, Lee SH. 2001. Control of clonorchiasis by repeated treatments with praziquantel. Korean J Parasitol 39:285–292. doi: 10.3347/kjp.2001.39.4.285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 282. Yajima A, Cong DT, Trung DD, Cam TDT, Montresor A. 2009. Cost comparison of rapid questionnaire screening for individuals at risk of clonorchiasis in low- and high-prevalence communities in northern Vietnam. Trans R Soc Trop Med Hyg 103:447–451. doi: 10.1016/j.trstmh.2009.01.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 283. Kaewpitoon N, Kaewpitoon SJ, Meererksom T, Chan-Aran S, Sangwalee W, Kujapun J, Norkaew J, Chuatanam J, Ponpimai S, Pothipim M, Padchasuwan N, Tongtawee T, Matrakool L, Panpimanmas S, Loyd RA, Wakkhuwatthapong P. 2018. Detection of risk groups for carcinogenic liver fluke infection by verbal screening questionnaire using a mobile application. Asian Pac J Cancer Prev 19:2013–2019. doi: 10.22034/APJCP.2018.19.7.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 284. Qian MB, Jiang ZH, Ge T, Wang X, Zhou CH, Zhu HH, Zhou XN. 2020. Rapid screening of Clonorchis sinensis infection: performance of a method based on raw-freshwater fish-eating practice. Acta Trop 207:105380. doi: 10.1016/j.actatropica.2020.105380 [DOI] [PubMed] [Google Scholar]
- 285. Qian MB, Zhou CH, Zhu HH, Chen YD, Zhou XN. 2021. Cost yield of different treatment strategies against Clonorchis sinensis infection. Infect Dis Poverty 10:136. doi: 10.1186/s40249-021-00917-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 286. Choi M-H, Park SK, Li Z, Ji Z, Yu G, Feng Z, Xu L, Cho S-Y, Rim H-J, Lee S-H, Hong S-T. 2010. Effect of control strategies on prevalence, incidence and re-infection of clonorchiasis in endemic areas of China. PLoS Negl Trop Dis 4:e601. doi: 10.1371/journal.pntd.0000601 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 287. Chen YD, Li HZ, Xu LQ, Qian MB, Tian HC, Fang YY, Zhou CH, Ji Z, Feng ZJ, Tang M, Li Q, Wang Y, Bergquist R, Zhou XN. 2021. Effectiveness of a community-based integrated strategy to control soil-transmitted helminthiasis and clonorchiasis in the People’s Republic of China. Acta Trop 214:105650. doi: 10.1016/j.actatropica.2020.105650 [DOI] [PubMed] [Google Scholar]
- 288. On behalf of the CASCAP investigators, Khuntikeo N, Chamadol N, Yongvanit P, Loilome W, Namwat N, Sithithaworn P, Andrews RH, Petney TN, Promthet S, Thinkhamrop K, Tawarungruang C, Thinkhamrop B. 2015. Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer 15:459. doi: 10.1186/s12885-015-1475-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 289. Khuntikeo N, Loilome W, Thinkhamrop B, Chamadol N, Yongvanit P. 2016. A comprehensive public health conceptual framework and strategy to effectively combat cholangiocarcinoma in Thailand. PLoS Negl Trop Dis 10:e0004293. doi: 10.1371/journal.pntd.0004293 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 290. Khuntikeo N, Titapun A, Loilome W, Yongvanit P, Thinkhamrop B, Chamadol N, Boonmars T, Nethanomsak T, Andrews RH, Petney TN, Sithithaworn P. 2018. Current perspectives on opisthorchiasis control and cholangiocarcinoma detection in Southeast Asia. Front Med (Lausanne) 5:117. doi: 10.3389/fmed.2018.00117 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 291. Huang XH, Qian MB, Zhu GH, Fang YY, Hao YT, Lai YS. 2020. Assessment of control strategies against Clonorchis sinensis infection based on a multi-group dynamic transmission model. PLoS Negl Trop Dis 14:e0008152. doi: 10.1371/journal.pntd.0008152 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 292. Oh JK, Lim MK, Yun EH, Cho H, Park EY, Choi MH, Shin HR, Hong ST. 2014. Control of clonorchiasis in Korea: effectiveness of health education for community leaders and individuals in an endemic area. Trop Med Int Health 19:1096–1104. doi: 10.1111/tmi.12338 [DOI] [PubMed] [Google Scholar]
- 293. Songserm N, Namwong W, Woradet S, Sripa B, Ali A. 2021. Public health interventions for preventing re-infection of Opisthorchis viverrini: application of the self-efficacy theory and group process in high-prevalent areas of Thailand. Trop Med Int Health 26:962–972. doi: 10.1111/tmi.13598 [DOI] [PubMed] [Google Scholar]
- 294. Bukkhunthod P, Meererksom T, Pechdee P, Ponphimai S, Khiaowichit J, Kaewpitoon N, Thueng-In K, Leng M, Namhong T, Taweepakdeechot A, Yardcharoen N, Srithongklang W, Wakhuwathapong P, Keeratibharat N, Kaewpitoon SJ. 2020. Animation as supplementary learning material about carcinogenic liver fluke in classes for primary schoolchildren. J Cancer Educ 35:14–21. doi: 10.1007/s13187-018-1434-5 [DOI] [PubMed] [Google Scholar]
- 295. Laithavewat L, Grundy-Warr C, Khuntikeo N, Andrews RH, Petney TN, Yongvanit P, Banchonhattakit P, Sithithaworn P. 2020. Analysis of a school-based health education model to prevent opisthorchiasis and cholangiocarcinoma in primary school children in northeast Thailand. Glob Health Promot 27:15–23. doi: 10.1177/1757975918767622 [DOI] [PubMed] [Google Scholar]
- 296. Qian MB, Gan XQ, Zhao JG, Zheng WJ, Li W, Jiang ZH, Zhu TJ, Zhou XN. 2020. Effectiveness of health education in improving knowledge, practice and belief related to clonorchiasis in children. Acta Trop 207:105436. doi: 10.1016/j.actatropica.2020.105436 [DOI] [PubMed] [Google Scholar]
- 297. Nissen S, Nguyen LAT, Thamsborg SM, Dalsgaard A, Johansen MV. 2014. Reinfection of dogs with fish-borne zoonotic trematodes in northern Vietnam following a single treatment with praziquantel. PLoS Negl Trop Dis 8:e2625. doi: 10.1371/journal.pntd.0002625 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 298. Sereerak P, Upontain S, Tangkawattana P, Mallory FF, Sripa B, Tangkawattana S. 2017. Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis. Parasitol Int 66:448–452. doi: 10.1016/j.parint.2016.08.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 299. Khamboonruang C, Keawvichit R, Wongworapat K, Suwanrangsi S, Hongpromyart M, Sukhawat K, Tonguthai K, Lima dos Santos CA. 1997. Application of hazard analysis critical control point (HACCP) as a possible control measure for Opisthorchis viverrini infection in cultured carp (Puntius gonionotus). Southeast Asian J Trop Med Public Health 28 Suppl 1:65–72. [PubMed] [Google Scholar]
- 300. Clausen JH, Madsen H, Murrell KD, Bui TN, Nguyen NT, Do DT, Thi LAN, Manh HN, Dalsgaard A. 2013. The effectiveness of different intervention strategies for the prevention of zoonotic metacercariae infection in cultured fish. Aquaculture 416–417:135–140. doi: 10.1016/j.aquaculture.2013.09.006 [DOI] [Google Scholar]
- 301. Clausen JH, Madsen H, Van PT, Dalsgaard A, Murrell KD. 2015. Integrated parasite management: path to sustainable control of fishborne trematodes in aquaculture. Trends Parasitol 31:8–15. doi: 10.1016/j.pt.2014.10.005 [DOI] [PubMed] [Google Scholar]
- 302. Clausen JH, Madsen H, Murrell KD, Phan Thi V, Nguyen Manh H, Viet KN, Dalsgaard A. 2012. Relationship between snail population density and infection status of snails and fish with zoonotic trematodes in Vietnamese carp nurseries. PLoS Negl Trop Dis 6:e1945. doi: 10.1371/journal.pntd.0001945 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 303. Tesana S, Thapsripair P, Thammasiri C, Prasopdee S, Suwannatrai A, Harauy S, Piratae S, Khampoosa P, Kulsantiwong J, Donthaisong C, Chalokepanrat P, Viyanant V, Malone JB. 2012. Effects of bayluscide on Bithynia siamensis goniomphalos, the first intermediate host of the human liver fluke, Opisthorchis viverrini, in laboratory and field trials. Parasitol Int 61:52–55. doi: 10.1016/j.parint.2011.08.003 [DOI] [PubMed] [Google Scholar]
- 304. Sripa B, Tangkawattana S, Laha T, Kaewkes S, Mallory FF, Smith JF, Wilcox BA. 2015. Toward integrated opisthorchiasis control in northeast Thailand: the Lawa project. Acta Trop 141:361–367. doi: 10.1016/j.actatropica.2014.07.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 305. Huang Y, Huang D, Geng Y, Fang S, Yang F, Wu C, Zhang H, Wang M, Zhang R, Wang X, Wu S, Cao J, Zhang R. 2017. An integrated control strategy takes Clonorchis sinensis under control in an endemic area in south China. Vector Borne Zoonotic Dis 17:791–798. doi: 10.1089/vbz.2017.2133 [DOI] [PubMed] [Google Scholar]
- 306. Wang YC, Liew TZ, Namsanor J, Sithithaworn P. 2020. Assessing the role of Filopaludina martensi martensi as a biocontrol agent of Bithynia siamensis goniomphalos, the first intermediate host of Opisthorchis viverrini. Parasitol Res 119:3415–3431. doi: 10.1007/s00436-020-06837-7 [DOI] [PubMed] [Google Scholar]
- 307. Deng LJ. 1997. Experimental study on Radix auriclaria’s praying on Parafossarulus striatulus, first intermediate host of Clonorchis sinensis . Zhongguo Ren Shou Gong Huan Bing Za Zhi 13:47–48. [Google Scholar]
- 308. Hung NM, Duc NV, Stauffer JR Jr, Madsen H. 2013. Use of black carp (Mylopharyngodon piceus) in biological control of intermediate host snails of fish-borne zoonotic trematodes in nursery ponds in the Red River Delta, Vietnam. Parasit Vectors 6:142. doi: 10.1186/1756-3305-6-142 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 309. Zhang XH, Yuan DH, Li ZH, Zhu BX, Yang JZ, Guo YY, Pan LQ, Bian CZ, Yang JG. 1986. Short report on experimental observation in application of ducks ingesting Parafossarulus striatulus. Henan Wei Sheng Fang Yi:128–129. [Google Scholar]
- 310. Quan FS, Lee HJ, Chung MS, Lee JS, Rim HJ, Joo KH. 2000. Chemotherapeutic efficacy of praziquantel in rats with protective immunity to Clonorchis sinensis infection. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 18:98–102. [PubMed] [Google Scholar]
- 311. Quan FS, Lee JB, Bae JS, Ohwatari N, Min YK, Yang HM. 2005. Resistance to reinfection in rats induced by irradiated metacercariae of Clonorchis sinensis. Mem Inst Oswaldo Cruz 100:549–554. doi: 10.1590/s0074-02762005000500016 [DOI] [PubMed] [Google Scholar]
- 312. Lee JS, Kim IS, Sohn WM, Lee J, Yong TS. 2006. Vaccination with DNA encoding cysteine proteinase confers protective immune response to rats infected with Clonorchis sinensis. Vaccine 24:2358–2366. doi: 10.1016/j.vaccine.2005.11.062 [DOI] [PubMed] [Google Scholar]
- 313. Lee JS, Kim IS, Sohn WM, Lee J, Yong TS. 2006. A DNA vaccine encoding a fatty acid-binding protein of Clonorchis sinensis induces protective immune response in Sprague-Dawley rats. Scand J Immunol 63:169–176. doi: 10.1111/j.1365-3083.2006.01721.x [DOI] [PubMed] [Google Scholar]
- 314. Zhou Z, Xia H, Hu X, Huang Y, Li Y, Li L, Ma C, Chen X, Hu F, Xu J, Lu F, Wu Z, Yu X. 2008. Oral administration of a Bacillus subtilis spore-based vaccine expressing Clonorchis sinensis tegumental protein 22.3 kDa confers protection against Clonorchis sinensis. Vaccine 26:1817–1825. doi: 10.1016/j.vaccine.2008.02.015 [DOI] [PubMed] [Google Scholar]
- 315. Lee DH, Kim AR, Lee SH, Quan FS. 2017. Virus-like particles vaccine containing Clonorchis sinensis tegumental protein induces partial protection against Clonorchis sinensis infection. Parasit Vectors 10:626. doi: 10.1186/s13071-017-2526-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 316. Xie HY, Hu XC, Xu J, Yu XB. 2010. Protective immunity of Cs-Rho GTPase recombinant protein against Clonorchis sinensis infection. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 28:176–179. [PubMed] [Google Scholar]
- 317. Wang X, Chen W, Li X, Zhou C, Deng C, Lv X, Fan Y, Men J, Liang C, Yu X. 2012. Identification and molecular characterization of a novel signaling molecule 14-3-3 epsilon in Clonorchis sinensis excretory/secretory products. Parasitol Res 110:1411–1420. doi: 10.1007/s00436-011-2642-7 [DOI] [PubMed] [Google Scholar]
- 318. Wang X, Chen W, Lv X, Tian Y, Men J, Zhang X, Lei H, Zhou C, Lu F, Liang C, Hu X, Xu J, Wu Z, Li X, Yu X. 2012. Identification and characterization of paramyosin from cyst wall of metacercariae implicated protective efficacy against Clonorchis sinensis infection. PLoS One 7:e33703. doi: 10.1371/journal.pone.0033703 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 319. Sun H, Lin Z, Zhao L, Chen T, Shang M, Jiang H, Tang Z, Zhou X, Shi M, Zhou L, Ren P, Qu H, Lin J, Li X, Xu J, Huang Y, Yu X. 2018. Bacillus subtilis spore with surface display of paramyosin from Clonorchis sinensis potentializes a promising oral vaccine candidate. Parasit Vectors 11:156. doi: 10.1186/s13071-018-2757-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 320. Wang X, Chen W, Tian Y, Mao Q, Lv X, Shang M, Li X, Yu X, Huang Y. 2014. Surface display of Clonorchis sinensis enolase on Bacillus subtilis spores potentializes an oral vaccine candidate. Vaccine 32:1338–1345. doi: 10.1016/j.vaccine.2014.01.039 [DOI] [PubMed] [Google Scholar]
- 321. Chen W, Wang X, Lv X, Tian Y, Xu Y, Mao Q, Shang M, Li X, Huang Y, Yu X. 2014. Characterization of the secreted cathepsin B cysteine proteases family of the carcinogenic liver fluke Clonorchis sinensis. Parasitol Res 113:3409–3418. doi: 10.1007/s00436-014-4006-6 [DOI] [PubMed] [Google Scholar]
- 322. Bai X, Song JH, Dai F, Lee JY, Hong SJ. 2020. Clonorchis sinensis secretory protein CsAg17 vaccine induces immune protection. Parasit Vectors 13:215. doi: 10.1186/s13071-020-04083-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 323. Chaiyadet S, Sotillo J, Krueajampa W, Thongsen S, Brindley PJ, Sripa B, Loukas A, Laha T. 2019. Vaccination of hamsters with Opisthorchis viverrini extracellular vesicles and vesicle-derived recombinant tetraspanins induces antibodies that block vesicle uptake by cholangiocytes and reduce parasite burden after challenge infection. PLoS Negl Trop Dis 13:e0007450. doi: 10.1371/journal.pntd.0007450 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 324. Phung LT, Chaiyadet S, Hongsrichan N, Sotillo J, Dieu HDT, Tran CQ, Brindley PJ, Loukas A, Laha T. 2019. Recombinant Opisthorchis viverrini tetraspanin expressed in Pichia pastoris as a potential vaccine candidate for opisthorchiasis. Parasitol Res 118:3419–3427. doi: 10.1007/s00436-019-06488-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 325. Phumrattanaprapin W, Chaiyadet S, Brindley PJ, Pearson M, Smout MJ, Loukas A, Laha T. 2021. Orally administered Bacillus spores expressing an extracellular vesicle-derived tetraspanin protect hamsters against challenge infection with carcinogenic human liver fluke. J Infect Dis 223:1445–1455. doi: 10.1093/infdis/jiaa516 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 326. Thi Phung L, Chaiyadet S, Hongsrichan N, Sotillo J, Dinh Thi Dieu H, Quang Tran C, Brindley PJ, Loukas A, Laha T. 2020. Partial protection with a chimeric tetraspanin-leucine aminopeptidase subunit vaccine against Opisthorchis viverrini infection in hamsters. Acta Trop 204:105355. doi: 10.1016/j.actatropica.2020.105355 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 327. Jiang H, Chen T, Sun H, Tang Z, Yu J, Lin Z, Ren P, Zhou X, Huang Y, Li X, Yu X. 2017. Immune response induced by oral delivery of Bacillus subtilis spores expressing enolase of Clonorchis sinensis in grass carps (Ctenopharyngodon idellus). Fish Shellfish Immunol 60:318–325. doi: 10.1016/j.fsi.2016.10.011 [DOI] [PubMed] [Google Scholar]
- 328. Tang Z, Sun H, Chen T, Lin Z, Jiang H, Zhou X, Shi C, Pan H, Chang O, Ren P, Yu J, Li X, Xu J, Huang Y, Yu X. 2017. Oral delivery of Bacillus subtilis spores expressing cysteine protease of Clonorchis sinensis to grass carp (Ctenopharyngodon idellus): induces immune responses and has no damage on liver and intestine function. Fish Shellfish Immunol 64:287–296. doi: 10.1016/j.fsi.2017.03.030 [DOI] [PubMed] [Google Scholar]
- 329. Sun H, Shang M, Tang Z, Jiang H, Dong H, Zhou X, Lin Z, Shi C, Ren P, Zhao L, Shi M, Zhou L, Pan H, Chang O, Li X, Huang Y, Yu X. 2020. Oral delivery of Bacillus subtilis spores expressing Clonorchis sinensis paramyosin protects grass carp from cercaria infection. Appl Microbiol Biotechnol 104:1633–1646. doi: 10.1007/s00253-019-10316-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 330. Norbury LJ, Shirakashi S, Power C, Nowak BF, Bott NJ. 2022. Praziquantel use in aquaculture - current status and emerging issues. Int J Parasitol Drugs Drug Resist 18:87–102. doi: 10.1016/j.ijpddr.2022.02.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 331. Prasopdee S, Thitapakorn V, Sathavornmanee T, Tesana S. 2019. A comprehensive review of omics and host-parasite interplays studies, towards control of Opisthorchis viverrini infection for prevention of cholangiocarcinoma. Acta Trop 196:76–82. doi: 10.1016/j.actatropica.2019.05.011 [DOI] [PubMed] [Google Scholar]
- 332. Mordvinov VA, Ershov NI, Zaparina OG, Pakharukova MY. 2020. Genomics and proteomics of the liver fluke Opisthorchis felineus. Vavilovskii Zhurnal Genet Selektsii 24:383–390. doi: 10.18699/VJ20.44-o [DOI] [PMC free article] [PubMed] [Google Scholar]
- 333. Wang X, Chen W, Huang Y, Sun J, Men J, Liu H, Luo F, Guo L, Lv X, Deng C, Zhou C, Fan Y, Li X, Huang L, Hu Y, Liang C, Hu X, Xu J, Yu X. 2011. The draft genome of the carcinogenic human liver fluke Clonorchis sinensis. Genome Biol 12:R107. doi: 10.1186/gb-2011-12-10-r107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 334. Young ND, Nagarajan N, Lin SJ, Korhonen PK, Jex AR, Hall RS, Safavi-Hemami H, Kaewkong W, Bertrand D, Gao S, Seet Q, Wongkham S, Teh BT, Wongkham C, Intapan PM, Maleewong W, Yang X, Hu M, Wang Z, Hofmann A, Sternberg PW, Tan P, Wang J, Gasser RB. 2014. The Opisthorchis viverrini genome provides insights into life in the bile duct. Nat Commun 5:4378. doi: 10.1038/ncomms5378 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 335. Ershov NI, Mordvinov VA, Prokhortchouk EB, Pakharukova MY, Gunbin KV, Ustyantsev K, Genaev MA, Blinov AG, Mazur A, Boulygina E, Tsygankova S, Khrameeva E, Chekanov N, Fan G, Xiao A, Zhang H, Xu X, Yang H, Solovyev V, Lee SM-Y, Liu X, Afonnikov DA, Skryabin KG. 2019. New insights from Opisthorchis felineus genome: update on genomics of the epidemiologically important liver flukes. BMC Genomics 20:399. doi: 10.1186/s12864-019-5752-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 336. Young ND, Stroehlein AJ, Kinkar L, Wang T, Sohn WM, Chang BCH, Kaur P, Weisz D, Dudchenko O, Aiden EL, Korhonen PK, Gasser RB. 2021. High-quality reference genome for Clonorchis sinensis . Genomics 113:1605–1615. doi: 10.1016/j.ygeno.2021.03.001 [DOI] [PubMed] [Google Scholar]
- 337. Kinkar L, Korhonen PK, Saarma U, Wang T, Zhu XQ, Harliwong I, Yang B, Fink JL, Wang D, Chang BCH, Chelomina GN, Koehler AV, Young ND, Gasser RB. 2023. Genome-wide exploration reveals distinctive northern and southern variants of Clonorchis sinensis in the Far East. Mol Ecol Resour 23:833–843. doi: 10.1111/1755-0998.13760 [DOI] [PubMed] [Google Scholar]
- 338. Young ND, Campbell BE, Hall RS, Jex AR, Cantacessi C, Laha T, Sohn WM, Sripa B, Loukas A, Brindley PJ, Gasser RB. 2010. Unlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverrini. PLoS Negl Trop Dis 4:e719. doi: 10.1371/journal.pntd.0000719 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 339. Jex AR, Young ND, Sripa J, Hall RS, Scheerlinck J-P, Laha T, Sripa B, Gasser RB. 2012. Molecular changes in Opisthorchis viverrini (Southeast Asian liver fluke) during the transition from the juvenile to the adult stage. PLoS Negl Trop Dis 6:e1916. doi: 10.1371/journal.pntd.0001916 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 340. Pomaznoy MY, Logacheva MD, Young ND, Penin AA, Ershov NI, Katokhin AV, Mordvinov VA. 2016. Whole transcriptome profiling of adult and infective stages of the trematode Opisthorchis felineus. Parasitol Int 65:12–19. doi: 10.1016/j.parint.2015.09.002 [DOI] [PubMed] [Google Scholar]
- 341. Huang Y, Chen W, Wang X, Liu H, Chen Y, Guo L, Luo F, Sun J, Mao Q, Liang P, Xie Z, Zhou C, Tian Y, Lv X, Huang L, Zhou J, Hu Y, Li R, Zhang F, Lei H, Li W, Hu X, Liang C, Xu J, Li X, Yu X. 2013. The carcinogenic liver fluke, Clonorchis sinensis: new assembly, reannotation and analysis of the genome and characterization of tissue transcriptomes. PLoS One 8:e54732. doi: 10.1371/journal.pone.0054732 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 342. Mulvenna J, Sripa B, Brindley PJ, Gorman J, Jones MK, Colgrave ML, Jones A, Nawaratna S, Laha T, Suttiprapa S, Smout MJ, Loukas A. 2010. The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini. Proteomics 10:1063–1078. doi: 10.1002/pmic.200900393 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 343. Shi Y, Yu K, Liang A, Huang Y, Ou F, Wei H, Wan X, Yang Y, Zhang W, Jiang Z. 2020. Identification and analysis of the tegument protein and excretory-secretory products of the carcinogenic liver fluke Clonorchis sinensis. Front Microbiol 11:555730. doi: 10.3389/fmicb.2020.555730 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 344. Intuyod K, Armartmuntree N, Jusakul A, Sakonsinsiri C, Thanan R, Pinlaor S. 2019. Current omics-based biomarkers for cholangiocarcinoma. Expert Rev Mol Diagn 19:997–1005. doi: 10.1080/14737159.2019.1673162 [DOI] [PubMed] [Google Scholar]
- 345. Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, McPherson JR, Allen GE, Ng CCY, Wong BH, Myint SS, Rajasegaran V, Heng HL, Gan A, Zang ZJ, Wu Y, Wu J, Lee MH, Huang D, Ong P, Chan-on W, Cao Y, Qian C-N, Lim KH, Ooi A, Dykema K, Furge K, Kukongviriyapan V, Sripa B, Wongkham C, Yongvanit P, Futreal PA, Bhudhisawasdi V, Rozen S, Tan P, Teh BT. 2012. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet 44:690–693. doi: 10.1038/ng.2273 [DOI] [PubMed] [Google Scholar]
- 346. Chan-on W, Nairismägi M-L, Ong CK, Lim WK, Dima S, Pairojkul C, Lim KH, McPherson JR, Cutcutache I, Heng HL, Ooi L, Chung A, Chow P, Cheow PC, Lee SY, Choo SP, Tan IBH, Duda D, Nastase A, Myint SS, Wong BH, Gan A, Rajasegaran V, Ng CCY, Nagarajan S, Jusakul A, Zhang S, Vohra P, Yu W, Huang D, Sithithaworn P, Yongvanit P, Wongkham S, Khuntikeo N, Bhudhisawasdi V, Popescu I, Rozen SG, Tan P, Teh BT. 2013. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet 45:1474–1478. doi: 10.1038/ng.2806 [DOI] [PubMed] [Google Scholar]
- 347. Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, Nellore V, Kongpetch S, Ng AWT, Ng LM, Choo SP, Myint SS, Thanan R, Nagarajan S, Lim WK, Ng CCY, Boot A, Liu M, Ong CK, Rajasegaran V, Lie S, Lim AST, Lim TH, Tan J, Loh JL, McPherson JR, Khuntikeo N, Bhudhisawasdi V, Yongvanit P, Wongkham S, Totoki Y, Nakamura H, Arai Y, Yamasaki S, Chow PK-H, Chung AYF, Ooi LLPJ, Lim KH, Dima S, Duda DG, Popescu I, Broet P, Hsieh S-Y, Yu M-C, Scarpa A, Lai J, Luo D-X, Carvalho AL, Vettore AL, Rhee H, Park YN, Alexandrov LB, Gordân R, Rozen SG, Shibata T, Pairojkul C, Teh BT, Tan P. 2017. Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. Cancer Discov 7:1116–1135. doi: 10.1158/2159-8290.CD-17-0368 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 348. Jinawath N, Chamgramol Y, Furukawa Y, Obama K, Tsunoda T, Sripa B, Pairojkul C, Nakamura Y. 2006. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma. Hepatology 44:1025–1038. doi: 10.1002/hep.21330 [DOI] [PubMed] [Google Scholar]
- 349. Haonon O, Rucksaken R, Pinlaor P, Pairojkul C, Chamgramol Y, Intuyod K, Onsurathum S, Khuntikeo N, Pinlaor S. 2016. Upregulation of 14-3-3 eta in chronic liver fluke infection is a potential diagnostic marker of cholangiocarcinoma. Proteomics Clin Appl 10:248–256. doi: 10.1002/prca.201500019 [DOI] [PubMed] [Google Scholar]
- 350. Rucksaken R, Charoensuk L, Pinlaor P, Pairojkul C, Khuntikeo N, Pinlaor S. 2017. Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma. Cancer Biomark 18:27–34. doi: 10.3233/CBM-160670 [DOI] [PubMed] [Google Scholar]
- 351. Khoontawad J, Hongsrichan N, Chamgramol Y, Pinlaor P, Wongkham C, Yongvanit P, Pairojkul C, Khuntikeo N, Roytrakul S, Boonmars T, Pinlaor S. 2014. Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma. Tumour Biol 35:1029–1039. doi: 10.1007/s13277-013-1137-9 [DOI] [PubMed] [Google Scholar]
- 352. Cantacessi C, Prasopdee S, Sotillo J, Mulvenna J, Tesana S, Loukas A. 2013. Coming out of the shell: building the molecular infrastructure for research on parasite-harbouring snails. PLoS Negl Trop Dis 7:e2284. doi: 10.1371/journal.pntd.0002284 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 353. Prasopdee S, Sotillo J, Tesana S, Laha T, Kulsantiwong J, Nolan MJ, Loukas A, Cantacessi C. 2014. RNA-Seq reveals infection-induced gene expression changes in the snail intermediate host of the carcinogenic liver fluke, Opisthorchis viverrini. PLoS Negl Trop Dis 8:e2765. doi: 10.1371/journal.pntd.0002765 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 354. Prasopdee S, Tesana S, Cantacessi C, Laha T, Mulvenna J, Grams R, Loukas A, Sotillo J. 2015. Proteomic profile of Bithynia siamensis goniomphalos snails upon infection with the carcinogenic liver fluke Opisthorchis viverrini. J Proteomics 113:281–291. doi: 10.1016/j.jprot.2014.09.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 355. Suwannatrai K, Suwannatrai A, Tabsripair P, Welbat JU, Tangkawattana S, Cantacessi C, Mulvenna J, Tesana S, Loukas A, Sotillo J. 2016. Differential protein expression in the hemolymph of Bithynia siamensis goniomphalos infected with Opisthorchis viverrini. PLoS Negl Trop Dis 10:e0005104. doi: 10.1371/journal.pntd.0005104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 356. Sripa B, Echaubard P. 2017. Prospects and challenges towards sustainable liver fluke control. Trends Parasitol 33:799–812. doi: 10.1016/j.pt.2017.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 357. Qian MB, Zhou XN. 2019. Human liver flukes in China and ASEAN: time to fight together. PLoS Negl Trop Dis 13:e0007214. doi: 10.1371/journal.pntd.0007214 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 358. Crellen T, Sithithaworn P, Pitaksakulrat O, Khuntikeo N, Medley GF, Hollingsworth TD. 2021. Towards evidence-based control of Opisthorchis viverrini. Trends Parasitol 37:370–380. doi: 10.1016/j.pt.2020.12.007 [DOI] [PubMed] [Google Scholar]
- 359. Sota P, Suttiprapa S, Tangkawattana S, Sripa M, Blair D, Sripa B. 2022. Does Opisthorchis viverrini circulate between humans and domestic cats in an endemic area in Thailand? Parasitology 149:1334–1338. doi: 10.1017/S0031182022000646 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 360. Hashizume H, Sato M, Sato MO, Ikeda S, Yoonuan T, Sanguankiat S, Pongvongsa T, Moji K, Minamoto T. 2017. Application of environmental DNA analysis for the detection of Opisthorchis viverrini DNA in water samples. Acta Trop 169:1–7. doi: 10.1016/j.actatropica.2017.01.008 [DOI] [PubMed] [Google Scholar]
- 361. Zinsstag J, Kaiser-Grolimund A, Heitz-Tokpa K, Sreedharan R, Lubroth J, Caya F, Stone M, Brown H, Bonfoh B, Dobell E, Morgan D, Homaira N, Kock R, Hattendorf J, Crump L, Mauti S, Del Rio Vilas V, Saikat S, Zumla A, Heymann D, Dar O, de la Rocque S. 2023. Advancing One human-animal-environment Health for global health security: what does the evidence say? Lancet 401:591–604. doi: 10.1016/S0140-6736(22)01595-1 [DOI] [PubMed] [Google Scholar]
- 362. He YT, Huang XH, Fang YY, Zeng QS, Li LD, Luo L, Lai YS. 2022. Cost-effectiveness evaluation of different control strategies for Clonorchis sinensis infection in a high endemic area of China: a modelling study. PLoS Negl Trop Dis 16:e0010429. doi: 10.1371/journal.pntd.0010429 [DOI] [PMC free article] [PubMed] [Google Scholar]



